Supporting Information 3: 1619 articles exclusion:
1.
Dao TL, Nemoto T. An evaluation of adrenalectomy and androgen in disseminated mammary
carcinoma. Surgery, gynecology & obstetrics. 1965;121:1257-1262.
2.
Malignant hepatoma--controlled therapeutic trials. South African primary liver cancer
research group. Initial report. South African medical journal = Suid-Afrikaanse tydskrif vir
geneeskunde. 1967;41:309-314.
3.
Nevinny HB, Hall TC. Chemotherapy with hydroxyurea (NSC-32065) in renal cell
carcinoma. The Journal of clinical pharmacology and the journal of new drugs. 1968;8:352-359.
4.
Anichkova SI, Datiashvili DS, Filov VA. [Determination of ammonia in the blood for the
purpose of diagnosing metastases to the liver]. Voprosy onkologii. 1969;15:100-101.
5.
Boyd CM, Lieberman LM, Beierwaltes WH, Varma VM. Diagnostic efficacy of a
radioiodinated chloroquine analog in patients with malignant melanoma. Journal of nuclear
medicine : official publication, Society of Nuclear Medicine. 1970;11:479-486.
6.
Gailani S, Blais M. Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl
cyclohexanecarbamate (NSC-112682). Cancer chemotherapy reports. Part 1. 1970;54:187-190.
7.
Drum DE, Christacopoulos JS. Hepatic scintigraphy in clinical decision making. Journal of
nuclear medicine : official publication, Society of Nuclear Medicine. 1972;13:908-915.
8.
Buyze EA, Nelemans FA. A study of postoperative cytostatic medication in patients with
operable carcinoma of the lung. Arzneimittel-Forschung. 1973;23:860-862.
9.
Gordan GS, Halden A, Horn Y, Fuery JJ, Parsons RJ, Walter RM. Calusterone
(7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer.
Oncology. 1973;28:138-146.
10. Roberts MM, Blumgart LH, Davies M, et al. Simple versus radical mastectomy. Preliminary
report of the Cardiff breast trial. Lancet. 1973;1:1073-1076.
11. Tormey DC, Bergevin P, Blom J, Petty W. Preliminary trials with a combination of
adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies. Cancer
chemotherapy reports. Part 1. 1973;57:413-418.
12. Falkson G, van Dyk JJ, van Eden EB, van der Merwe AM, Falkson HC. Calusterone
(NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced
breast cancer. Cancer chemotherapy reports. Part 1. 1974;58:939-941.
13. Lessner HE, Vogler WR. Toxicity study of BCNU (NSC-409962) given orally. Cancer
chemotherapy reports. Part 1. 1974;58:407-411.
14. Stoliar B, Albert DJ. SCH 13521 in the treatment of advanced carcinoma of the prostate. The
Journal of urology. 1974;111:803-807.
15. Vogler WR, Arkun S, Velez-Garcia E. Phase I study of twice weekly 5-azacytidine
(NSC-102816). Cancer chemotherapy reports. Part 1. 1974;58:895-899.
16. Young RC, Canellos GP, Chabner BA, Schein PS, Brereton HD, DeVita VT. Treatment of
malignant
melanoma
with
methyl
CCNU.
Clinical
pharmacology
and
therapeutics.
1974;15:617-622.
17. de Palo GM, de Lena M, Di Re F, Luciani L, Valagussa P, Bonadonna G. Melphalan versus
adriamycin in the treatment of advanced carcinoma of the ovary. Surgery, gynecology & obstetrics.
1975;141:899-902.
18. Fortuny IE, Theologides A, Kennedy BJ. Hepatic arterial infusion for liver metastases from
colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893). Cancer
chemotherapy reports. Part 1. 1975;59:401-404.
19. Gallmeier WM, Bruntsch U, Schmidt CG. [Chemotherapy of metastasizing breast cancers.
Indications and results]. Deutsche medizinische Wochenschrift (1946). 1975;100:35-41.
20. Hahn RG, Moertel CG, Schutt AJ, Bruckner HW. A double-blind comparison of intensive
course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinoma.
Cancer. 1975;35:1031-1035.
21. Buroker T, Samson M, Correa J, Fraile R, Vaitkevicius VK. Hepatic artery infusion of
5-FUDR after prior systemic 5-fluorouracil. Cancer treatment reports. 1976;60:1277-1279.
22. Canellos GP, Pocock SJ, Taylor SG, 3rd, Sears ME, Klaasen DJ, Band PR. Combination
chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy
with L-phenylalanine mustard. Cancer. 1976;38:1882-1886.
23. Lerner HJ, Band PR, Israel L, Leung BS. Phase II study of tamoxifen: report of 74 patients
with stage IV breast cancer. Cancer treatment reports. 1976;60:1431-1435.
24. McCartney WH, Hoffer PB. Carcinoembryonic antigen assay in hepatic metastases detection.
An adjunct to liver scanning. JAMA : the journal of the American Medical Association.
1976;236:1023-1027.
25. Newlands ES, Oon CJ, Roberts JT, et al. Clinical trial of combination chemotherapy and
specific active immunotherapy in disseminated melanoma. British journal of cancer.
1976;34:174-179.
26. Ong GB, Chan PK. Primary carcinoma of the liver. Surgery, gynecology & obstetrics.
1976;143:31-38.
27. Schmidt JD, Gibbons RP, Johnson DE, Prout GR, Scott WW, Murphy GP. Chemotherapy of
advanced prostatic cancer. Evaluation of response parameters. Urology. 1976;7:602-610.
28. Costanza ME, Nathanson L, Schoenfeld D, et al. Results with methyl-CCNU and DTIC in
metastatic melanoma. Cancer. 1977;40:1010-1015.
29. Heal JM, Schein PS. Management of gastrointestinal cancer. The Medical clinics of North
America. 1977;61:991-999.
30. Massidda B, Mascia V, Broccia G, et al. [Hormonal therapy with androgenic steroids in
diffuse malignant neoplasms of the breast]. Minerva medica. 1977;68:235-241.
31. Shukla HS, Hughes LE, Davis PW, Whitehead RH, Leach KG. Distribution of 5-fluorouracil
to body tissues compared after intraluminal, intravenous, and intramural administration in
gastrointestinal cancer. American journal of surgery. 1977;133:346-350.
32. Taylor I, Brooman P, Rowling JT. Adjuvant liver perfusion in colorectal cancer: initial results
of a clinical trial. British medical journal. 1977;2:1320-1322.
33. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the
treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for
Breast Cancer. Cancer. 1978;41:758-760.
34. Edsmyr F, Esposti PL, Johansson B, Strindberg B. Clinical experimental randomized study of
2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of
prostatic carcinoma. The Journal of urology. 1978;120:705-707.
35. George SL, Hoogstraten B. Prognostic factors in the initial response to therapy by patients
with advanced breast cancer. Journal of the National Cancer Institute. 1978;60:731-736.
36. Hoth D, Woolley P, Green D, Macdonald J, Schein P. Phase I studies on chlorozotocin.
Clinical pharmacology and therapeutics. 1978;23:712-722.
37. McCartney WH, Hoffer PB. Carcinoembryonic antigen assay: an adjunct to liver scanning in
hepatic metastases detection. Cancer. 1978;42:1457-1462.
38. Taylor I. Cytotoxic perfusion for colorectal liver metastases. The British journal of surgery.
1978;65:109-114.
39. Chlebowski RT, Paroly WS, Pugh RP, Weiner JM, Bateman JR. Treatment of advanced
gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery. Cancer
treatment reports. 1979;63:1979-1981.
40. Gall FP, Muhe E, Angermann B. [Surgical treatment of pulmonary metastases (author's
transl)]. Deutsche medizinische Wochenschrift (1946). 1979;104:835-837.
41. Grage TB, Vassilopoulos PP, Shingleton WW, et al. Results of a prospective randomized
study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients
with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery.
1979;86:550-555.
42. Gregor A, Morgan PG, Morgan RL, Scadding FH, Turner-Warwick M. Small cell carcinoma:
combined approach to treatment. Thorax. 1979;34:789-793.
43. Taylor I, Rowling J, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. The
British journal of surgery. 1979;66:833-837.
44. Cummings FJ, Gelman R, Tormey DC, DeWys W, Glick J. Adriamycin plus vincristine alone
or with dibromodulcitol or ICRF-159 in metastatic breast cancer. Cancer clinical trials.
1981;4:253-260.
45. Gehan EA, Nesbit ME, Jr., Burgert EO, Jr., et al. Prognostic factors in children with Ewing's
sarcoma. National Cancer Institute monograph. 1981:273-278.
46. Jacquillat C, Auclerc G, Auclerc MF, Weil M, Bassot V, Debonniere C. [Combined
chemotherapy and radiation therapy in breast cancer: a retrospective study of 406 patients
(author's transl)]. Bulletin du cancer. 1981;68:166-170.
47. Lininger TR, Fleming TR, Eagan RT. Evaluation of alternating chemotherapy and sites and
extent of disease in extensive small cell lung cancer. Cancer. 1981;48:2147-2153.
48. Ruge-Anderson S, Burcharth F, Miskowiak J, Steen J. Urea--treatment of liver metastases.
Clinical oncology. 1981;7:69-71.
49. Staquet M, Rozencweig M, Lee YJ, Muggia FM. Methodology for the assessment of new
dichotomous diagnostic tests. Journal of chronic diseases. 1981;34:599-610.
50. Castro JR, Saunders WM, Quivey JM, et al. Clinical problems in radiotherapy of carcinoma
of the pancreas. American journal of clinical oncology. 1982;5:579-587.
51. Coombes RC, Chilvers C, Dowsett M, et al. Adjuvant aminoglutethimide therapy for
postmenopausal patients with primary breast cancer: progress report. Cancer research.
1982;42:3415s-3419s.
52. Dillman RO, Taetle R, Seagren S, Royston I, Koziol J, Mendelsohn J. Extensive disease
small cell carcinoma of the lung: trial of non-cross resistant chemotherapy and consolidation
radiotherapy. Cancer. 1982;49:2003-2008.
53. Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS. Incidence and detection of occult
hepatic metastases in colorectal carcinoma. British medical journal (Clinical research ed.).
1982;284:803-805.
54. Javadpour N, Ozols RF, Anderson T, Barlock AB, Wesley R, Young RC. A randomized trial
of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage
testicular cancer with poor prognostic features. Cancer. 1982;50:2004-2010.
55. Lavin PT, Bruckner HW, Plaxe SC. Studies in prognostic factors relating to chemotherapy for
advanced gastric cancer. Cancer. 1982;50:2016-2023.
56. Rudolf Z, Plesnicar S. Chemotherapy of disseminated malignant melanoma with imidazol
carboxamide (DTIC) and cyclophosphamide. Preliminary results. Anticancer research.
1982;2:37-39.
57. Sears HF, Atkinson B, Mattis J, et al. Phase-I clinical trial of monoclonal antibody in
treatment of gastrointestinal tumours. Lancet. 1982;1:762-765.
58. Wagstaff J, Phadke K, Adam N, Thatcher N, Crowther D. The "hot spleen" phenomenon in
metastatic malignant melanoma: its incidence and relationship with the immune system. Cancer.
1982;49:439-444.
59. Wassif SB. The role of pre-operative adjuvant therapy in the management of borderline
operability rectal cancer. Clinical radiology. 1982;33:353-358.
60. Balch CM, Urist MM, Soong SJ, McGregor M. A prospective phase II clinical trial of
continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally
implantable drug infusion pump. Annals of surgery. 1983;198:567-573.
61. Bedikian AY, Stroehlein J, Korinek J, Karlin D, Bodey GP. A comparative study of oral
tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancer. American
journal of clinical oncology. 1983;6:181-186.
62. Bruckner HW, Lavin P, Plaxe S, Storch JA, Livstone E. Routine clinical chemistries as
improved determinates of prognosis for patients with metastatic cancer of the stomach. Oncology.
1983;40:31-35.
63. Chlebowski RT, Pugh R, Weiner JM, Block JB, Bateman JR. Doxorubicin and CCNU with or
without vincristine in patients with advanced refractory breast cancer. A randomized trial. Cancer.
1983;52:606-609.
64. Kemeny N. The systemic chemotherapy of hepatic metastases. Seminars in oncology.
1983;10:148-158.
65. Mann BD, Storm FK, Morton DL, et al. Predictability of response to clinical
thermochemotherapy by the clonogenic assay. Cancer. 1983;52:1389-1394.
66. Melia WM, Johnson PJ, Williams R. Induction of remission in hepatocellular carcinoma. A
comparison of VP 16 with adriamycin. Cancer. 1983;51:206-210.
67. Ochiai T, Sato H, Hayashi R, Asano T, Sato H, Yamamura Y. Postoperative adjuvant
immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a
randomized clinical trial. Cancer immunology, immunotherapy : CII. 1983;14:167-171.
68. Powles TJ. The role of aromatase inhibitors in breast cancer. Seminars in oncology.
1983;10:20-24.
69. Roszkowski K, Nozdryn-Plotnicki B, Roszkowski W, Ko HL, Pulverer G, Jeljaszewicz J.
Immunochemotherapy of breast cancer with Propionibacterium granulosum. Cancer immunology,
immunotherapy : CII. 1983;15:23-26.
70. Smalley RV, Bartolucci AA, Moore M, et al. Southeastern Cancer Study Group: breast cancer
studies
1972-1982.
International
journal
of
radiation
oncology,
biology,
physics.
1983;9:1867-1874.
71. Weltz MD, Perry DJ, Blom J, Butler WM. Methyl-CCNU, 5-fluorouracil, vincristine, and
streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 1983;1:135-137.
72. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a
randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in
combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization
on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer.
1984;53:1811-1818.
73. Daly JM, Kemeny N, Oderman P, Botet J. Long-term hepatic arterial infusion chemotherapy.
Anatomic considerations, operative technique, and treatment morbidity. Archives of surgery
(Chicago, Ill. : 1960). 1984;119:936-941.
74. Jones B, Breslow NE, Takashima J. Toxic deaths in the Second National Wilms' Tumor Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1984;2:1028-1033.
75. Kolaric K, Roth A, Vukas D, Cervek J. CAP (cyclophosphamide, adriamycin, platinum) vs
CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination
chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical
study. Cancer chemotherapy and pharmacology. 1984;13:142-144.
76. Murphy GP. Workshop on response criteria and evaluation of the stable disease category in
carcinoma of the prostate, breast, and large bowel. Oncology. 1984;41:64-67.
77. Queisser W, Schnitzler G, Heim ME, et al. [Prospective randomized study in advanced
stomach cancer. Comparison between combinations of 5-fluorouracil and carmustine without and
with adriamycin]. Deutsche medizinische Wochenschrift (1946). 1984;109:976-980.
78. Taylor RH, Gilbert JM, Evans MG, Lane HG, Cassell PG. Prospective serial liver ultrasound
scanning in resectable colorectal cancer treated with adjuvant razoxane. Clinical & experimental
metastasis. 1984;2:321-331.
79. Elias D, Lasser P, Rougier P, Piot G, Droz JP. [Intermittent and ambulatory intra-arterial
chemotherapy using a subcutaneous access chamber in the treatment of isolated hepatic metastases.
Preliminary results]. Annales de gastroenterologie et d'hepatologie. 1985;21:95-97.
80. Gerard A, Pector JC, Bleiberg H. [Liver perfusion in the treatment of metastases of colorectal
origin]. Acta gastro-enterologica Belgica. 1985;48:447-453.
81. Kemeny MM, Goldberg DA, Browning S, Metter GE, Miner PJ, Terz JJ. Experience with
continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from
colorectal primaries. A prospective randomized study. Cancer. 1985;55:1265-1270.
82. Kolaric K, Vukas D, Roth A, Potrebica V, Cervek J, Cerar O. Cyclophosphamide, adriamycin
and platinum (CAP) combination chemotherapy, a new effective approach in the treatment of
disseminated breast cancer. Preliminary report. Tumori. 1985;71:159-165.
83. Konishi T, Kitamura M, Suzuki T, Mori T, Awane Y, Kosaki G. [Intra-arterial infusion therapy
with angiotensin II in gastric carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy.
1985;12:1905-1914.
84. Manni A, Santen RJ, Boucher A, et al. Hormone stimulation and chemotherapy in advanced
prostate cancer: preliminary results of a prospective controlled clinical trial. Anticancer research.
1985;5:161-165.
85. Page JP, Levi JA, Woods RL, Tattersall MN, Fox RM, Coates AS. Randomized trial of
combination chemotherapy in hormone-resistant metastatic prostate carcinoma. Cancer treatment
reports. 1985;69:105-107.
86. Prorokov VV, Ozhiganov EL, Abramova NA. [Adjuvant chemotherapy following radical
operations for cancer of the large intestine]. Voprosy onkologii. 1985;31:10-14.
87. Robert J, Vrignaud P, Nguyen-Ngoc T, Iliadis A, Mauriac L, Hurteloup P. Comparative
pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast
cancer. Cancer treatment reports. 1985;69:633-640.
88. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of
autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with
metastatic cancer. The New England journal of medicine. 1985;313:1485-1492.
89. Salzer H, Gitsch E, Dittrich C, et al. [Results of the first Austrian multicenter ovarian cancer
study:
prospective
randomized
comparison
of
sequential
chemotherapy
(adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols
(adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]. Geburtshilfe
und Frauenheilkunde. 1985;45:761-768.
90. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE. Prospective
randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or
rectal cancer. Seminars in oncology. 1985;12:101-111.
91. Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C. A randomized controlled trial of
adjuvant portal vein cytotoxic perfusion in colorectal cancer. The British journal of surgery.
1985;72:359-363.
92. Wunderlich M, Schiessel R, Rainer H, et al. Effect of adjuvant chemo- or immunotherapy on
the prognosis of colorectal cancer operated for cure. The British journal of surgery. 1985;72
Suppl:S107-110.
93. A randomized trial in postmenopausal patients with advanced breast cancer comparing
endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New
Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1986;4:186-193.
94. Balch CM, Urist MM. Intraarterial chemotherapy for colorectal liver metastases and
hepatomas using a totally implantable drug infusion pump. Recent results in cancer research.
Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1986;100:234-247.
95. Douillard JY, Lehur PA, Vignoud J, et al. Monoclonal antibodies specific immunotherapy of
gastrointestinal tumors. Hybridoma. 1986;5 Suppl 1:S139-149.
96. Fossa SD, de Garis ST, Heier MS, et al. Recombinant interferon alfa-2a with or without
vinblastine in metastatic renal cell carcinoma. Cancer. 1986;57:1700-1704.
97. Fritze D, Queisser W, Schmid H, et al. Prospective randomized trial concerning hyper- and
normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Onkologie. 1986;9:305-312.
98. Gall FP, Scheele J, Altendorf A. Typical and atypical resection techniques of hepatic
metastases. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les
recherches sur le cancer. 1986;100:212-220.
99. Hellmann K. Antimetastatic drugs: function and value. Progress in clinical and biological
research. 1986;212:1-16.
100. Hodgson WJ, Friedland M, Ahmed T, et al. Treatment of colorectal hepatic metastases by
intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic
disease. Annals of surgery. 1986;203:420-425.
101. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ. Toxicities and
complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer.
1986;57:465-470.
102. Hojo K, Kajitani T. [Adjuvant chemotherapy of colorectal cancer--results of prospective
randomized trials]. Gan to kagaku ryoho. Cancer & chemotherapy. 1986;13:3063-3073.
103. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma
metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278-284.
104. Kemeny MM, Goldberg D, Beatty JD, et al. Results of a prospective randomized trial of
continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from
colorectal primaries. Cancer. 1986;57:492-498.
105. Kemeny MM, Hogan JM, Ganteaume L, Goldberg DA, Terz JJ. Preoperative staging with
computerized axial tomography and biochemical laboratory tests in patients with hepatic
metastases. Annals of surgery. 1986;203:169-172.
106. Kolaric K, Potrebica V, Stanovnik M. Controlled phase III clinical study of 4-epi-doxorubicin
+ 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
Oncology. 1986;43:73-77.
107. Lasser P, Elias D, Rougier P, et al. [Isolated hepatic metastases. Treatment by intra-arterial
chemotherapy using a subcutaneous access chamber]. Presse medicale (Paris, France : 1983).
1986;15:237-240.
108. Livingston RB, Schulman S, Mira JG, et al. Combined alkylators and multiple-site irradiation
for extensive small cell lung cancer: a Southwest Oncology Group Study. Cancer treatment reports.
1986;70:1395-1401.
109. Osterlind K, Hansen HH, Hansen M, Dombernowsky P, Andersen PK. Long-term
disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. Journal
of clinical oncology : official journal of the American Society of Clinical Oncology.
1986;4:1307-1313.
110. Rausch RL, Wilson JF, McMahon BJ, O'Gorman MA. Consequences of continuous
mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial.
Annals of tropical medicine and parasitology. 1986;80:403-419.
111. Richards F, 2nd, Case LD, White DR, et al. Combination chemotherapy (5-fluorouracil,
methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated
colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1986;4:565-570.
112. Rothmund M, Bruckner R, Keller E, Quint B, Knuth A, Schicketanz KH. [Regional
chemotherapy of liver metastases of colorectal carcinoma using implanted gas pressure pumps.
Results of a prospective phase II study]. Deutsche medizinische Wochenschrift (1946).
1986;111:652-658.
113. Salzer
H.
Ovarian
tumours.
Drugs
under
experimental
and
clinical
research.
1986;12:119-134.
114. Skibba JL, Quebbeman EJ. Tumoricidal effects and patient survival after hyperthermic liver
perfusion. Archives of surgery (Chicago, Ill. : 1960). 1986;121:1266-1271.
115. Soininen K, Kleimola T, Elomaa I, Salmo M, Rissanen P. The steady-state pharmacokinetics
of tamoxifen and its metabolites in breast cancer patients. The Journal of international medical
research. 1986;14:162-165.
116. Sugarbaker PH, van de Velde CJ, Veenhof CH. A matrix for controlled clinical trials for the
study of hepatic metastases: proceedings of a workshop. Journal of surgical oncology.
1986;31:94-99.
117. Verrill H, Goldberg M, Rosenbaum R, et al. Clinical trial of Wistar Institute 17-1A
monoclonal antibody in patients with advanced gastrointestinal adenocarcinoma: a preliminary
report. Hybridoma. 1986;5 Suppl 1:S175-183.
118. Abdel-Nabi HH, Schwartz AN, Higano CS, Wechter DG, Unger MW. Colorectal carcinoma:
detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
Radiology. 1987;164:617-621.
119. Buyukunal E, Derman U, Serdengecti S, Berkarda B. A clinical trial of mitoxantrone
(novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast
cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.
1987;6:377-379.
120. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A
prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine
chemotherapy in
the
treatment
of
colorectal
liver
metastases.
Annals of
surgery.
1987;206:685-693.
121. Daly JM, Kemeny N, Sigurdson E, Oderman P, Thom A. Regional infusion for colorectal
hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein. Archives
of surgery (Chicago, Ill. : 1960). 1987;122:1273-1277.
122. Encke A, Hottenrott C, Lorenz M. [Regional chemotherapy of liver metastases].
Langenbecks Archiv fur Chirurgie. 1987;371:137-148.
123. Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus
ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung
cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1987;5:113-124.
124. Henze E, Kubel R, Waitzinger J, Buchler M, Adam WE, Beger HG. Tumor scintigraphy with
131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer. European journal of
nuclear medicine. 1987;13:125-129.
125. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic
infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A
randomized trial. Annals of internal medicine. 1987;107:459-465.
126. Lacroix A, Bhat PV, Karabatsos A, et al. Plasma levels of retinol in cancer patients
supplemented with retinol. Oncology. 1987;44:108-114.
127. Leibel SA, Pajak TF, Massullo V, et al. A comparison of misonidazole sensitized radiation
therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation
Therapy Oncology Group randomized prospective trial. International journal of radiation oncology,
biology, physics. 1987;13:1057-1064.
128. Lillis PK, Brown TD, Beougher K, Koeller J, Marcus SG, Von Hoff DD. Phase II trial of
recombinant beta interferon in advanced colorectal cancer. Cancer treatment reports.
1987;71:965-967.
129. Lise M, Gerard A, Nitti D, et al. Adjuvant therapy for colorectal cancer. The EORTC
experience and a review of the literature. Diseases of the colon and rectum. 1987;30:847-854.
130. Mavligit GM, Faintuch J, Levin B, et al. Gastroduodenal mucosal injury during hepatic
arterial infusion of chemotherapeutic agents. Lack of cytoprotection by prostaglandin E1 analogue.
Gastroenterology. 1987;92:566-569.
131. Pedrazzini A, Cavalli F, Brunner KW, Goldhirsch A, Mermillod B. Complete remission
following endocrine or combined cytotoxic and hormonal treatment in advanced breast cancer. A
retrospective analysis. Oncology. 1987;44:51-59.
132. Stark DD, Wittenberg J, Butch RJ, Ferrucci JT, Jr. Hepatic metastases: randomized,
controlled comparison of detection with MR imaging and CT. Radiology. 1987;165:399-406.
133. Bruckner HW, Crown J, McKenna A, Hart R. Leucovorin and 5-fluorouracil as a treatment
for disseminated cancer of the pancreas and unknown primary tumors. Cancer research.
1988;48:5570-5572.
134. Burtin C, Noirot C, Scheinmann P, Galoppin L, Sabolovic D, Bernard P. Clinical
improvement in advanced cancer disease after treatment combining histamine and
H2-antihistaminics (ranitidine or cimetidine). European journal of cancer & clinical oncology.
1988;24:161-167.
135. Friedlander ML, Hedley DW, Swanson C, Russell P. Prediction of long-term survival by flow
cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. Journal of
clinical oncology : official journal of the American Society of Clinical Oncology. 1988;6:282-290.
136. Friedman MA, Phillips TL, Hannigan JF, Jr., Carter SK. Phase III trial of irradiation plus
chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern
California Oncology Group. NCI monographs : a publication of the National Cancer Institute.
1988:259-264.
137. Gerard A. Pilot study on the regional treatment of colorectal liver metastases by intermittent
arterial ischaemia with degradable starch microspheres and arterial and portal infusion with
mitomycin C plus 5-fluorouracil--a clinical trial led by the Gastrointestinal Tumour Cooperative
Group E.O.R.T.C. Gan to kagaku ryoho. Cancer & chemotherapy. 1988;15:2627-2632.
138. Jeekel J. Prevention of metastases in curative treatment of colorectal cancer. Scandinavian
journal of gastroenterology. Supplement. 1988;149:117-119.
139. Kairaluoma MI, Leinonen A, Niemela R, Kiviniemi H, Siniluoto T, Stahlberg M.
Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology
and the British Association of Surgical Oncology. 1988;14:45-50.
140. Koks CH, Brouwers JR, Sleijfer DT. Regional infusion of fluoropyrimidines for hepatic
metastases of colorectal cancer. Pharmaceutisch weekblad. Scientific edition. 1988;10:69-75.
141. Mazzaferro V, Dindzans VJ, Makowka L, Van Thiel DH. Approach to hepatic metastases
from colorectal adenocarcinoma. Seminars in liver disease. 1988;8:247-253.
142. Mohiuddin M, Cantor RJ, Biermann W, Weiss SM, Barbot D, Rosato FE. Combined modality
treatment of localized unresectable adenocarcinoma of the pancreas. International journal of
radiation oncology, biology, physics. 1988;14:79-84.
143. Molzahn E, Gruenagel HH, Freund U, Gross D. [Concepts in the prevention and treatment of
liver metastases of colorectal cancer by regional chemotherapy]. Der Chirurg; Zeitschrift fur alle
Gebiete der operativen Medizen. 1988;59:34-40.
144. Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC. A randomized trial of
standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis
nonseminomatous germ-cell tumors. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1988;6:1031-1040.
145. Patt YZ, Lamki LM, Haynie TP, et al. Improved tumor localization with increasing dose of
indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic
colorectal cancer. Journal of clinical oncology : official journal of the American Society of
Clinical Oncology. 1988;6:1220-1230.
146. Sorensen JB. Chemotherapy for advanced adenocarcinoma of the lung: the Copenhagen
study and review of the literature. Seminars in oncology. 1988;15:56-57.
147. Vinik AI, Tsai S, Moattari AR, Cheung P. Somatostatin analogue (SMS 201-995) in patients
with gastrinomas. Surgery. 1988;104:834-842.
148. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a
controlled prospective trial. The British journal of surgery. 1988;75:409-415.
149. Angelini F, Coppetelli U, Carassai A, Lopez M. [Current results and prospects of
intra-arterial chemotherapy in hepatic metastases of carcinoma of the colorectum]. La Clinica
terapeutica. 1989;130:303-317.
150. Balslev I, Pedersen M, Teglbjaerg PS, et al. [Prognosis in synchronous liver metastasis from
colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the
rectosigmoid colon]. Ugeskrift for laeger. 1989;151:1045-1048.
151. Dutcher JP, Creekmore S, Weiss GR, et al. A phase II study of interleukin-2 and
lymphokine-activated killer cells in patients with metastatic malignant melanoma. Journal of
clinical oncology : official journal of the American Society of Clinical Oncology. 1989;7:477-485.
152. Ettinger DS, Finkelstein DM, Donehower RC, et al. Phase II study of N-methylformamide,
spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer
(EST 3583): an Eastern Cooperative Oncology Group study. Medical and pediatric oncology.
1989;17:197-201.
153. Fornari F, Civardi G, Cavanna L, et al. Complications of ultrasonically guided fine-needle
abdominal biopsy. Results of a multicenter Italian study and review of the literature. The
Cooperative Italian Study Group. Scandinavian journal of gastroenterology. 1989;24:949-955.
154. Hansen R, Quebbeman E, Ausman R, et al. Continuous systemic 5-fluorouracil infusion in
advanced colorectal cancer: results in 91 patients. Journal of surgical oncology. 1989;40:177-181.
155. Harrison JD, Morris DL, Ellis IO, Jones JA, Jackson I. The effect of tamoxifen and estrogen
receptor status on survival in gastric carcinoma. Cancer. 1989;64:1007-1010.
156. Herrmann R. [Is there a primary indication for regional therapy of liver metastases of
gastrointestinal tumors?]. Zeitschrift fur Gastroenterologie. Verhandlungsband. 1989;24:192-193.
157. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous
versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the
Northern California Oncology Group trial. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 1989;7:1646-1654.
158. Hottenrott C, Lorenz M. [Can the occurrence of extrahepatic metastases in regional
chemotherapy of the liver be prevented by adding systemic chemotherapy? A randomized
multicenter study]. Zeitschrift fur Gastroenterologie. Verhandlungsband. 1989;24:199-201.
159. Hottenrott C, Lorenz M. [European topic: liver surgery II--regional chemotherapy].
Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur
Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress. 1989:273-277.
160. Hunt TM, Flowerdew AD, Taylor I, Ackery DM, Blaquiere RM, Dewbury K. A comparison
of methods to measure the percentage hepatic replacement with colorectal metastases. Annals of
the Royal College of Surgeons of England. 1989;71:11-13.
161. Igawa M, Ueki T, Ueda M, et al. [M-VAC (methotrexate, vinblastine, adriamycin and
cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1989;16:2577-2582.
162. Inoue Y, Sawada T, Shimizu T, et al. [Effects of prophylactic intraportal chemotherapy on
liver function, blood profile and survival in patients with colo-rectal cancer]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1989;16:3024-3027.
163. Kodaira S, Kikuchi K, Inokuchi K, et al. [Cooperative study of surgical adjuvant
chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study
Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1989;16:3399-3408.
164. Laffer U. [Intra-portal chemoprevention and therapy of liver metastases]. Zeitschrift fur
Gastroenterologie. Verhandlungsband. 1989;24:189-191.
165. Lorenz M, Hottenrott C, Inglis R, Kirkowa-Reimann M. Prevention of extrahepatic disease
during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic
5-fluorouracil treatment? A prospective multicenter study. Gan to kagaku ryoho. Cancer &
chemotherapy. 1989;16:3662-3671.
166. Miller RL, Steis RG, Clark JW, et al. Randomized trial of recombinant alpha 2b-interferon
with or without indomethacin in patients with metastatic malignant melanoma. Cancer research.
1989;49:1871-1876.
167. Minsky BD, Leibel SA. The treatment of hepatic metastases from colorectal cancer with
radiation therapy alone or combined with chemotherapy or misonidazole. Cancer treatment
reviews. 1989;16:213-219.
168. Oberg K, Norheim I, Theodorsson E, Ahlman H, Lundqvist G, Wide L. The effects of
octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome. The
Journal of clinical endocrinology and metabolism. 1989;68:796-800.
169. Rizzo M, Bartoletti R, Selli C, Sicignano A, Criscuolo D. Interferon alpha-2a and vinblastine
in the treatment of metastatic renal carcinoma. European urology. 1989;16:271-277.
170. Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH. Regional chemotherapy
for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous
intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer. 1989;64:379-387.
171. Safi F, Roscher R, Bitter R, Schumacher KA, Gaus W, Beger HG. [Regional chemotherapy of
liver metastases in colorectal carcinoma. Intra-arterial vs intravenous plus intra-arterial therapy].
Deutsche medizinische Wochenschrift (1946). 1989;114:1478-1483.
172. Sakuma H, Matsuki N, Katayama K, et al. [Effect of PMU hepatic arterial chemotherapy for
liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference]. Gan to kagaku
ryoho. Cancer & chemotherapy. 1989;16:2557-2562.
173. Schmitz R, Krakamp B, Mennigen R, Barkun J, Klauke H. Value of in vivo tissue testing in
predicting the clinical response to regional perfusion chemotherapy in colorectal cancer patients
with
liver
metastases.
Strahlentherapie
und
Onkologie
:
Organ
der
Deutschen
Rontgengesellschaft ... [et al]. 1989;165:546-547.
174. Siccardi AG, Buraggi GL, Callegaro L, et al. Immunoscintigraphy of adenocarcinomas by
means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal
antibody: a multicenter study. Cancer research. 1989;49:3095-3103.
175. Sidibe S, Rougier P, Lumbroso J, et al. [Control of perfusion by angioscintigraphy during
hepatic intra-arterial chemotherapy]. Presse medicale (Paris, France : 1983). 1989;18:2045-2049.
176. Stevenson HC, Gazdar AF, Linnoila RI, et al. Lack of relationship between in vitro tumor cell
growth and prognosis in extensive-stage small-cell lung cancer. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 1989;7:923-931.
177. Stier G, Gurtler R, Schmidt UM. [Experience in the treatment of metastatic breast carcinoma
with norethisterone acetate in a clinical study]. Archiv fur Geschwulstforschung. 1989;59:93-98.
178. Stillwagon GB, Order SE, Guse C, et al. 194 hepatocellular cancers treated by radiation and
chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study.
International journal of radiation oncology, biology, physics. 1989;17:1223-1229.
179. Wiedenmann B, Reichardt P, Rath U, et al. Phase-I trial of intravenous continuous infusion of
tumor necrosis factor in advanced metastatic carcinomas. Journal of cancer research and clinical
oncology. 1989;115:189-192.
180. Wiley AL, Jr., Wirtanen GW, Stephenson JA, Ramirez G, Demets D, Lee JW. Combined
hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study. Cancer.
1989;64:1783-1789.
181. al-Idrissi HY. Combined 5-fluorouracil, adriamycin and mitomycin C in the management of
adenocarcinoma metastasizing to the liver from an unknown primary site. The Journal of
international medical research. 1990;18:425-429.
182. Arai Y, Endo T, Miyake Y, Kido C. [Requirements for the randomized trial of i.a. vs. i.v.
administration to reveal the impact of hepatic arterial infusion on survival in the treatment of liver
metastases]. Gan to kagaku ryoho. Cancer & chemotherapy. 1990;17:1674-1677.
183. Avril MF, Beerblock K, Dreno B, et al. [Treatment of metastatic melanoma with dacarbazine
recombinant interferon alfa 2A combination: results of multicentric study]. Bulletin du cancer.
1990;77:1183-1191.
184. Awan AM, Weichselbaum RR. Palliative radiotherapy. Hematology/oncology clinics of North
America. 1990;4:1169-1181.
185. Castoldi MC, Spreafico C, Marchiano A, Audisio R. [Preoperative hepatic vascular
evaluation: comparison of angiography and Doppler-echography]. La Radiologia medica.
1990;80:48-55.
186. Cheslyn-Curtis S, Fielding LP, Hittinger R, Fry JS, Phillips RK. Large bowel cancer: the
effect of perioperative blood transfusion on outcome. Annals of the Royal College of Surgeons of
England. 1990;72:53-59.
187. Chevallier B, Fumoleau P, Kerbrat P, et al. Association of bolus tetrahydropyranyl adriamycin
and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancer.
American journal of clinical oncology. 1990;13 Suppl 1:S40-43.
188. Das AK, Carson CC, Bolick D, Paulson DF. Primary carcinoma of the upper urinary tract.
Effect of primary and secondary therapy on survival. Cancer. 1990;66:1919-1923.
189. Doerr RJ, Abdel-Nabi H, Baker JM, Steinberg S. Detection of primary colorectal cancer with
indium 111 monoclonal antibody B72.3. Archives of surgery (Chicago, Ill. : 1960).
1990;125:1601-1605.
190. Fornasiero A, Daniele O, Ghiotto C, Aversa SM, Morandi P, Fiorentino MV. Alpha-2
interferon and 5-fluorouracil in advanced colorectal cancer. Tumori. 1990;76:385-388.
191. Fumoleau P, Bastit P, Horner D, et al. [Phase II trial as 2nd line chemotherapy with 5
fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer]. Bulletin du cancer.
1990;77:805-810.
192. Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdle CS. Regional chemotherapy for
colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for
colorectal liver metastases. The British journal of surgery. 1990;77:1238-1240.
193. Harrison JD, Jones JA, Morris DL. The effect of the gastrin receptor antagonist proglumide
on survival in gastric carcinoma. Cancer. 1990;66:1449-1452.
194. Hunt TM, Flowerdew AD, Birch SJ, Williams JD, Mullee MA, Taylor I. Prospective
randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with
5-fluorouracil and degradable starch microspheres for colorectal liver metastases. The British
journal of surgery. 1990;77:779-782.
195. Leibel SA, Guse C, Order SE, et al. Accelerated fractionation radiation therapy for liver
metastases: selection of an optimal patient population for the evaluation of late hepatic injury in
RTOG studies. International journal of radiation oncology, biology, physics. 1990;18:523-528.
196. Martin JK, Jr., O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic
fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Archives of surgery
(Chicago, Ill. : 1960). 1990;125:1022-1027.
197. Mavligit GM, Zukiwski AA, Gutterman JU, Salem P, Charnsangavej C, Wallace S. Splenic
versus hepatic artery infusion of interleukin-2 in patients with liver metastases. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1990;8:319-324.
198. Morris DL, Charnley RM, Ballantyne KC, Jones J. A pilot randomized control trial of
proglumide (a gastrin receptor antagonist) in advanced colorectal cancer. European journal of
surgical oncology : the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 1990;16:423-425.
199. Parkinson DR, Abrams JS, Wiernik PH, et al. Interleukin-2 therapy in patients with
metastatic malignant melanoma: a phase II study. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology. 1990;8:1650-1656.
200. Rougier P, Munck JN, Elias D, et al. Intra-arterial hepatic chemotherapy with pirarubicin.
Preclinical and clinical studies. American journal of clinical oncology. 1990;13 Suppl 1:S1-4.
201. Rustin RB, Vogt DP, Bukowski RM, Shepard KV. Hepatic artery infusion chemotherapy for
colorectal liver metastases. Cleveland Clinic journal of medicine. 1990;57:692-696.
202. Sawaguchi S, Kaneko M, Uchino J, et al. Treatment of advanced neuroblastoma with
emphasis on intensive induction chemotherapy. A report from the Study Group of Japan. Cancer.
1990;66:1879-1887.
203. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma:
impact of surgical resection on the natural history. The British journal of surgery.
1990;77:1241-1246.
204. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal
cancer--competitive analysis of treatment results in synchronous versus metachronous metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology
and the British Association of Surgical Oncology. 1990;16:360-365.
205. Schultheis KH, Gebhardt C, Schwemmle K, Richter EI, Schumacher F. [Chemoembolization
of colorectal liver metastases]. Zentralblatt fur Chirurgie. 1990;115:933-947.
206. Trillet V, Chauvin F, Champel F, et al. [Small cell lung carcinoma. Value of the evaluation of
extension for the therapeutic strategy]. Presse medicale (Paris, France : 1983). 1990;19:655-660.
207. Trump DL, Elson P, Madajewicz S, et al. Randomized phase II evaluation of carboplatin and
CHIP in advanced transitional cell carcinoma of the urothelium. The Eastern Cooperative
Oncology Group. The Journal of urology. 1990;144:1119-1122.
208. Wagman LD, Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the
treatment of colorectal cancer metastatic to the liver. Journal of clinical oncology : official journal
of the American Society of Clinical Oncology. 1990;8:1885-1893.
209. Wereldsma JC, Bruggink ED, Meijer WS, Roukema JA, van Putten WL. Adjuvant portal
liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control.
Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer.
1990;65:425-432.
210. Wolmark N, Rockette H, Wickerham DL, et al. Adjuvant therapy of Dukes' A, B, and C
adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of
National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 1990;8:1466-1475.
211. Yamashita Y, Takahashi M, Koga Y, et al. Prognostic factors in liver metastases after
transcatheter arterial embolization or arterial infusion. Acta radiologica (Stockholm, Sweden :
1987). 1990;31:269-274.
212. Aass N, Klepp O, Cavallin-Stahl E, et al. Prognostic factors in unselected patients with
nonseminomatous metastatic testicular cancer: a multicenter experience. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1991;9:818-826.
213. Ajani JA, Pazdur R, Winn RJ, et al. Phase II study of intravenous 6-thioguanine in patients
with advanced carcinoma of the pancreas. Investigational new drugs. 1991;9:369-371.
214. Akaza H, Kameyama S, Kanemura M, et al. [Treatment of renal cell carcinoma with human
lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial]. Nihon
Hinyokika Gakkai zasshi. The japanese journal of urology. 1991;82:1053-1058.
215. Anderson JH, Goldberg JA, Eley JG, et al. A phase I study of regionally administered
mitomycin microcapsules for patients with colorectal liver metastases. European journal of cancer
(Oxford, England : 1990). 1991;27:1189-1190.
216. Aoki Y, Takakuwa K, Kodama S, et al. Use of adoptive transfer of tumor-infiltrating
lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with
epithelial ovarian cancer. Cancer research. 1991;51:1934-1939.
217. Beger HG, Safi F. [Regional chemotherapy of liver metastases]. Deutsche medizinische
Wochenschrift (1946). 1991;116:595.
218. Budd GT, Green S, Baker LH, Hersh EP, Weick JK, Osborne CK. A Southwest Oncology
Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer. Cancer.
1991;68:1694-1695.
219. Campana F, Palangie T, Fourquet A, Pouillart P, Vilcoq JR. [Concomitant association of
radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
Bulletin du cancer. 1991;78:445-452.
220. Cerny T, Martinelli G, Goldhirsch A, et al. Continuous 5-day infusion of ifosfamide with
mesna in inoperable pancreatic cancer patients: a phase II study. Journal of cancer research and
clinical oncology. 1991;117 Suppl 4:S135-138.
221. Charnley RM, Morris DL, Dennison AR, Amar SS, Hardcastle JD. Detection of colorectal
liver metastases using intraoperative ultrasonography. The British journal of surgery.
1991;78:45-48.
222. Civalleri D, Esposito M, Fulco RA, et al. Liver and tumor uptake and plasma
pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients
with liver metastases. Cancer. 1991;68:988-994.
223. Cosimelli M, Mannella E, Anza M, et al. Two consecutive clinical trials on cisplatin (CDDP),
hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable
colorectal liver metastases: an alternative to FUdR-based regimens? Journal of surgical oncology.
Supplement. 1991;2:63-68.
224. del Giglio A, Zukiwski AA, Ali MK, Mavligit GM. Severe, symptomatic, dose-limiting
hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in
patients with liver metastases. Cancer. 1991;67:2459-2461.
225. Dinshaw KA, Sharma V, Pendse AM, et al. The role of intraluminal radiotherapy and
concurrent 5-fluorouracil infusion in the management of carcinoma esophagus: a pilot study.
Journal of surgical oncology. 1991;47:155-160.
226. Estape J, Grau JJ, Lcobendas F, et al. Mitomycin C as an adjuvant treatment to resected
gastric cancer. A 10-year follow-up. Annals of surgery. 1991;213:219-221.
227. Eton O, Bajorin DF, Casper ES, Houghton AN. Phase II trial of N-methylformamide in
patients with metastatic melanoma. Investigational new drugs. 1991;9:97-100.
228. Falkson G, Gelman R, Falkson CI, Glick J, Harris J. Factors predicting for response, time to
treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a
prospective Eastern Cooperative Oncology Group study. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 1991;9:2153-2161.
229. Gerard A, Buyse M, Pector JC, et al. Hepatic artery ligation with and without portal infusion
of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal
carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group). European
journal of surgical oncology : the journal of the European Society of Surgical Oncology and the
British Association of Surgical Oncology. 1991;17:289-294.
230. Hamazoe R, Murakami A, Hirooka Y, Maeta M, Kaibara N. A phase II pilot study of the
combined application of hyperthermia and intra-hepato-arterial chemotherapy using cisplatinum
and 5-fluorouracil. Journal of surgical oncology. 1991;48:127-132.
231. Hayward RL, Leonard RC, Prescott RJ. A critical analysis of prognostic factors for survival
in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma
Group Therapy Working Party. British journal of cancer. 1991;63:945-952.
232. Huan SD, Legha SS, Raber MN, Krakoff IH. Phase I studies of trimetrexate using single and
weekly dose schedules. Investigational new drugs. 1991;9:199-206.
233. Jeremic B, Djuric L, Mijatovic L. Carboplatinum and cytosine arabinoside in patients with
disseminated malignant melanoma. A phase II study. Investigational new drugs. 1991;9:277-280.
234. Khayat D, Cour V, Bizzari JP, et al. Fotemustine (S 10036) in the intra-arterial treatment of
liver metastasis from malignant melanoma. A phase II Study. American journal of clinical
oncology. 1991;14:400-404.
235. Kolaric K, Vukas D. Carboplatin activity in untreated metastatic breast cancer
patients--results of a phase II study. Cancer chemotherapy and pharmacology. 1991;27:409-412.
236. Leitha T, Walter R, Schlick W, Dudczak R. 99mTc-anti-CEA radioimmunoscintigraphy of
lung adenocarcinoma. Chest. 1991;99:14-19.
237. Lewis CR, Fossa SD, Mead G, et al. BOP/VIP--a new platinum-intensive chemotherapy
regimen for poor prognosis germ cell tumours. Annals of oncology : official journal of the
European Society for Medical Oncology / ESMO. 1991;2:203-211.
238. Martoni A, Melotti B, Guaraldi M, Pannuti F. Activity of high-dose epirubicin in advanced
non-small cell lung cancer. European journal of cancer (Oxford, England : 1990).
1991;27:1231-1234.
239. Metzger U, Weder W, Rothlin M, Largiader F. Phase II study of intra-arterial fluorouracil and
mitomycin-C for liver metastases of colorectal cancer. Recent results in cancer research.
Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1991;121:198-204.
240. Ninane J, Perilongo G, Stalens JP, Guglielmi M, Otte JB, Mancini A. Effectiveness and
toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular
carcinoma: a SIOP pilot study. Medical and pediatric oncology. 1991;19:199-203.
241. Oldham RK, Dillman RO, Yannelli JR, et al. Continuous infusion interleukin-2 and
tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study
Group Trial. Molecular biotherapy. 1991;3:68-73.
242. Parnes HL, Abrams JS, Tchekmedyian NS, Tait N, Aisner J. A phase I/II study of high-dose
megestrol acetate in the treatment of metastatic breast cancer. Breast cancer research and treatment.
1991;18:171-177.
243. Planting A, Hoff A, van der Burg M, Verweij J, Stoter G. Phase II study of ACNU as first-line
treatment in advanced colorectal cancer. Annals of oncology : official journal of the European
Society for Medical Oncology / ESMO. 1991;2:767-768.
244. Riggi M, Ruffie P, Voisin S, et al. Influence of pretreatment clinical characteristics on the
response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer.
ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques). European journal of
cancer (Oxford, England : 1990). 1991;27:1238-1242.
245. Roth BJ, Sledge GW, Jr., Williams SD, Meyer SC, Ansari R, Fisher WB. Methotrexate,
vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier
Oncology Group. Cancer. 1991;68:248-252.
246. Ruszniewski P, Hochlaf S, Rougier P, Mignon M. [Intravenous chemotherapy with
streptozotocin and 5 fluorouracil for hepatic metastases of Zollinger-Ellison syndrome. A
prospective multicenter study in 21 patients]. Gastroenterologie clinique et biologique.
1991;15:393-398.
247. Scheidhauer K, Muller S, Smolarz K, Brautigam P, Briele B. [Tumor scintigraphy using
123I-labeled estradiol in breast cancer--receptor scintigraphy]. Nuklearmedizin. Nuclear medicine.
1991;30:84-99.
248. Shimizu Y, Nakayama K, Seimiya Y, et al. [Treatment of advanced or recurrent cervical
cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose
consecutive cisplatin]. Nihon Sanka Fujinka Gakkai zasshi. 1991;43:549-556.
249. Stagg RJ, Venook AP, Chase JL, et al. Alternating hepatic intra-arterial floxuridine and
fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. Journal
of the National Cancer Institute. 1991;83:423-428.
250. Steele G, Jr., Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective
evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal
Tumor Study Group Protocol 6584. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1991;9:1105-1112.
251. Steffens TA, Bajorin DF, Chapman PB, et al. A phase II trial of high-dose cisplatin and
dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Cancer. 1991;68:1230-1237.
252. Stillwagon GB, Order SE, Guse C, et al. Prognostic factors in unresectable hepatocellular
cancer: Radiation Therapy Oncology Group Study 83-01. International journal of radiation
oncology, biology, physics. 1991;20:65-71.
253. Vassiliades VG, Foley WD, Alarcon J, et al. Hepatic metastases: CT versus MR imaging at
1.5T. Gastrointestinal radiology. 1991;16:159-163.
254. Wadler S, Lembersky B, Atkins M, Kirkwood J, Petrelli N. Phase II trial of fluorouracil and
recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern
Cooperative Oncology Group study. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1991;9:1806-1810.
255. Wampler GL, Heim WJ, Ellison NM, Ahlgren JD, Fryer JG. Comparison of
cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate,
etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of
extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study. Journal of
clinical oncology : official journal of the American Society of Clinical Oncology.
1991;9:1438-1445.
256. Yamaguchi A, Ishida T, Nishimura G, et al. Detection by CT during arterial portography of
colorectal cancer metastases to liver. Diseases of the colon and rectum. 1991;34:37-40.
257. Yiu CY, Baker LA, Boulos PB. Anti-epithelial membrane antigen monoclonal antibodies and
radioimmunolocalization of colorectal cancer. The British journal of surgery. 1991;78:1212-1215.
258. Abdel-Nabi HH, Doerr RJ. Multicenter clinical trials of monoclonal antibody
B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal
carcinoma. Targeted diagnosis and therapy. 1992;6:73-88.
259.Ajani JA, Dumas P. Evaluation of oral etoposide in patients with metastatic gastric carcinoma:
a preliminary report. Seminars in oncology. 1992;19:45-47.
260. Anderson JH, Kerr DJ, Cooke TG, McArdle CS. A phase I study of regional 5-fluorouracil
and systemic folinic acid for patients with colorectal liver metastases. British journal of cancer.
1992;65:913-915.
261. Anderson JH, Kerr DJ, Setanoians A, Cooke TG, McArdle CS. A pharmacokinetic
comparison of intravenous versus intra-arterial folinic acid. British journal of cancer.
1992;65:133-135.
262. Andersson R, Holmberg A. Intraperitoneal 5-fluorouracil in the management of colorectal
liver cancer. European journal of surgical oncology : the journal of the European Society of
Surgical Oncology and the British Association of Surgical Oncology. 1992;18:152-155.
263. Arai Y, Endo T, Sone Y, et al. Management of patients with unresectable liver metastases
from colorectal and gastric cancer employing an implantable port system. Cancer chemotherapy
and pharmacology. 1992;31 Suppl:S99-102.
264. Balfe DM. Hepatic metastases from colorectal cancer: radiologic strategies for improved
selection. Radiology. 1992;185:18-19.
265. Bernhard H, Klein O, Meyer zum Buschenfelde KH, Knuth A. Treatment of refractory
colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a. Seminars in oncology.
1992;19:204-207.
266. Boutkan H, Luth W, Meyer S, Cuesta M, van Heuzen E, Prevoo W. The impact of
intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal
malignancies and hepatic metastases. European journal of surgical oncology : the journal of the
European Society of Surgical Oncology and the British Association of Surgical Oncology.
1992;18:342-346.
267. Bukowski RM, Inoshita G, Yalavarthi P, et al. A phase I trial of 5-fluorouracil, folinic acid,
and
alpha-2a-interferon
in
patients
with
metastatic
colorectal
carcinoma.
Cancer.
1992;69:889-892.
268. Camaggi CM, Strocchi E, Carisi P, et al. Idarubicin metabolism and pharmacokinetics after
intravenous and oral administration in cancer patients: a crossover study. Cancer chemotherapy
and pharmacology. 1992;30:307-316.
269. Chen SC, Lian SL, Chuang WL, et al. Radiotherapy in the treatment of hepatocellular
carcinoma and its metastases. Cancer chemotherapy and pharmacology. 1992;31 Suppl:S103-105.
270. Collier BD, Abdel-Nabi H, Doerr RJ, et al. Immunoscintigraphy performed with
In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. Radiology.
1992;185:179-186.
271. Engelstein D, Shmueli J, Kessler O, et al. [Immunotherapy for metastatic renal cell
carcinoma: treatment with PLAK cells and low-dose interleukin-2]. Harefuah. 1992;122:72-76.
272. Fielding LP, Hittinger R, Grace RH, Fry JS. Randomised controlled trial of adjuvant
chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
Lancet. 1992;340:502-506.
273. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP--initial
clinical results in 40 patients. Radiology. 1992;182:167-174.
274. Hiddemann W, Ruelfs C, Ottensmeier C, et al. Interleukin-2 followed by fluorouracil and
folinic acid in refractory colorectal cancer--results of a clinical phase II study. Seminars in
oncology. 1992;19:225-227.
275. JN IJ, Scheringa M, van der Schelling GP, Geerling RA, Marquet RL, Jeekel J. Injection of
recombinant tumor necrosis factor directly into liver metastases: an experimental and clinical
approach. Clinical & experimental metastasis. 1992;10:91-97.
276. Kan N, Kodama H, Hori T, et al. [Intrapleural treatment of breast cancer patients with pleural
effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast
Cancer Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy. 1992;19:1632-1635.
277. Kato H, Tachimori Y, Watanabe H, et al. Intramural metastasis of thoracic esophageal
carcinoma. International journal of cancer. Journal international du cancer. 1992;50:49-52.
278. Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of
fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of
metastatic colorectal cancer. Cancer. 1992;69:327-334.
279. Kemeny NE. Is hepatic infusion of chemotherapy effective treatment for liver metastases?
Yes! Important advances in oncology. 1992:207-227.
280. Kochupillai V, Gupta P, Misra A. A phase II trial of cyclophosphamide, doxorubicin, and
cisplatin in advanced breast cancer. American journal of clinical oncology. 1992;15:388-391.
281. Komaki R, Wadler S, Peters T, et al. High-dose local irradiation plus prophylactic hepatic
irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report
of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer.
1992;69:2807-2812.
282. Kopp AF, Laniado M, Aicher KP, Gronewaller EF, Claussen CD. [Manganese DPDP as a
contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20
patients]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
1992;157:539-547.
283. Kouri M, Pyrhonen S, Kuusela P. Elevated CA19-9 as the most significant prognostic factor
in advanced colorectal carcinoma. Journal of surgical oncology. 1992;49:78-85.
284. Laffer U, Metzger U, Aeberhard P, et al. [Final evaluation of the randomized multicenter
study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].
Helvetica chirurgica acta. 1992;58:755-758.
285. Lee
SM,
Thatcher
N,
Crowther
D,
Margison
GP.
In
vivo
depletion
of
O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB
10-277, a new DTIC analogue. Cancer chemotherapy and pharmacology. 1992;31:240-246.
286. Lorenz M, Hottenrott C, Maier P, Reimann M, Inglis R, Encke A. Continuous regional
treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of
modulation with leucovorin. Seminars in oncology. 1992;19:163-170.
287. Martin M, Diaz-Rubio E, Casado A, et al. Carboplatin: an active drug in metastatic breast
cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1992;10:433-437.
288. Murphy BR, Rynard SM, Einhorn LH, Loehrer PJ. A phase II trial of interferon alpha-2A
plus fluorouracil in advanced renal cell carcinoma. A Hoosier Oncology Group study.
Investigational new drugs. 1992;10:225-230.
289. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome.
Results of a 10-year prospective study. Annals of surgery. 1992;215:8-18.
290. O'Connell MJ. Is hepatic infusion of chemotherapy effective treatment for liver metastases?
No! Important advances in oncology. 1992:229-234.
291. Okuno K, Ohnishi H, Koh K, Shindo H, Yoshioka H, Yasutomi M. Clinical trials of
intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer.
Biotherapy (Dordrecht, Netherlands). 1992;4:257-265.
292. Owen RR, Sells RA, Gilmore IT, New RR, Stringer RE. A phase I clinical evaluation of
liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic
malignancy. Anti-cancer drugs. 1992;3:101-107.
293. Preiss J. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in
colorectal cancer. Seminars in oncology. 1992;19:220-224.
294. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients
with liver metastases from colorectal carcinoma: long-term results of a prospective randomized
trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1992;10:1112-1118.
295. Rustin GJ, Stratford MR, Lamont A, et al. Phase I study of intravenous 4-hydroxyanisole.
European journal of cancer (Oxford, England : 1990). 1992;28a:1362-1364.
296. Schlag P, Manasterski M, Gerneth T, et al. Active specific immunotherapy with
Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases
in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer immunology,
immunotherapy : CII. 1992;35:325-330.
297. Schornagel JH, van der Vegt S, Verweij J, et al. Phase II study of edatrexate in
chemotherapy-naive patients with metastatic breast cancer. Annals of oncology : official journal of
the European Society for Medical Oncology / ESMO. 1992;3:549-552.
298. Sella A, Logothetis CJ, Fitz K, et al. Phase II study of interferon-alpha and chemotherapy
(5-fluorouracil and mitomycin C) in metastatic renal cell cancer. The Journal of urology.
1992;147:573-577.
299. Sinnige HA, Nanninga AG, Verschueren RC, et al. A phase I-II study of 14-days continuous
infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma.
European journal of cancer (Oxford, England : 1990). 1992;28a:885-888.
300. van der Schelling GP, JN IJ, Kok TC, et al. A phase I study of local treatment of liver
metastases with recombinant tumour necrosis factor. European journal of cancer (Oxford,
England : 1990). 1992;28a:1073-1078.
301. van Ooijen B, Wiggers T, Meijer S, et al. Hepatic resections for colorectal metastases in The
Netherlands. A multiinstitutional 10-year study. Cancer. 1992;70:28-34.
302. Villar A, Candel MT, Delgado F, et al. [Size of breast cancer at the time of initial diagnosis].
Medicina clinica. 1992;98:285-289.
303. Winkelmann M, Ebeling K, Strohmeyer G, et al. Treatment results of the thioether lipid
ilmofosine in patients with malignant tumours. Journal of cancer research and clinical oncology.
1992;118:405-407.
304. Winzelberg GG, Grossman SJ, Rizk S, et al. Indium-111 monoclonal antibody B72.3
scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology,
immunohistology, and human immune response. Cancer. 1992;69:1656-1663.
305. Ahonen A, Kairemo K, Karnani P, et al. Radioimmunodetection of prostate cancer by
111In-labeled monoclonal antibody against prostatic acid phosphatase. Acta oncologica
(Stockholm, Sweden). 1993;32:723-727.
306. Ahren B. Interferon-alpha in the treatment of neuroendocrine tumours: effect on glucose
tolerance and glucose-stimulated insulin secretion. The European journal of surgery = Acta
chirurgica. 1993;159:209-212.
307. Alberto P. Phase II study of an oral combination of doxifluridine, prednimustine and
idarubicin (FUPRIDA) for first line treatment of advanced breast cancer. Annals of oncology :
official journal of the European Society for Medical Oncology / ESMO. 1993;4:423-425.
308. Arai Y, Sone Y, Inaba Y, et al. [Intermittent hepatic arterial infusion of high-dose 5-FU for
liver metastases from colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy.
1993;20:1527-1530.
309. Asano T, Kleinerman ES. Liposome-encapsulated MTP-PE: a novel biologic agent for cancer
therapy. Journal of immunotherapy with emphasis on tumor immunology : official journal of the
Society for Biological Therapy. 1993;14:286-292.
310. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic
cancer surgery. Risk factors influencing the short-term results. Annals of surgery.
1993;217:356-368.
311. Ben-Baruch N, Denicoff AM, Goldspiel BR, O'Shaughnessy JA, Cowan KH. Phase II study
of fazarabine (NSC 281272) in patients with metastatic colon cancer. Investigational new drugs.
1993;11:71-74.
312. Blumenreich MS, Kellihan MJ, Joseph UG, et al. Long-term intravenous hydroxyurea
infusions in patients with advanced cancer. A phase I trial. Cancer. 1993;71:2828-2832.
313. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-fluorouracil for
metastatic colorectal cancer localised to the liver. Australian and New Zealand journal of medicine.
1993;23:32-34.
314. Chauvin F, Souquet PJ, Trillet-Lenoir V, et al. [Clinical and economic evaluation of the initial
assessment of small cell cancer of the lung. Alternatives to classic evaluation. LGTO. The Lyon
Group of Thoracic Oncology]. Revue des maladies respiratoires. 1993;10:445-451.
315. Coates A, Thomson D, McLeod GR, et al. Prognostic value of quality of life scores in a trial
of chemotherapy with or without interferon in patients with metastatic malignant melanoma.
European journal of cancer (Oxford, England : 1990). 1993;29a:1731-1734.
316. Crown J, Hakes T, Reichman B, et al. Phase II trial of carboplatin and etoposide in metastatic
breast cancer. Cancer. 1993;71:1254-1257.
317. Curley SA, Roh MS, Chase JL, Hohn DC. Adjuvant hepatic arterial infusion chemotherapy
after curative resection of colorectal liver metastases. American journal of surgery.
1993;166:743-746; discussion 746-748.
318. Divgi CR, McDermott K, Griffin TW, et al. Lesion-by-lesion comparison of computerized
tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in
colorectal carcinoma: a multicenter trial. Journal of nuclear medicine : official publication, Society
of Nuclear Medicine. 1993;34:1656-1661.
319. Eriksson B, Bergstrom M, Lilja A, Ahlstrom H, Langstrom B, Oberg K. Positron emission
tomography (PET) in neuroendocrine gastrointestinal tumors. Acta oncologica (Stockholm,
Sweden). 1993;32:189-196.
320. Feusner JH, Krailo MD, Haas JE, Campbell JR, Lloyd DA, Ablin AR. Treatment of
pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens
Cancer Group. Cancer. 1993;71:859-864.
321. Grau JJ, Estape J, Alcobendas F, Pera C, Daniels M, Teres J. Positive results of adjuvant
mitomycin-C in resected gastric cancer: a randomised trial on 134 patients. European journal of
cancer (Oxford, England : 1990). 1993;29a:340-342.
322. Hamblin TJ, Sadullah S, Williamson P, et al. A phase-III study of recombinant interleukin 2
and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer. British journal of
cancer. 1993;68:1186-1189.
323. Heys SD, Eremin O, Franks CR, Broom J, Whiting PH. Lithium clearance measurements
during recombinant interleukin 2 treatment: tubular dysfunction in man. Renal failure.
1993;15:195-201.
324. Hidalgo OF, Rebollo J, Vieitez JM, et al. Intra-arterial hepatic treatment with carboplatin
(CBDCA) and 5-fluorouracil (5-FU) in metastases from colorectal carcinoma. American journal of
clinical oncology. 1993;16:30-33.
325. Howard TJ, Sawicki MP, Stabile BE, Watt PC, Passaro E, Jr. Biologic behavior of sporadic
gastrinoma located to the right and left of the superior mesenteric artery. American journal of
surgery. 1993;165:101-105; discussion 105-106.
326. Janknegt RA. Total androgen blockade with the use of orchiectomy and nilutamide
(Anandron) or placebo as treatment of metastatic prostate cancer. Anandron International Study
Group. Cancer. 1993;72:3874-3877.
327. Kemeny N, Cohen A, Seiter K, et al. Randomized trial of hepatic arterial floxuridine,
mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver
metastases from colorectal cancer. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1993;11:330-335.
328. Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined
with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of
colorectal hepatic metastases. Cancer. 1993;71:1964-1971.
329. Klotz HP, Weder W, Largiader F. Local and systemic toxicity of intra-hepato-arterial
chemotherapy for treatment of unresectable liver metastases of colorectal cancer with
5-Fluorouracil and high dose Leucovorin. Helvetica chirurgica acta. 1993;60:283-286.
330. Lissoni P, Barni S, Ardizzoia A, et al. Cancer immunotherapy with low-dose interleukin-2
subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant
treatment with the pineal hormone melatonin. Journal of biological regulators and homeostatic
agents. 1993;7:121-125.
331. Martin M, Casado A, Lluch A, Adrover E, Diaz-Rubio E, Garcia-Conde J. Preliminary results
of a phase II trial of chronic oral etoposide in breast cancer. Cancer treatment reviews. 1993;19
Suppl C:47-52.
332. Mercer PM, Ebbs SR, Fraser SC, Coltart RS, Bates T. Trial of aminoglutethimide vs
hydrocortisone as second-line hormone treatment of advanced breast cancer. European journal of
surgical oncology : the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 1993;19:254-258.
333. Murakami K, Watanabe T, Tadokoro M, et al. [Radioimmunodetection of colorectal cancer,
using anti-CEA monoclonal antibody CEA102: experience of 20 cases]. Nihon Geka Gakkai
zasshi. 1993;94:119-127.
334. Newling DW, Denis L, Vermeylen K. Orchiectomy versus goserelin and flutamide in the
treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used
in the European Organization for Research and Treatment of Cancer--Genitourinary Group Study
30853. Cancer. 1993;72:3793-3798.
335. Nishisaka N, Yoshihara H, Nakatani T, et al. [Clinical study of immunotherapy with
interferon alpha and gamma in metastatic renal cell carcinoma]. Nihon Hinyokika Gakkai zasshi.
The japanese journal of urology. 1993;84:1987-1993.
336. Nole F, Colleoni M, Buzzoni R, Bajetta E. Fluorouracil plus folinic acid in metastatic
adenocarcinoma of unknown primary site suggestive of a gastrointestinal primary. Tumori.
1993;79:116-118.
337.Paquet KJ, Lazar A, Rambach W, Kuhn R. [Single hepatocellular carcinoma (phi < or = 5 cm)
in liver cirrhosis. Early diagnosis and surgical removal]. Der Chirurg; Zeitschrift fur alle Gebiete
der operativen Medizen. 1993;64:784-788.
338. Pazdur R, Ajani JA, Patt YZ, Gomez J, Bready B, Levin B. Phase II evaluation of
recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated
metastatic colorectal adenocarcinoma. Cancer. 1993;71:1214-1218.
339. Perez CA, Cosmatos D, Garcia DM, Eisbruch A, Poulter CA. Irradiation in relapsing
carcinoma of the prostate. Cancer. 1993;71:1110-1122.
340. Pisegna JR, Slimak GG, Doppman JL, et al. An evaluation of human recombinant alpha
interferon in patients with metastatic gastrinoma. Gastroenterology. 1993;105:1179-1183.
341. Planting AS, Stoter G, Verweij J. Phase II study of daily oral miltefosine
(hexadecylphosphocholine) in advanced colorectal cancer. European journal of cancer (Oxford,
England : 1990). 1993;29a:518-519.
342. Ron IG, Inbar MJ, Gutman M, Merimsky O, Chaitchik S. Recombinant interferon alpha-2a in
combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of
long-term responding patients. Cancer immunology, immunotherapy : CII. 1993;37:61-66.
343. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated
hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose
escalating
protocol.
International
journal
of
radiation
oncology,
biology,
physics.
1993;27:117-123.
344. Ruszniewski P, Rougier P, Roche A, et al. Hepatic arterial chemoembolization in patients
with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer.
1993;71:2624-2630.
345. Saito H, Takamura A, Sakurai Y, et al. [Concomitant arterial infusion chemotherapy with
tamoxifen therapy for hepatic metastases from pancreatic adenocarcinoma--a preliminary report].
Gan to kagaku ryoho. Cancer & chemotherapy. 1993;20:2177-2182.
346. Shiiba K, Ouchi A, Yamamoto K, et al. [A randomized trial of intrahepatic infusion
chemotherapy for unresectable colorectal liver metastases. Sendai Study Group]. Gan to kagaku
ryoho. Cancer & chemotherapy. 1993;20:1531-1534.
347. Shimada Y, Yoshino M, Wakui A, et al. Phase II study of CPT-11, a new camptothecin
derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. Journal
of clinical oncology : official journal of the American Society of Clinical Oncology.
1993;11:909-913.
348. Small WC, Mehard WB, Langmo LS, et al. Preoperative determination of the resectability of
hepatic tumors: efficacy of CT during arterial portography. AJR. American journal of
roentgenology. 1993;161:319-322.
349. Su WC, Chen TY, Kao RH, Tsao CJ. Chemotherapy with cisplatin and continuous infusion of
5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan.
Oncology. 1993;50:205-208.
350. Taguchi T, Kondo M, Tanikawa K, Nakamura H, Okawa T, Ogawa N. [Comparative clinical
study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and
intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres)].
Gan to kagaku ryoho. Cancer & chemotherapy. 1993;20:2027-2035.
351. Taguchi T, Tanikawa K, Sano K, et al. [Multi-center cooperative phase II study of combined
infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer].
Gan to kagaku ryoho. Cancer & chemotherapy. 1993;20:2015-2025.
352. Thomas DS, Nauta RJ, Rodgers JE, et al. Intraoperative high-dose rate interstitial irradiation
of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer.
1993;71:1977-1981.
353. Trudeau M, Zukiwski A, Langleben A, Boos G, Hayden K, Batist G. A phase I study of
escalating interferon alpha-2a combined with 5-fluorouracil and leucovorin in patients with
gastrointestinal malignancies. Acta oncologica (Stockholm, Sweden). 1993;32:537-539.
354. Tsujitani S, Okuyama T, Watanabe A, Abe Y, Maehara Y, Sugimachi K. Intraperitoneal
cisplatin during surgery for gastric cancer and peritoneal seeding. Anticancer research.
1993;13:1831-1834.
355. Van Overhagen H, Lameris JS, Berger MY, et al. Improved assessment of supraclavicular and
abdominal metastases in oesophageal and gastro-oesophageal junction carcinoma with the
combination of ultrasound and computed tomography. The British journal of radiology.
1993;66:203-208.
356. Walpole ET, Dutcher JP, Sparano J, et al. Survival after phase II treatment of advanced renal
cell carcinoma with taxol or high-dose interleukin-2. Journal of immunotherapy with emphasis on
tumor immunology : official journal of the Society for Biological Therapy. 1993;13:275-281.
357. Weber W, Laffer U, Metzger U. Adjuvant portal liver infusion with 5-fluorouracil and
mitomycin in colorectal cancer. SAKK. Anticancer research. 1993;13:1839-1840.
358. Yamasaki S, Kan N, Harada T, et al. Relationship between immunological parameters and
survival of patients with liver metastases from breast cancer given immuno-chemotherapy. Breast
cancer research and treatment. 1993;26:55-65.
359. Impact of follow-up testing on survival and health-related quality of life in breast cancer
patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA : the journal
of the American Medical Association. 1994;271:1587-1592.
360. Abdel-Nabi H, Doerr RJ, Evans NH, et al. Radioimmunodetection of colorectal carcinoma
with 111In-labelled monoclonal antibody IVP ZCE 025 (a tissue culture-produced anti-CEA
MAb). Nuclear medicine communications. 1994;15:81-93.
361. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival
with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet.
1994;344:1255-1260.
362. Aoyama H, Asaishi K, Abe R, et al. [Clinical evaluation of CGS16949A in advanced or
recurrent breast cancer--a multi-institutional late phase II clinical trial]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1994;21:477-484.
363. Arai K, Kitamura M, Iwasaki Y. [Effects and problems of intraarterial noradrenaline-induced
hypertensive chemotherapy for liver metastasis of gastric cancer]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1994;21:2132-2135.
364. Arai Y, Sone Y, Inaba Y, Ariyoshi Y, Kido C. Hepatic arterial infusion chemotherapy for liver
metastases from breast cancer. Cancer chemotherapy and pharmacology. 1994;33 Suppl:S142-144.
365. Bading JR, Sigurdson ER, Finn RD, et al. Transport limits cellular entry of hepatic arterially
injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumors. Drug metabolism and
disposition: the biological fate of chemicals. 1994;22:643-650.
366. Balaban EP, Graham M, Perkins S, et al. Double modulation of 5-fluorouracil in the
treatment of advanced colorectal carcinoma: report of a trial with sequential methotrexate,
intravenous (loading dose) folinic acid, 5-fluorouracil, and a literature review. Cancer
investigation. 1994;12:12-19.
367. Balen FG, Little A, Smith AC, et al. Biopsy of inoperable pancreatic tumors does not
adversely influence patient survival time. Radiology. 1994;193:753-755.
368. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with
superparamagnetic iron oxide in MR imaging. Radiology. 1994;193:657-663.
369. Bourguignat A, Albert A, Dumont G, et al. [Semeiologic value of laboratory examination:
multicenter application to the screening of hepatic metastases]. Annales de biologie clinique.
1994;52:787-797.
370. Campani R, Bozzini A, Calliada F, et al. Color Doppler imaging of liver metastases. The
value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering. La Radiologia medica.
1994;87:32-40.
371. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced
rectal cancer following combined preoperative chemotherapy and high dose radiation.
International journal of radiation oncology, biology, physics. 1994;30:169-175.
372. Corasaniti MT, Gatti G, Crema F, Attardo-Parrinello G, Barzaghi N, Perucca E. The
disposition of theophylline in patients with lung and breast cancer. Drugs under experimental and
clinical research. 1994;20:115-120.
373. Cortesi E, Capussotti L, Di Tora P, et al. Bolus vs. continuous hepatic arterial infusion of
cisplatin plus intravenous 5-fluorouracil chemotherapy for unresectable colorectal metastases.
Diseases of the colon and rectum. 1994;37:S138-143.
374. Dai JR, Shi ML, Li YP. [Computed tomography of the retroperitoneum following
nephrectomy for renal cell carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology].
1994;16:144-147.
375. Dazzi C, Fiorentini G, Davitti B, et al. High-dose intra-arterial plus intraperitoneal
chemotherapy combined with hemofiltration in liver metastases from colorectal cancer. Tumori.
1994;80:204-208.
376. De Bree R, Roos JC, Quak JJ, Den Hollander W, Snow GB, Van Dongen GA. Clinical
screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours
in the upper aerodigestive and respiratory tract. Nuclear medicine communications.
1994;15:613-627.
377. de Graaf H, Willemse PH, Sleijfer DT, et al. Effective conditioning regimen for
premenopausal patients with advanced breast cancer. Anticancer research. 1994;14:2799-2804.
378. Divgi CR, Scott AM, McDermott K, et al. Clinical comparison of radiolocalization of two
monoclonal antibodies (mAbs) against the TAG-72 antigen. Nuclear medicine and biology.
1994;21:9-15.
379. Donato N, Dario C, Giovanni S, et al. Retrospective study on adjuvant chemotherapy after
surgical resection of colorectal cancer metastatic to the liver. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 1994;20:454-460.
380. Doria MI, Jr., Doria LK, Faintuch J, Levin B. Gastric mucosal injury after hepatic arterial
infusion
chemotherapy
with
floxuridine.
A clinical
and
pathologic
study.
Cancer.
1994;73:2042-2047.
381. Duda SH, Laniado M, Kopp AF, et al. [The MR tomography of focal liver lesions with the
superparamagnetic contrast agent AMI-25 at 1.5 tesla]. RoFo : Fortschritte auf dem Gebiete der
Rontgenstrahlen und der Nuklearmedizin. 1994;160:46-51.
382. Dunphy FR, Spitzer G, Fornoff JE, et al. Factors predicting long-term survival for metastatic
breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer.
1994;73:2157-2167.
383. Ercan MT, Aras T, Aktas A, Kaya S, Bekdik CF. Accumulation of 99mTc-glutathione in head
and neck tumors. Nuklearmedizin. Nuclear medicine. 1994;33:224-228.
384. Eriksson B, Lilja A, Ahlstrom H, et al. Positron-emission tomography as a radiological
technique in neuroendocrine gastrointestinal tumors. Annals of the New York Academy of
Sciences. 1994;733:446-452.
385. Falcone A, Pfanner E, Ricci S, et al. Oral doxifluridine in elderly patients with metastatic
colorectal cancer: a multicenter phase II study. Annals of oncology : official journal of the
European Society for Medical Oncology / ESMO. 1994;5:760-762.
386. Feun LG, Reddy KR, Yrizarry JM, et al. A phase I study of chemoembolization with cisplatin
and lipiodol for primary and metastatic liver cancer. American journal of clinical oncology.
1994;17:405-410.
387. Filippone A, Basilico R, Guidotti A, Boni R, Belfiore G, Bonomo L. [Color Doppler
ultrasonography in the identification and characterization of secondary focal lesions of the liver].
La Radiologia medica. 1994;87:283-288.
388. Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for
metastatic colorectal cancer. Annals of surgery. 1994;220:657-662.
389. Fornari F, Filice C, Rapaccini GL, et al. Small (< or = 3 cm) hepatic lesions. Results of
sonographically guided fine-needle biopsy in 385 patients. Digestive diseases and sciences.
1994;39:2267-2275.
390. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT. Surgery in Zollinger-Ellison
syndrome alters the natural history of gastrinoma. Annals of surgery. 1994;220:320-328;
discussion 328-330.
391. Frasci G, Leone F, Monaco M, et al. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of
Dukes C colorectal cancer. Diseases of the colon and rectum. 1994;37:643-650.
392. Frenette PS, Thirlwell MP, Trudeau M, Thomson DM, Joseph L, Shuster JS. The diagnostic
value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA
19-9 in breast and gastrointestinal malignancies. Tumour biology : the journal of the International
Society for Oncodevelopmental Biology and Medicine. 1994;15:247-254.
393. Furukawa Y, Otani Y, Ihara A, et al. [Effect of prophylactic intra-arterial infusion of
anticancer drugs on post hepatic resection for hepatic metastasis of colorectal cancer]. Gan to
kagaku ryoho. Cancer & chemotherapy. 1994;21 Suppl 4:453-457.
394. Futatsuki K, Wakui A, Nakao I, et al. [Late phase II study of irinotecan hydrochloride
(CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group]. Gan to
kagaku ryoho. Cancer & chemotherapy. 1994;21:1033-1038.
395. Giovannini M, Seitz JF. Ultrasound-guided percutaneous alcohol injection of small liver
metastases. Results in 40 patients. Cancer. 1994;73:294-297.
396. Goss PE, Baptiste J, Fernandes B, Baker M, Dennis JW. A phase I study of swainsonine in
patients with advanced malignancies. Cancer research. 1994;54:1450-1457.
397. Hafstrom L, Engaras B, Holmberg SB, et al. Treatment of liver metastases from colorectal
cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A
randomized clinical trial. Cancer. 1994;74:2749-2756.
398. Hafstrom LR, Holmberg SB, Naredi PL, et al. Isolated hyperthermic liver perfusion with
chemotherapy for liver malignancy. Surgical oncology. 1994;3:103-108.
399. Ham B, Reichel M, Vogl T, Taupitz M, Wolf KJ. [Superparamagnetic iron particles. The
clinical results in the MR diagnosis of liver metastases]. RoFo : Fortschritte auf dem Gebiete der
Rontgenstrahlen und der Nuklearmedizin. 1994;160:52-58.
400. Hata Y, Morita S, Hisa N, et al. [Evaluation of arterial infusion chemotherapy for advanced
gallbladder cancer using implantable port]. Gan to kagaku ryoho. Cancer & chemotherapy.
1994;21:2639-2643.
401. Hayakawa M, Morise K, Chin K, et al. Combination chemotherapy with Tegafur. Uracil
(UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. Japanese
journal of clinical oncology. 1994;24:282-288.
402. Hohneker JA. A summary of vinorelbine (Navelbine) safety data from North American
clinical trials. Seminars in oncology. 1994;21:42-46; discussion 46-47.
403. Hu RH, Lee CS, Lee PH, et al. Therapeutic effect of liver resection in patients with
metastatic liver tumors. Journal of the Formosan Medical Association = Taiwan yi zhi.
1994;93:227-233.
404. Huland E, Heinzer H, Huland H. Inhaled interleukin-2 in combination with low-dose
systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell
carcinoma: effectiveness and toxicity of mainly local treatment. Journal of cancer research and
clinical oncology. 1994;120:221-228.
405. Hussain M, Wolf M, Marshall E, Crawford ED, Eisenberger M. Effects of continued
androgen-deprivation therapy and other prognostic factors on response and survival in phase II
chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1994;12:1868-1875.
406. Iacobelli S, Sismondi P, Giai M, et al. Prognostic value of a novel circulating serum 90K
antigen in breast cancer. British journal of cancer. 1994;69:172-176.
407. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic
artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for
adenocarcinoma of the pancreas. American journal of surgery. 1994;168:361-364.
408. Itoh T, Anzai K, Ishii M, et al. [Evaluation of combination chemotherapy for advanced
gastric carcinoma as a neoadjuvant chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:495-500.
409. Izumi R, Shimizu K, Iyobe T, et al. Postoperative adjuvant hepatic arterial infusion of
Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology
(Baltimore, Md.). 1994;20:295-301.
410. Jeng KS, Chen BF, Lin HJ. En bloc resection for extensive hepatocellular carcinoma: is it
advisable? World journal of surgery. 1994;18:834-839.
411. Jodrell DI, Murray LS, Reed NS, Canney PA, Kaye SB, Cassidy J. Bolus/infusional
5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being
used in the UK? British journal of cancer. 1994;70:749-752.
412. Juhlin C, Papanicolaou V, Arnberg H, et al. Clinical and biochemical effects in vivo of
monoclonal antitumor antibody in Verner-Morrison's syndrome. Cancer. 1994;73:1346-1352.
413. Kameyama M, Nakamori S, Imaoka S, et al. [Adjuvant chemo-endocrine chemotherapy with
gastrin antagonist after resection of liver metastasis in colorectal cancer]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1994;21:2169-2171.
414. Keilholz U, Scheibenbogen C, Brado M, et al. Regional adoptive immunotherapy with
interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases. European journal
of cancer (Oxford, England : 1990). 1994;30a:103-105.
415. Kemeny N, Conti JA, Cohen A, et al. Phase II study of hepatic arterial floxuridine,
leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1994;12:2288-2295.
416. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for
unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
Cancer. 1994;73:1134-1142.
417. Kim H, Rosenberg SA, Steinberg SM, Cole DJ, Weber JS. A randomized double-blinded
comparison of the antiemetic efficacy of ondansetron and droperidol in patients receiving
high-dose interleukin-2. Journal of immunotherapy with emphasis on tumor immunology : official
journal of the Society for Biological Therapy. 1994;16:60-65.
418. Kirsch CM, von Pawel J, Grau I, Tatsch K. Indium-111 pentetreotide in the diagnostic
work-up of patients with bronchogenic carcinoma. European journal of nuclear medicine.
1994;21:1318-1325.
419. Leen E, Angerson WJ, Warren HW, et al. Improved sensitivity of colour Doppler flow
imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report. The
British journal of surgery. 1994;81:252-254.
420. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cooke TG, McArdle CS. Comparison of
the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver
metastases. Evaluation with postoperative follow-up results. Annals of surgery. 1994;220:663-667.
421. Maffioli L, Mascheroni L, Mongioj V, et al. Scintigraphic detection of melanoma metastases
with a radiolabeled benzamide ([iodine-123]-(S)-IBZM). Journal of nuclear medicine : official
publication, Society of Nuclear Medicine. 1994;35:1741-1747.
422. Maresca G, Barbaro B, Summaria V, et al. Color Doppler ultrasonography in the differential
diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience. La Radiologia medica.
1994;87:41-49.
423. Martin M, Lluch A, Casado A, et al. Clinical activity of chronic oral etoposide in previously
treated metastatic breast cancer. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1994;12:986-991.
424. Martinelli DJ, Wadler S, Bakal CW, et al. Utility of embolization or chemoembolization as
second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer.
1994;74:1706-1712.
425. Maruo H, Kosaka A. [Evaluation of cases of metastatic liver tumors resected following
intra-arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy.
1994;21:2143-2146.
426. Masuyama M, Taniguchi H, Takeuchi K, et al. [Recurrence and survival rate of advanced
gastric cancer after preoperative EAP-II intra-arterial infusion therapy]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1994;21:2253-2255.
427. Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of
hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of
metastatic hepatocellular carcinoma. Hepatology (Baltimore, Md.). 1994;20:1418-1425.
428. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in
predicting recurrent disease following curative resection of colorectal cancer. Diseases of the
colon and rectum. 1994;37:875-881.
429. Metzger U, Laffer U, Egeli R, et al. [Status of portal perfusion in colorectal cancer. Swiss
Study Group for Clinical Cancer Research]. Der Chirurg; Zeitschrift fur alle Gebiete der
operativen Medizen. 1994;65:509-513.
430. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas:
distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology.
1994;193:49-57.
431. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced
carcinoid tumors and islet cell carcinomas. Annals of internal medicine. 1994;120:302-309.
432. Morita M, Kuwano H, Toh Y, Matsuda H, Matsumata T, Sugimachi K. The clinical
characteristics of patients with synchronous squamous cell carcinoma of the esophagus and
hepatocellular carcinoma. Surgery today. 1994;24:803-808.
433. Munck JN, Rougier P, Chabot GG, et al. Phase I and pharmacological study of intra-arterial
hepatic administration of pirarubicin in patients with advanced hepatic metastases. European
journal of cancer (Oxford, England : 1990). 1994;30a:289-294.
434. Murray JL, Rosenblum MG, Zhang HZ, et al. Comparative tumor localization of whole
immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4
F(ab')2 in colorectal cancer patients. Cancer. 1994;73:850-857.
435. Muss HB, Case LD, Atkins JN, et al. Tamoxifen versus high-dose oral medroxyprogesterone
acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont
Oncology Association study. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1994;12:1630-1638.
436. Nordlinger B, Vaillant JC, Guiguet M, et al. Survival benefit of repeat liver resections for
recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1994;12:1491-1496.
437. Okawa T, Tanaka M, Kita M, et al. Radiotherapy for superficial esophageal cancer.
International journal of radiation oncology, biology, physics. 1994;30:959-964.
438. Pavlidis N, Kalef-Ezra J, Briassoulis E, et al. Evaluation of six tumor markers in patients
with carcinoma of unknown primary. Medical and pediatric oncology. 1994;22:162-167.
439. Pazdur R, Lassere Y, Rhodes V, et al. Phase II trial of uracil and tegafur plus oral leucovorin:
an effective oral regimen in the treatment of metastatic colorectal carcinoma. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1994;12:2296-2300.
440. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from
colorectal cancer. Indications and results. Diseases of the colon and rectum. 1994;37:1078-1082.
441. Pelizzo MR, Bernante P, Piotto A, et al. The extent of surgery for thyroid medullary cancer.
Tumori. 1994;80:427-432.
442. Philip PA, Carmichael J, Tonkin K, Ganesan TA, Harris AL. A phase II study of high-dose
hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.
European journal of cancer (Oxford, England : 1990). 1994;30a:1027-1029.
443. Possinger K, Jonat W, Hoffken K. Formestane in the treatment of advanced postmenopausal
breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology
/ ESMO. 1994;5 Suppl 7:S7-10.
444. Raoul JL, Guyader D, Bretagne JF, et al. Randomized controlled trial for hepatocellular
carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical
support. Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
1994;35:1782-1787.
445. Rodot S, Darcourt J, Bussiere F, et al. A radiolabelled iodobenzamide for malignant
melanoma staging. Melanoma research. 1994;4:307-312.
446. Rollan Villamarin V, Garcia Aroca J, Costa Borras E, et al. [Neuroblastoma IV-S. A
multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica. 1994;7:167-170.
447. Rossi P, Bezzi M, Rossi M, et al. Metallic stents in malignant biliary obstruction: results of a
multicenter European study of 240 patients. Journal of vascular and interventional radiology :
JVIR. 1994;5:279-285.
448. Rubin J, Charboneau JW, Reading C, Kovach JS. Phase I study of immunotherapy of hepatic
metastases of colorectal carcinoma by direct gene transfer. Human gene therapy.
1994;5:1385-1399.
449. Sakata Y, Shimada Y, Yoshino M, et al. [A late phase II study of CPT-11, irinotecan
hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on
Gastrointestinal Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:1039-1046.
450. Saltz L, Murphy B, Kemeny N, et al. A phase I trial of intrahepatic verapamil and
doxorubicin. Regional therapy to overcome multidrug resistance. Cancer. 1994;74:2757-2764.
451. Sansalone CV, Colella G, Caccamo L, et al. Orthotopic liver transplantation for primary
biliary tumors: Milan multicenter experience. Transplantation proceedings. 1994;26:3561-3563.
452. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin
chemotherapy does not improve long-term survival after surgery for advanced gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1994;12:970-974.
453. Secco GB, Fardelli R, Campora E, et al. Preoperative intra-arterial mitomycin-C in the
management of sigmoid adenocarcinoma: long-term results of a pilot study. Tumori.
1994;80:339-343.
454. Sella A, Kilbourn RG, Gray I, et al. Phase I study of interleukin-2 combined with
interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer. Cancer biotherapy.
1994;9:103-111.
455. Seshimo A, Aratake T, Matsumoto M, et al. [Intraarterial infusion combination therapy with
LV and 5-FU in hepatic metastases from colorectal cancer]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1994;21:2162-2164.
456. Solomon MJ, Stephen MS, Gallinger S, White GH. Does intraoperative hepatic
ultrasonography change surgical decision making during liver resection? American journal of
surgery. 1994;168:307-310.
457. Takahashi K, Mori T, Takahashi T. [Hepatic arterial infusion after hepatectomy for liver
metastases of colorectal carcinoma to prevent residual hepatic recurrence]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1994;21:2165-2168.
458. Takahashi T, Misuta K, Masui H, Ike H, Ohki S, Shimada H. [A study of regional
chemotherapy: hepatic arterial infusion for metastatic liver tumors]. Gan to kagaku ryoho. Cancer
& chemotherapy. 1994;21:2155-2157.
459. Takano S, Moriguchi M, Seki N, et al. [The significance of portal infusion chemotherapy for
prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:2176-2178.
460. Takeda J, Tanaka T, Koufuji K, Kodama I, Tsuji Y, Kakegawa T. Gastric cancer surgery in
patients aged at least 80 years old. Hepato-gastroenterology. 1994;41:516-520.
461. Tamaki Y, Tono T, Kobayashi K, et al. [Combination with intra-hepatic arterial infusion of
low-dose cisplatin and oral administration of high-dose doxyfluridine in patients with liver
metastases of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:2140-2142.
462. Thigpen JT, Blessing JA, DiSaia PJ, Yordan E, Carson LF, Evers C. A randomized
comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management
of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. Journal
of clinical oncology : official journal of the American Society of Clinical Oncology.
1994;12:1408-1414.
463. Tomita K, Arai Y, Inaba Y, Ohashi K, Ariyoshi Y. [The value of hepatic arterial infusion
chemotherapy for liver metastases--discussion from viewpoints of prevention of hepatic death and
QOL]. Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:2147-2150.
464. Tono T, Tamaki Y, Yagyu T, et al. [Evaluation of prophylactic intra-hepatic-arterial infusion
chemotherapy after resection of hepatic metastases from colorectal primaries]. Gan to kagaku
ryoho. Cancer & chemotherapy. 1994;21:2158-2161.
465. Tosteson AN, Weinstein MC, Wittenberg J, Begg CB. ROC curve regression analysis: the use
of ordinal regression models for diagnostic test assessment. Environmental health perspectives.
1994;102 Suppl 8:73-78.
466. Valeri A, Mini E, Tonelli P, et al. Intra-arterial hepatic chemotherapy with 5-fluorouracil and
5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer.
Anticancer research. 1994;14:2215-2219.
467. Virgolini I, Raderer M, Kurtaran A, et al. Vasoactive intestinal peptide-receptor imaging for
the localization of intestinal adenocarcinomas and endocrine tumors. The New England journal of
medicine. 1994;331:1116-1121.
468. Vogel CL, Gomez EG. A phase I clinical trial of a combination of mitoxantrone,
5-fluorouracil, and high-dose leucovorin given on a day 1 and day 8 schedule to patients with
metastatic breast cancer. American journal of clinical oncology. 1994;17:45-49.
469. Vogl TJ, Hammerstingl R, Pegios W, et al. [The value of the liver-specific superparamagnetic
contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors
versus metastases]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der
Nuklearmedizin. 1994;160:319-328.
470. Warren HW, Anderson JH, O'Gorman P, et al. A phase II study of regional 5-fluorouracil
infusion with intravenous folinic acid for colorectal liver metastases. British journal of cancer.
1994;70:677-680.
471. Weber J, Gunn H, Yang J, et al. A phase I trial of intravenous interleukin-6 in patients with
advanced cancer. Journal of immunotherapy with emphasis on tumor immunology : official
journal of the Society for Biological Therapy. 1994;15:292-302.
472. Welt S, Divgi CR, Scott AM, et al. Antibody targeting in metastatic colon cancer: a phase I
study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal
fibroblasts. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 1994;12:1193-1203.
473. Wilson WH, Berg SL, Bryant G, et al. Paclitaxel in doxorubicin-refractory or
mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1994;12:1621-1629.
474. Yamamura T. [Home therapy approach in cancer patients-chemotherapy (case 2-2)]. Gan to
kagaku ryoho. Cancer & chemotherapy. 1994;21 Suppl 4:554-556; discussion 557.
475. Zalcberg JR, Pietersz G, Toohey B, et al. A phase I/II study of the intralesional injection of
ricin-monoclonal antibody conjugates in patients with hepatic metastases. European journal of
cancer (Oxford, England : 1990). 1994;30a:1227-1231.
476. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer.
Swiss Group for Clinical Cancer Research (SAKK). Lancet. 1995;345:349-353.
477. Adenis A, Carlier D, Darloy F, Pion JM, Bonneterre J, Demaille A. Cytarabine and cisplatin
as salvage therapy in patients with metastatic colorectal cancer who failed 5-fluorouracil + folinic
acid regimen. French Northern Oncology Group. American journal of clinical oncology.
1995;18:158-160.
478. Arai K, Kitamura M, Iwasaki Y. [Changes in CT-scan findings of liver metastases from
gastric carcinoma treated by hepatic arterial infusion chemotherapy, especially after
chemo-embolization and induced hypertensive chemotherapy]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1995;22:1504-1507.
479. Atzpodien J, Kirchner H, Duensing S, et al. Biochemotherapy of advanced metastatic
renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil,
vinblastine, and 13-cis-retinoic acid. World journal of urology. 1995;13:174-177.
480. Atzpodien J, Lopez Hanninen E, Kirchner H, et al. Multiinstitutional home-therapy trial of
recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell
carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 1995;13:497-501.
481. Bignami P, Doci R, Montalto F, Fissi S, di Bartolomeo M, Gennari L. Feasibility of
intraportal chemotherapy with fluorouracil and folinic acid immediately after hepatic resection for
colorectal metastases. Tumori. 1995;81:96-101.
482. Bruno S, Puerto VL, Mickiewicz E, et al. Phase II trial of weekly i.v. vinorelbine as a single
agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
American journal of clinical oncology. 1995;18:392-396.
483. Closon MT, Verbeke L, Kains JP, Tijtgat J, Schallier D. Combination chemotherapy with
carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer. Anticancer research.
1995;15:591-595.
484. Crivellari D, Price KN, Hagen M, et al. Routine tests during follow-up of patients after
primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group
(IBCSG). Annals of oncology : official journal of the European Society for Medical Oncology /
ESMO. 1995;6:769-776.
485. Cunningham D, Zalcberg JR, Rath U, et al. 'Tomudex' (ZD1694): results of a randomised
trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia.
The 'Tomudex' Colorectal Cancer Study Group. European journal of cancer (Oxford, England :
1990). 1995;31a:1945-1954.
486. Daldrup HE, Reimer P, Rummeny EJ, et al. [New super-paramagnetic iron particles for MRI.
Phase II study of malignant liver tumors]. Der Radiologe. 1995;35:486-493.
487. de Wit R, Stoter G, Sleijfer DT, et al. Four cycles of BEP versus an alternating regime of PVB
and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study
of the EORTC Genitourinary Tract Cancer Cooperative Group. British journal of cancer.
1995;71:1311-1314.
488. Bozzetti F, Terno G, Longoni C. [Postoperative parenteral hyperalimentation and wound
healing in oncological surgery (author's transl)]. Tumori. 1974;60:53-63.
489. Farmer RG. Preoperative preparation of the patients with carcinoma of the colon. The
Surgical clinics of North America. 1975;55:1335-1341.
490. Goldring J, McNaught W, Scott A, Gillespie G. Prophylactic oral antimicrobial agents in
elective colonic surgery. A controlled trial. Lancet. 1975;2:997-1000.
491. Bruckner R, Kempf P, Kutzner J, Brunner H. [Preliminary results of preoperative
radiotherapy in carcinoma of the rectum (author's transl)]. Deutsche medizinische Wochenschrift
(1946). 1977;102:195-198.
492. Kligerman MM. Radiotherapy and rectal cancer. Cancer. 1977;39:896-900.
493.Yura J, Kato F, Shibata K. Postoperative infections in colorectal surgery. International surgery.
1978;63:61-62.
494. Keighley MR, Arabi Y, Alexander-Williams J, Youngs D, Burdon DW. Comparison between
systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979;1:894-897.
495. Molin K, Rieger A. Effect of preoperative oral administration of oxytetracycline and
neomycin on postoperative infectious complications in cases of cancer coli-recti. Acta chirurgica
Scandinavica. 1979;145:177-183.
496. Terranova O, Sandei F, Rebuffat C, Maruotti R, Pezzuoli G. Management of the perineal
wound after rectal excision for neoplastic disease: a controlled clinical trial. Diseases of the colon
and rectum. 1979;22:228-233.
497. Bolton RA, Britton DC. Restorative surgery of the rectum with a circumferential stapler.
Lancet. 1980;1:850-851.
498. Nilsson E, Lamke LO, Liljedahl SO, Elfstrom K. Is albumin therapy worthwhile in surgery
for colorectal cancer? Acta chirurgica Scandinavica. 1980;146:619-622.
499. Aeberhard P, Fluckiger M, Berger J, Novak A. [Parenteral antibiotic prophylaxis or oral
antimicrobial bowel preparation for colorectal surgery (author's transl)]. Langenbecks Archiv fur
Chirurgie. 1981;353:233-240.
500. Oberst MT, Graham D, Geller NL, Stearns MW, Jr., Tiernan E. Catheter management
programs and postoperative urinary dysfunction. Research in nursing & health. 1981;4:175-181.
501. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in rectosigmoid
cancer Dukes' B and C: interim report from a randomized multicentre study. British journal of
cancer. 1982;46:551-556.
502. Steele G, Jr., Ellenberg S, Ramming K, et al. CEA monitoring among patients in
multi-institutional adjuvant G.I. therapy protocols. Annals of surgery. 1982;196:162-169.
503. Graffner H, Fredlund P, Olsson SA, Oscarson J, Petersson BG. Protective colostomy in low
anterior resection of the rectum using the EEA stapling instrument. A randomized study. Diseases
of the colon and rectum. 1983;26:87-90.
504. Knysh VI, Aliev BM, Barsukov Iu A. [Combination treatment of rectal cancer using 2
variants of preoperative concentration gamma therapy]. Meditsinskaia radiologiia. 1983;28:12-17.
505. Roth E, Funovics J, Karner J, Huk I, Schulz F, Fritsch A. [Lack of stimulation of nitrogen
retention and plasma protein synthesis due to increased intake of branched-chain amino acids].
Infusionstherapie und klinische Ernahrung. 1983;10:259-266.
506. Bauer E, Graber R, Brodtke R, Lunstedt B, Seifert J. [Nutrition physiologic, immunologic
and clinical parameters in prospective randomized patients by enteral or parenteral nutrition
therapy following large intestine operations]. Infusionstherapie und klinische Ernahrung.
1984;11:165-167.
507. Cummings BJ. Adjuvant radiation therapy for rectal adenocarcinoma. Diseases of the colon
and rectum. 1984;27:826-836.
508. Higgins GA, Donaldson RC, Rogers LS, Juler GL, Keehn RJ. Efficacy of MER
immunotherapy when added to a regimen of 5-fluorouracil and methyl-CCNU following resection
for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
Cancer. 1984;54:193-198.
509. Knysh VI, Aliev BM, Bondar GV, Dvoirin VV, Barsukov Iu A. [Effectiveness of combined
and complex treatment of patients with operable cancer of the rectum]. Voprosy onkologii.
1984;30:42-48.
510. Kujath P, Bruch HP, Schmidt E, Doll W. [Perioperative prophylaxis in elective colorectal
surgery]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1984;55:519-522.
511. Lohr J, Wagner PK, Rothmund M. [Perioperative antibiotic prophylaxis (single or multiple
dose) in elective colorectal surgery. A randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete
der operativen Medizen. 1984;55:512-514.
512. Wacha H, Probst M. [Healing of the sacral wound cavity after abdomino-perineal extirpation
of the rectum. A prospective randomized study using metronidazole]. Der Chirurg; Zeitschrift fur
alle Gebiete der operativen Medizen. 1984;55:29-31.
513. Athanasiadis S, Kuhlgatz C, Hahnel E. [Perioperative antibiotic prevention in colon and
rectum surgery. A randomized study on the value of single dose prevention]. Zentralblatt fur
Chirurgie. 1985;110:532-538.
514. Cedermark B, Theve NO, Rieger A, et al. Preoperative short-term radiotherapy in rectal
carcinoma. A preliminary report of a prospective randomized study. Cancer. 1985;55:1182-1185.
515. Duus BR, Philipsen T, Christensen JD, Lundvall F, Sondergaard J. Refractory condylomata
acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment.
Genitourinary medicine. 1985;61:59-61.
516. Fleites RA, Marshall JB, Eckhauser ML, Mansour EG, Imbembo AL, McCullough AJ. The
efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel
preparation for elective colonic surgery: a randomized, prospective, blinded clinical trial. Surgery.
1985;98:708-717.
517. Jacobsen MB, Sorensen B, Melsom M, Aspestrand F, Andersen J. [Postoperative control of
patients operated on for colonic cancer. A comparative study of coloscopy and double contrast
radiography]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
1985;105:742-743.
518. Pahlman L, Glimelius B, Graffman S. Pre- versus postoperative radiotherapy in rectal
carcinoma: an interim report from a randomized multicentre trial. The British journal of surgery.
1985;72:961-966.
519. Parker MC, Ashby EC, Nicholls MW, Dowding CH, Brookes JC. Povidone-iodine bowel
irrigation before resection of colorectal carcinoma. Annals of the Royal College of Surgeons of
England. 1985;67:227-228.
520. Winkler R. [Adjuvant radiotherapy in rectosigmoid cancers]. Zentralblatt fur Chirurgie.
1985;110:124-136.
521. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C
carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer.
1986;58:22-28.
522. Fujimoto M, Sakai K, Ueda T. [Significance of amikacin administered orally prior to
operation for prevention of postoperative infections in colonic cancer surgery]. The Japanese
journal of antibiotics. 1986;39:2889-2896.
523. Higgins GA, Humphrey EW, Dwight RW, Roswit B, Lee LE, Jr., Keehn RJ. Preoperative
radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group
Trial II. Cancer. 1986;58:352-359.
524. Kingston RD, Duthie J. Serious postoperative bleeding associated with a single intravenous
dose of cefuroxime and metronidazole. The Journal of hospital infection. 1986;7:100-101.
525. Nakazato H, Ichihashi H, Kondo T. [Clinical results of a randomized controlled trial on the
effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively
resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai
Gastrointestinal Oncology Group]. Gan to kagaku ryoho. Cancer & chemotherapy.
1986;13:308-318.
526. Short-term preoperative radiotherapy for adenocarcinoma of the rectum. An interim analysis
of a randomized multicenter trial. Stockholm Rectal Cancer Study Group. American journal of
clinical oncology. 1987;10:369-375.
527. Adalsteinsson B, Pahlman L, Hemmingsson A, Glimelius B, Graffman S. Computed
tomography in early diagnosis of local recurrence of rectal carcinoma. Acta radiologica
(Stockholm, Sweden : 1987). 1987;28:41-47.
528. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. The immediate and long-term
effects of postoperative total parenteral nutrition on body composition. International journal of
colorectal disease. 1987;2:139-145.
529. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. Postoperative complications in
colorectal surgery in relation to preoperative clinical and nutritional state and postoperative
nutritional treatment. International journal of colorectal disease. 1987;2:87-92.
530. Hallerback B, Carlsen E, Carlsson K, et al. Beta-adrenoceptor blockade in the treatment of
postoperative adynamic ileus. Scandinavian journal of gastroenterology. 1987;22:149-155.
531. Racette DL, Chang FC, Trekell ME, Farha GJ. Is nasogastric intubation necessary in colon
operations? American journal of surgery. 1987;154:640-642.
532. Windle R, Bell PR, Shaw D. Five year results of a randomized trial of adjuvant 5-fluorouracil
and levamisole in colorectal cancer. The British journal of surgery. 1987;74:569-572.
533. Zilli L, Pietroiusti M, Bertario L. Colonoscopy in ostomy patients. Results at the first
postoperative examination. Diseases of the colon and rectum. 1987;30:687-691.
534. Balslev I, Pedersen M, Teglbjaerg PS, et al. [Postoperative radiotherapy in cancer of the
rectum and rectosigmoid. A prospective randomized multicenter study]. Ugeskrift for laeger.
1988;150:1958-1961.
535. Buess G, Kipfmuller K, Ibald R, et al. Clinical results of transanal endoscopic microsurgery.
Surgical endoscopy. 1988;2:245-250.
536. Chlebowski RT, Nystrom S, Reynolds R, Weiner JM, Bateman JR. Long-term survival
following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study
Group Trial. Oncology. 1988;45:141-143.
537.Coppa GF, Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery.
Surgery. 1988;104:853-858.
538. Grundmann R, Weber F, Kluger J, Wienand P, Pulverer G. [Preoperative nonspecific
immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer.
A prospective randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
1988;59:272-278.
539. Kikuchi K, Shimizu H. [Clinical study of postoperative infection of gastrointestinal cancer.
Randomized study of preventive efficacy of cefmetazole versus cephalothin in postoperative
infection
of
gastric
and
colorectal
cancer].
The
Japanese
journal
of
antibiotics.
1988;41:1480-1492.
540. Lau WY, Chu KW, Poon GP, Ho KK. Prophylactic antibiotics in elective colorectal surgery.
The British journal of surgery. 1988;75:782-785.
541. Petrelli NJ, Conte CC, Herrera L, Stulc J, O'Neill P. A prospective, randomized trial of
perioperative prophylactic cefamandole in elective colorectal surgery for malignancy. Diseases of
the colon and rectum. 1988;31:427-429.
542. Vara-Thorbeck R, Rosell J, Salvi M, Vara-Thorbeck C. [Preoperative hemodilution for the
prevention of postoperative deep venous thrombosis and early infectious complications in
colorectal resections]. Zentralblatt fur Chirurgie. 1988;113:1204-1209.
543. Bittner R, Butters M, Rampf W, Kapfer X. [Duration of the preventive use of antibiotics in
colorectal surgery--single administration versus short-term prevention]. Langenbecks Archiv fur
Chirurgie. 1989;374:272-279.
544. Fielding LP, Phillips RK, Hittinger R. Factors influencing mortality after curative resection
for large bowel cancer in elderly patients. Lancet. 1989;1:595-597.
545. Jauch KW, Gunther B, Wicklmayr M, Dietze GJ, Schrofel L. Bradykinin infusion in long
term postoperative parenteral nutrition improves nitrogen balance and protein synthesis. Advances
in experimental medicine and biology. 1989;247A:581-585.
546. Kling PA, Dahlgren S. Oral prophylaxis with neomycin and erythromycin in colorectal
surgery. More proof for efficacy than failure. Archives of surgery (Chicago, Ill. : 1960).
1989;124:705-707.
547. Knysh VI, Prorokov VV, Goldobenko GV, Barkanov AI. [Use of preoperative intensive
irradiation in the combined treatment of patients with colon cancer]. Voprosy onkologii.
1989;35:25-30.
548. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal
cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.
Scandinavian journal of gastroenterology. 1989;24:599-606.
549. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel
carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The
North Central Cancer Treatment Group and the Mayo Clinic. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 1989;7:1447-1456.
550. Lewis RT, Goodall RG, Marien B, Lloyd-Smith W, Park M, Wiegand FM. Is neomycin
necessary for bowel preparation in surgery of the colon? Oral neomycin plus erythromycin versus
erythromycin-metronidazole. Canadian journal of surgery. Journal canadien de chirurgie.
1989;32:265-270.
551. Mertes N, Pfisterer M, Winde G, et al. [Protein oriented peripheral venous nutrition following
surgical trauma]. Infusionstherapie (Basel, Switzerland). 1989;16:60-66.
552. Mitomi T, Tsuchiya S, Iijima N, et al. [Randomized controlled study on adjuvant
immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study
Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum]. Gan to
kagaku ryoho. Cancer & chemotherapy. 1989;16:2241-2249.
553. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on
muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231-233.
554. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective
randomized trial. Stockholm Rectal Cancer Study Group. Cancer. 1990;66:49-55.
555. Alberts DS, Einspahr J, Rees-McGee S, et al. Effects of dietary wheat bran fiber on rectal
epithelial cell proliferation in patients with resection for colorectal cancers. Journal of the National
Cancer Institute. 1990;82:1280-1285.
556. Beart RW, Jr., Moertel CG, Wieand HS, et al. Adjuvant therapy for resectable colorectal
carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and
the North Central Cancer Treatment Group. Archives of surgery (Chicago, Ill. : 1960).
1990;125:897-901.
557. Braga M, Baccari P, Di Palo S, et al. Effectiveness of perioperative short-term antibiotic
prophylaxis in reducing surgical risk induced by malnutrition and anergy. Acta chirurgica
Scandinavica. 1990;156:751-757.
558. Burke ER, Welvaart K. Complications of stapled anastomoses in anterior resection for rectal
carcinoma: colorectal anastomosis versus coloanal anastomosis. Journal of surgical oncology.
1990;45:180-183.
559. Butters M, Miller W, Bittner R. [Effect of enteral and parenteral nutrition on glucose
tolerance
in
the
early
postoperative
phase].
Infusionstherapie
(Basel,
Switzerland).
1990;17:257-260.
560. Harju E, Huttunen J, Yla-Herttuala S. Clinical and metabolic effects and wound healing
metabolism in controlled total parenteral nutrition with high vs. low nitrogen content for seven
days after abdominoperineal rectum resection for carcinoma. Chirurgia italiana. 1990;42:151-164.
561. Horn A, Morild I, Dahl O. Tumour shrinkage and down staging after preoperative radiation
of rectal adenocarcinomas. Radiotherapy and oncology : journal of the European Society for
Therapeutic Radiology and Oncology. 1990;18:19-28.
562. Knysh VI, Bondar GV, Barsukov Iu A, Timofeev Iu M, Basheev V. [Combined treatment of
rectal cancer using intensive macrofractional preoperative irradiation]. Khirurgiia. 1990:53-57.
563. Lehner B, Schlag P, Liebrich W, Schirrmacher V. Postoperative active specific immunization
in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell
vaccine. Cancer immunology, immunotherapy : CII. 1990;32:173-178.
564. Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in human gastrointestinal
malignancies. Digestion. 1990;46 Suppl 2:430-438.
565. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant
therapy of resected colon carcinoma. The New England journal of medicine. 1990;322:352-358.
566. Nikolov K. [The postoperative changes in the cellular immune response in vivo in patients
with colorectal carcinoma after preoperative acute normovolemic hemodilution--a randomized,
prospective and comparative study]. Khirurgiia. 1990;43:25-30.
567. Nikolov K, Videlov D, Lazarov S, Kalcheva V, Atanasov A. [A modified technic of
preoperative acute normovolemic hemodilution--the advantages and economic effect of its use in
planned colorectal surgery]. Khirurgiia. 1990;43:30-37.
568. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid
carcinoma. Report from a randomized multicenter trial. Annals of surgery. 1990;211:187-195.
569. Peters KM, Bornhofen B, Grundmann R, et al. [Neopterin as a marker of aspecific
immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors.
A prospective randomized study]. Medizinische Klinik (Munich, Germany : 1983).
1990;85:421-424.
570. Rosenthal SA, Trock BJ, Coia LR. Randomized trials of adjuvant radiation therapy for rectal
carcinoma: a review. Diseases of the colon and rectum. 1990;33:335-343.
571. Rouffet F, Mathon C, Vendroux J. [Extend of colonic excision in the curative treatment of
cancers of the left colon. Left or segmental hemicolectomy? A controlled prospective multicenter
study]. Chirurgie; memoires de l'Academie de chirurgie. 1990;116:419-423; discussion 424.
572. Thirlby RC. Preoperative radiotherapy is better than postoperative radiotherapy in patients
with rectal cancer. Gastroenterology. 1990;99:895-897.
573. Becker JM, Alexander DP. Colectomy, mucosal proctectomy, and ileal pouch-anal
anastomosis. A prospective trial of optimal antibiotic management. Annals of surgery.
1991;213:242-247.
574. Carli F, Webster J, Pearson M, et al. Postoperative protein metabolism: effect of nursing
elderly patients for 24 h after abdominal surgery in a thermoneutral environment. British journal
of anaesthesia. 1991;66:292-299.
575. Daly L. The first international urokinase/warfarin trial in colorectal cancer. Clinical &
experimental metastasis. 1991;9:3-11.
576. Herbert SH, Curran WJ, Jr., Solin LJ, Stafford PM, Lanciano RM, Hanks GE. Decreasing
gastrointestinal morbidity with the use of small bowel contrast during treatment planning for
pelvic irradiation. International journal of radiation oncology, biology, physics. 1991;20:835-842.
577. James RD, Haboubi N, Schofield PF, Mellor M, Salhab N. Prognostic factors in colorectal
carcinoma treated by preoperative radiotherapy and immediate surgery. Diseases of the colon and
rectum. 1991;34:546-551.
578. Marks G, Mohiuddin M, Eitan A, Masoni L, Rakinic J. High-dose preoperative radiation and
radical sphincter-preserving surgery for rectal cancer. Archives of surgery (Chicago, Ill. : 1960).
1991;126:1534-1540.
579. Mutch RS, Hutson PR. Levamisole in the adjuvant treatment of colon cancer. Clinical
pharmacy. 1991;10:95-109.
580. Rosen HR, Marczell AP, Czerwenka E, Stierer MO, Spoula H, Wasl H. Local gentamicin
application for perineal wound healing following abdominoperineal rectum excision. American
journal of surgery. 1991;162:438-441.
581. Treurniet-Donker AD, van Putten WL, Wereldsma JC, et al. Postoperative radiation therapy
for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The
Netherlands. Cancer. 1991;67:2042-2048.
582. Radiation therapy and fluorouracil with or without semustine for the treatment of patients
with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1992;10:549-557.
583. Arnaud JP, Bellissant E, Boissel P, et al. Single-dose amoxycillin-clavulanic acid vs.
cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized
study. The PRODIGE Group. The Journal of hospital infection. 1992;22 Suppl A:23-32.
584. Bentzen SM, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of
Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A
multivariate regression analysis. British journal of cancer. 1992;65:102-107.
585. Braga M, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. [Perioperative administration of
thymopentin for the prevention of infections in oncologic surgery]. Minerva chirurgica.
1992;47:125-130.
586. Brivio F, Lissoni P, Tisi E, et al. Effects of a preoperative therapy with interleukin-2 on
surgery-induced lymphocytopenia in cancer patients. Oncology. 1992;49:215-218.
587. Buess G, Mentges B, Manncke K, Starlinger M, Becker HD. Technique and results of
transanal endoscopic microsurgery in early rectal cancer. American journal of surgery.
1992;163:63-69; discussion 69-70.
588. Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G. Prophylaxis of
infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis
undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial.
Surgery. 1992;112:24-31.
589. Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R. Continuing evolution
of the pelvic pouch procedure. Annals of surgery. 1992;216:506-511; discussion 511-502.
590. Coucke PA. Postoperative radiation therapy for rectal cancer: an interim analysis of a
prospective, randomized multicenter trial in The Netherlands. Cancer. 1992;69:3016-3017.
591. Folli S, Wagnieres G, Pelegrin A, et al. Immunophotodiagnosis of colon carcinomas in
patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.
Proceedings of the National Academy of Sciences of the United States of America.
1992;89:7973-7977.
592. Hermanek P. [Multivisceral resection of colorectal cancer--experiences of the Colorectal
Cancer Study Group]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche
Gesellschaft fur Chirurgie. Kongress. 1992:95-100.
593. Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M. Growth of colorectal polyps: design of a
prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps.
European journal of cancer prevention : the official journal of the European Cancer Prevention
Organisation (ECP). 1992;1:415-422.
594. Hoynck van Papendrecht MA, Hop W, Langenhorst BL, Kothe FC, Marquet RL, Jeekel J.
Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results
from a randomized clinical study. Vox sanguinis. 1992;62:102-107.
595. Kuroda M, Inamura K, Tahara S, et al. Report of a study using phantom materials, and
clinical experience with simultaneous radio-hyperthermotherapy. Acta medica Okayama.
1992;46:417-426.
596. Liu T, Liu Y, He S, Zhang Z, Kligerman MM. Use of radiation with or without WR-2721 in
advanced rectal cancer. Cancer. 1992;69:2820-2825.
597. Lohde E, Scholz L, Gemperle A, et al. [Comparative analysis of mezlocillin/metronidazole
and amoxicillin/clavulanic acid as "one shot" preventive antibiotic administration in colorectal
interventions]. Zentralblatt fur Chirurgie. 1992;117:325-330.
598. Lumley JW, Siu SK, Pillay SP, et al. Single dose ceftriaxone as prophylaxis for sepsis in
colorectal surgery. The Australian and New Zealand journal of surgery. 1992;62:292-296.
599. Mendenhall WM, Bland KI, Copeland EM, 3rd, et al. Does preoperative radiation therapy
enhance the probability of local control and survival in high-risk distal rectal cancer? Annals of
surgery. 1992;215:696-705; discussion 705-696.
600. Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant
immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study
Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Diseases of the colon and rectum. 1992;35:123-130.
601. Nichols PH, Ramsden CW, Ward U, Sedman PC, Primrose JN. Perioperative immunotherapy
with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer
research. 1992;52:5765-5769.
602. Poortmans PM, Hamers HP. Postoperative radiation therapy for rectal cancer: an interim
analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer.
1992;69:3017-3019.
603. Riwar A, Schar B, Grotzinger U. [Effect of continuous postoperative analgesia with peridural
bupivacaine on intestinal motility following colorectal resection]. Helvetica chirurgica acta.
1992;58:729-733.
604. Rosenthal SA, Yeung RS, Weese JL, et al. Conservative management of extensive low-lying
rectal carcinomas with transanal local excision and combined preoperative and postoperative
radiation therapy. A report of a phase I-II trial. Cancer. 1992;69:335-341.
605. Shoji Y, Kusunoki M, Fujita S, Yamamura T, Utsunomiya J. Functional role of the preserved
rectal cuff in ileoanal anastomosis. Surgery. 1992;111:266-273.
606. Wolters U, Keller HW, Schlesinger A, Pichlmaier H. [Preoperative intestinal lavage with a
polyethyleneglycol-containing solution. A prospective randomized study in comparison with
Ringer's lactate solution]. Zentralblatt fur Chirurgie. 1992;117:412-416.
607. Initial report from a Swedish multicentre study examining the role of preoperative irradiation
in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. The
British journal of surgery. 1993;80:1333-1336.
608. Bonzanini C, Ubiali P, Invernizzi R. [The use of piperacillin in the preoperative prophylaxis
of colorectal surgery]. Minerva chirurgica. 1993;48:1437-1443.
609. Brivio F, Lissoni P, Barni S, et al. Effects of a preoperative course of interleukin-2 on surgical
and immunobiological variables in patients with colorectal cancer: a phase 2 study. The European
journal of surgery = Acta chirurgica. 1993;159:43-47.
610. Cosimelli M, Tedesco M, Giannarelli D, et al. The role of the administration time of
prophylactic antibiotic therapy in colorectal cancer surgery: a review of 6,069 patients from 36
randomized clinical trials. Annali italiani di chirurgia. 1993;64:527-532.
611. Coucke PA, Cuttat JF, Mirimanoff RO. Adjuvant postoperative accelerated hyperfractionated
radiotherapy in rectal cancer: a feasibility study. International journal of radiation oncology,
biology, physics. 1993;27:885-889.
612. Falk PM, Beart RW, Jr., Wexner SD, et al. Laparoscopic colectomy: a critical appraisal.
Diseases of the colon and rectum. 1993;36:28-34.
613. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in
adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of
late secondary effects. Diseases of the colon and rectum. 1993;36:564-572.
614. Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg FW. [Clinical effects
of blood transfusion-associated immune modulation on outcome of tumor surgery].
Infusionstherapie und Transfusionsmedizin. 1993;20 Suppl 2:25-29.
615. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on
infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
616. Huber PJ, Jr., Reiss G. Rectal tumors: treatment with a posterior approach. American journal
of surgery. 1993;166:760-763.
617. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil,
high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer.
1993;71:3486-3492.
618. Petrelli NJ, Stulc JP, Rodriguez-Bigas M, Blumenson L. Nasogastric decompression
following elective colorectal surgery: a prospective randomized study. The American surgeon.
1993;59:632-635.
619. Quattlebaum JK, Jr., Flanders HD, Usher CH, 3rd. Laparoscopically assisted colectomy.
Surgical laparoscopy & endoscopy. 1993;3:81-87.
620. Sagar PM, Couse N, Kerin M, May J, MacFie J. Randomized trial of drainage of colorectal
anastomosis. The British journal of surgery. 1993;80:769-771.
621. Schirrmacher V, Schlag P, Liebrich W, Patel BT, Stoeck M. Specific immunotherapy of
colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from
resected liver metastasis. Annals of the New York Academy of Sciences. 1993;690:364-366.
622. Takahashi T, Horie H, Kojima O, Itoh M. Preoperative combined treatment with radiation,
intraluminal hyperthermia, and 5-fluorouracil suppositories for patients with rectal cancer. Surgery
today. 1993;23:1043-1048.
623. Tate JJ, Kwok S, Dawson JW, Lau WY, Li AK. Prospective comparison of laparoscopic and
conventional anterior resection. The British journal of surgery. 1993;80:1396-1398.
624. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as
postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant
Breast and Bowel Project protocol C-03. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 1993;11:1879-1887.
625. Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L. Cimetidine preserves
non-specific immune function after colonic resection for cancer. The Australian and New Zealand
journal of surgery. 1994;64:847-852.
626. AhChong K, Yip AW, Lee FC, Chiu KM. Comparison of prophylactic ampicillin/sulbactam
with gentamicin and metronidazole in elective colorectal surgery: a randomized clinical study. The
Journal of hospital infection. 1994;27:149-154.
627. Allardice JT, Abulafi AM, Grahn MF, Williams NS. Adjuvant intraoperative photodynamic
therapy for colorectal carcinoma: a clinical study. Surgical oncology. 1994;3:1-10.
628. Braga M, Costantini E, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. Impact of
thymopentin on the incidence and severity of postoperative infection: a randomized controlled
trial. The British journal of surgery. 1994;81:205-208.
629. Briusov PG, Inoiatov IM, Perekhodov SN. [Prevention of incompetence of sigmoid-rectal
anastomosis after frontal resection of rectum in the treatment of cancer]. Khirurgiia. 1994:29-32.
630. Chlebowski RT, Lillington L, Nystrom JS, Sayre J. Late mortality and levamisole adjuvant
therapy in colorectal cancer. British journal of cancer. 1994;69:1094-1097.
631. Costantino GN, Mukalian GG. Laparoscopic reversal of Hartmann procedure. Journal of
laparoendoscopic surgery. 1994;4:429-433.
632. Delalande JP, Hay JM, Fingerhut A, Kohlmann G, Paquet JC. Perineal wound management
after abdominoperineal rectal excision for carcinoma with unsatisfactory hemostasis or gross
septic contamination: primary closure vs. packing. A multicenter, controlled trial. French
Association for Surgical Research. Diseases of the colon and rectum. 1994;37:890-896.
633. Diez M, Cerdan FJ, Pollan M, et al. Prognostic significance of preoperative serum CA 19.9
assay in patients with colorectal carcinoma. Anticancer research. 1994;14:2819-2825.
634. Eckardt VF, Stamm H, Kanzler G, Bernhard G. Improved survival after colorectal cancer in
patients complying with a postoperative endoscopic surveillance program. Endoscopy.
1994;26:523-527.
635. Elia P, Lombardo G, Delpiano C, Granello M. [Prevention of immunodeficiency and
postoperative infective complications in patients undergoing surgical resection for carcinoma of
the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in
particular]. Minerva chirurgica. 1994;49:575-580.
636. Elizarova AL, Madzhuga AV, Somonova OV, Larionova VB, Gorobets ES, Anan'ev VS.
[Prevention of hemostatic disorders at different stages of surgical treatment in patients with
colonic cancer]. Anesteziologiia i reanimatologiia. 1994:39-42.
637. Goeters C, Mertes N, Kuhmann M, Lange V, Dietl KH, Lawin P. [Safety and tolerance of a
new dipeptide-containing amino acid solution DP-Gln 20 versus a conventional amino acid
solution Vamin 18EF in patients after elective colon surgery]. Anasthesiologie, Intensivmedizin,
Notfallmedizin, Schmerztherapie : AINS. 1994;29:146-149.
638. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence:
first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal
cancer surgery. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 1994;12:1859-1867.
639. Hermanek P, Jr., Wiebelt H, Riedl S, Staimmer D, Hermanek P. [Long-term results of surgical
therapy of colon cancer. Results of the Colorectal Cancer Study Group]. Der Chirurg; Zeitschrift
fur alle Gebiete der operativen Medizen. 1994;65:287-297.
640. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing
transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
Lancet. 1994;344:573-578.
641. Houry S, Amenabar J, Rezvani A, Huguier M. Should patients over 80 years old be operated
on for colorectal or gastric cancer? Hepato-gastroenterology. 1994;41:521-525.
642. Kawashima A, Goldman SM, Fishman EK, et al. CT of intraabdominal desmoid tumors: is
the tumor different in patients with Gardner's disease? AJR. American journal of roentgenology.
1994;162:339-342.
643. Letschert JG, Lebesque JV, Aleman BM, et al. The volume effect in radiation-related late
small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative
Group in patients treated for rectal carcinoma. Radiotherapy and oncology : journal of the
European Society for Therapeutic Radiology and Oncology. 1994;32:116-123.
644. Mentges B, Buess G, Raestrup H, Manncke K, Becker HD. TEM results of the Tuebingen
group. Endoscopic surgery and allied technologies. 1994;2:247-250.
645. Minsky BD, Enker WE, Cohen AM, Lauwers G. Local excision and postoperative radiation
therapy for rectal cancer. American journal of clinical oncology. 1994;17:411-416.
646. Mobarhan S, Shiau A, Grande A, et al. beta-Carotene supplementation results in an increased
serum and colonic mucosal concentration of beta-carotene and a decrease in alpha-tocopherol
concentration in patients with colonic neoplasia. Cancer epidemiology, biomarkers & prevention :
a publication of the American Association for Cancer Research, cosponsored by the American
Society of Preventive Oncology. 1994;3:501-505.
647. Odariuk TS, Kapuller LL, Podmarenkova LF, Tsar'kov PV, Frolov SA. [Long-term results of
formation of smooth muscle sphincter in the perineal colostomy area in patients after rectal
extirpation]. Khirurgiia. 1994:23-26.
648. O'Riordain MG, Fearon KC, Ross JA, et al. Glutamine-supplemented total parenteral
nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection.
Annals of surgery. 1994;220:212-221.
649. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. Randomised trial of monoclonal
antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid
17-1A Study Group. Lancet. 1994;343:1177-1183.
650. Rouffet F, Hay JM, Vacher B, et al. Curative resection for left colonic carcinoma:
hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French
Association for Surgical Research. Diseases of the colon and rectum. 1994;37:651-659.
651. Sause WT, Pajak TF, Noyes RD, et al. Evaluation of preoperative radiation therapy in
operable colorectal cancer. Annals of surgery. 1994;220:668-675.
652. Seifart W. Technique and results using the glass-rectoscope for tumour resection. Endoscopic
surgery and allied technologies. 1994;2:265-268.
653. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of
recombinant human growth hormone in patients undergoing gastrointestinal surgery.
Infusionstherapie und Transfusionsmedizin. 1994;21:24-29.
654. Wang FA, Liao HY, Yan QH. [Scanning electron microscopy of intestinal mucosa after
enteric preparation in patients with carcinoma of large bowel]. Zhonghua wai ke za zhi [Chinese
journal of surgery]. 1994;32:51-52.
655. Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Experimental colonic
healing in relation to timing of 5-fluorouracil therapy. The British journal of surgery.
1994;81:1677-1680.
656. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized
clinical trial comparing subtotal colectomy with segmental resection following intraoperative
irrigation. The SCOTIA Study Group. Subtotal Colectomy versus On-table Irrigation and
Anastomosis. The British journal of surgery. 1995;82:1622-1627.
657. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre
Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345:939-944.
658. Altomare DF, Lupo L, Pannarale OC, Di Corcia MG, Memeo V. Reduction of postoperative
immunosuppression with ranitidine in patients with cancer of the stomach or large bowel. The
European journal of surgery = Acta chirurgica. 1995;161:109-113.
659. Arcangeli G, Angelini F, Arcangeli G, et al. A pilot study of concomitant protracted venous
infusion 5-fluorouracil and hyperfractionated radiotherapy in rectal tumors. American journal of
clinical oncology. 1995;18:369-375.
660. Bardram L, Funch-Jensen P, Jensen P, Crawford ME, Kehlet H. Recovery after laparoscopic
colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet.
1995;345:763-764.
661. Bertsch DJ, Burak WE, Jr., Young DC, Arnold MW, Martin EW, Jr. Radioimmunoguided
Surgery system improves survival for patients with recurrent colorectal cancer. Surgery.
1995;118:634-638; discussion 638-639.
662. Buchmann P, Christen D, Flury R, Luthy A, Bischofberger U. [Does laparoscopic colonic
carcinoma surgery satisfy the radicality criteria of open surgery?]. Schweizerische medizinische
Wochenschrift. 1995;125:1825-1829.
663. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative
short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm
Colorectal Cancer Study Group. Cancer. 1995;75:2269-2275.
664. Ceragioli T, Nervi M, Marrucci G, Marioni A, Giuliani L. [Colorectal carcinoma in the
elderly. Assessment of prognostic factors]. Minerva chirurgica. 1995;50:185-189.
665. Chen FC, Mackay JR, Woods RJ, Collopy BT, Fink RJ, Guiney MJ. Early experience with
postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity. The Australian
and New Zealand journal of surgery. 1995;65:732-736.
666. Coucke PA, Sartorelli B, Cuttat JF, Jeanneret W, Gillet M, Mirimanoff RO. The rationale to
switch
from
postoperative
hyperfractionated
accelerated
radiotherapy
to
preoperative
hyperfractionated accelerated radiotherapy in rectal cancer. International journal of radiation
oncology, biology, physics. 1995;32:181-188.
667. D'Agostino G, Scollo MA, Vallo B, Robecchi A. [Current role of abdomino-perineal
amputation]. Minerva chirurgica. 1995;50:325-329.
668. Docherty JG, McGregor JR, Akyol AM, Murray GD, Galloway DJ. Comparison of manually
constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland
Anastomosis Study Group. Annals of surgery. 1995;221:176-184.
669. Elias D, Farace F, Triebel F, et al. Phase I-II randomized study on prehepatectomy
recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and
rectum. Journal of the American College of Surgeons. 1995;181:303-310.
670. Farina EC, Garino M, Resegotti A, Tapparo A, Fusi D. Immunological controls of
postoperative infections in colorectal tumours. Tumori. 1995;81:84-88.
671. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal
metastasis. Repeat Hepatic Metastases Registry. Surgery. 1995;117:296-304.
672. Fine AP, Lanasa S, Gannon MP, Cline CW, James R. Laparoscopic colon surgery: report of a
series. The American surgeon. 1995;61:412-416.
673. Fingerhut A, Hay JM, Delalande JP, Paquet JC. Passive vs. closed suction drainage after
perineal wound closure following abdominoperineal rectal excision for carcinoma. A multicenter,
controlled trial. The French Association for Surgical Research. Diseases of the colon and rectum.
1995;38:926-932.
674. Gemos K, Rizzotti L, Tsardis P, et al. [Indications for prophylactic ovariectomy in patients
with colorectal carcinoma]. Minerva chirurgica. 1995;50:89-92.
675. Ghigi G, Garcea D, Canini R, et al. [Transrectal ultrasonography in the study of recurrences
in patients surgically treated for rectal neoplasms]. La Radiologia medica. 1995;90:56-61.
676. Goldberg PA, Nicholls RJ. Prediction of local recurrence and survival of carcinoma of the
rectum by surgical and histopathological assessment of local clearance. The British journal of
surgery. 1995;82:1054-1056.
677. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum
carcinoma--experience of the German Multicentre Study SGCRC. German Study Group
Colo-Rectal Carcinoma. Tumori. 1995;81:60-64.
678. Holm T, Rutqvist LE, Johansson H, Cedermark B. Abdominoperineal resection and anterior
resection in the treatment of rectal cancer: results in relation to adjuvant preoperative radiotherapy.
The British journal of surgery. 1995;82:1213-1216.
679. Jamieson GG, Miller RJ. An initial experience with a posterior intrahepatic approach for liver
resections. The Australian and New Zealand journal of surgery. 1995;65:316-319.
680. Kallinowski F, Eble MJ, Buhr HJ, Wannenmacher M, Herfarth C. Intraoperative radiotherapy
for primary and recurrent rectal cancer. European journal of surgical oncology : the journal of the
European Society of Surgical Oncology and the British Association of Surgical Oncology.
1995;21:191-194.
681. Kronborg O. [Acute colonic ileus caused by left-sided colorectal cancer. A randomized trial
of emergency ostomy versus resection]. Ugeskrift for laeger. 1995;157:5858-5861.
682. Kronborg O. Acute obstruction from tumour in the left colon without spread. A randomized
trial of emergency colostomy versus resection. International journal of colorectal disease.
1995;10:1-5.
683. Lacy AM, Garcia-Valdecasas JC, Pique JM, et al. Short-term outcome analysis of a
randomized study comparing laparoscopic vs open colectomy for colon cancer. Surgical
endoscopy. 1995;9:1101-1105.
684. Leinskold T, Permert J, Olaison G, Larsson J. Effect of postoperative insulin-like growth
factor I supplementation on protein metabolism in humans. The British journal of surgery.
1995;82:921-925.
685. Marsh PJ, James RD, Schofield PF. Definition of local recurrence after surgery for rectal
carcinoma. The British journal of surgery. 1995;82:465-468.
686. Martenson JA, Jr., Urias R, Smalley SR, et al. Radiation therapy quality control in a clinical
trial of adjuvant postoperative treatment for rectal cancer. International journal of radiation
oncology, biology, physics. 1995;32:51-55.
687. Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Frankel J. Efficacy of
postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically
resectable rectal cancer. Cancer investigation. 1995;13:1-7.
688. Minsky BD, Conti JA, Huang Y, Knopf K. Relationship of acute gastrointestinal toxicity and
the volume of irradiated small bowel in patients receiving combined modality therapy for rectal
cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1995;13:1409-1416.
689. Moertel CG, Fleming TR, Macdonald JS, et al. Intergroup study of fluorouracil plus
levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 1995;13:2936-2943.
690. Molina Esquivel J, Vargas Sandoval G, Rodriguez del Rincon E, Velazquez Lopez J. [Is
radiotherapy necessary in the control of colorectal cancer?]. Ginecologia y obstetricia de Mexico.
1995;63:256-261.
691. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery
for colorectal carcinoma. Randomized comparison with no follow-up. Diseases of the colon and
rectum. 1995;38:619-626.
692. Riedl S, Wiebelt H, Bergmann U, Hermanek P, Jr. [Postoperative complications and fatalities
in surgical therapy of colon carcinoma. Results of the German multicenter study by the Colorectal
Carcinoma Study Group]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
1995;66:597-606.
693. Said S, Stippel D. Transanal endoscopic microsurgery in large, sessile adenomas of the
rectum. A 10-year experience. Surgical endoscopy. 1995;9:1106-1112.
694. Seenu V, Goel AK. Early oral feeding after elective colorectal surgery: is it safe. Tropical
gastroenterology : official journal of the Digestive Diseases Foundation. 1995;16:72-73.
695. Seifert JK, Walgenbach S, Junginger T. [Orthograde intestinal irrigation or Fordtran solution
for bowel preparation in elective colorectal surgery. Prospective outcome study]. Langenbecks
Archiv fur Chirurgie. 1995;380:327-332.
696. Seow-Choen F, Goh HS. Prospective randomized trial comparing J colonic pouch-anal
anastomosis and straight coloanal reconstruction. The British journal of surgery. 1995;82:608-610.
697. Tang G, Shiau A, Russell RM, Mobarhan S. Serum retinoic acid levels in patients with
resected benign and malignant colonic neoplasias on beta-carotene supplementation. Nutrition and
cancer. 1995;23:291-298.
698. Vignali A, Braga M, Dionigi P, et al. Impact of a programme of autologous blood donation on
the incidence of infection in patients with colorectal cancer. The European journal of surgery =
Acta chirurgica. 1995;161:487-492.
699. Vorobev GI, Odariuk TS, Shelygin Iu A, et al. [Differential diagnosis of non-epithelial rectal
neoplasms]. Khirurgiia. 1995:45-50.
700. Wiesenfeld M, O'Connell MJ, Wieand HS, et al. Controlled clinical trial of interferon-gamma
as postoperative surgical adjuvant therapy for colon cancer. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 1995;13:2324-2329.
701. Williamson ME, Lewis WG, Finan PJ, Miller AS, Holdsworth PJ, Johnston D. Recovery of
physiologic and clinical function after low anterior resection of the rectum for carcinoma: myth or
reality? Diseases of the colon and rectum. 1995;38:411-418.
702. Wurschmidt F, Baumann M. [Successful use of adjuvant immunotherapy in resected
colorectal tumors]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ...
[et al]. 1995;171:175-176.
703. Yoshioka Y, Ichikawa D, Iizuka R, et al. [Clinico-pathological studies on three preoperative
combined treatments for rectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy.
1995;22:1551-1554.
704. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer
of
the
rectum.
Medical
Research
Council
Rectal
Cancer
Working
Party.
Lancet.
1996;348:1610-1614.
705. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially
operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party.
Lancet. 1996;348:1605-1610.
706. Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal
Cancer Study Group. Annals of surgical oncology. 1996;3:423-430.
707. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy
compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial. The
European journal of surgery = Acta chirurgica. 1996;162:397-402.
708. Alberts DS, Ritenbaugh C, Story JA, et al. Randomized, double-blinded, placebo-controlled
study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected
adenomatous colon polyps. Journal of the National Cancer Institute. 1996;88:81-92.
709. Barillari P, Ramacciato G, Manetti G, Bovino A, Sammartino P, Stipa V. Surveillance of
colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and
survival of patients treated for cure. Diseases of the colon and rectum. 1996;39:388-393.
710. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions
by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind
multicenter study. Journal of the American College of Surgeons. 1996;183:297-306.
711. Bertsch DJ, Burak WE, Jr., Young DC, Arnold MW, Martin EW, Jr. Radioimmunoguided
surgery for colorectal cancer. Annals of surgical oncology. 1996;3:310-316.
712. Braga M, Gianotti L, Cestari A, et al. Gut function and immune and inflammatory responses
in patients perioperatively fed with supplemented enteral formulas. Archives of surgery (Chicago,
Ill. : 1960). 1996;131:1257-1264; discussion 1264-1255.
713. Ceelen W, Praet M, Villeirs G, et al. Initial experience with the use of preoperative
transarterial chemoembolization in the treatment of liver metastasis. Acta chirurgica Belgica.
1996;96:37-40.
714. Cooper ME, Akdeniz A, Hardy KJ. Effects of liver transplantation and resection on lipid
parameters: a longitudinal study. The Australian and New Zealand journal of surgery.
1996;66:743-746.
715. Franklin ME, Jr., Rosenthal D, Abrego-Medina D, et al. Prospective comparison of open vs.
laparoscopic colon surgery for carcinoma. Five-year results. Diseases of the colon and rectum.
1996;39:S35-46.
716. Golfieri R, Totaro C, Giampalma E, et al. [Computerized tomography and magnetic
resonance in the diagnosis of recurrent rectal neoplasms: comparison of reliability and errors of
both methods]. La Radiologia medica. 1996;91:601-609.
717. Grundel K, Schwenk W, Bohm B, Muller JM. [Effect of orthograde intestinal irrigation with
Prepacol and polyethyleneglycol solution on duration of postoperative ileus after colorectal
resections]. Langenbecks Archiv fur Chirurgie. 1996;381:160-164.
718. Hansen O, Graupe F, Schwenk W, Stock W. [Maltose--an alternative in hypocaloric
parenteral nutrition?]. Zentralblatt fur Chirurgie. 1996;121:44-50.
719. Heiss MM, Tarabichi A, Delanoff C, et al. Perisurgical erythropoietin application in anemic
patients with colorectal cancer: A double-blind randomized study. Surgery. 1996;119:523-527.
720. Holm T, Singnomklao T, Rutqvist LE, Cedermark B. Adjuvant preoperative radiotherapy in
patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized
trials. Cancer. 1996;78:968-976.
721. Houbiers JG, van de Watering LM, van de Velde CH, Brand A. Postoperative infection after
colorectal surgery. Lancet. 1996;348:1665-1666.
722. Huscher C, Silecchia G, Croce E, et al. Laparoscopic colorectal resection. A multicenter
Italian study. Surgical endoscopy. 1996;10:875-879.
723. Iversen LH, Okholm M, Thorlacius-Ussing O. Pre- and postoperative state of coagulation
and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary
study. Thrombosis and haemostasis. 1996;76:523-528.
724. Jeekel J. Autologous blood donation and epoetin alfa in cancer surgery. Seminars in
hematology. 1996;33:43-46; discussion 47.
725. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of
leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal
surgery. Lancet. 1996;348:841-845.
726. Kienle P, Stern J, Herfarth C. [Restorative proctectomy, reconstruction of continuity with or
without colon J pouch]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche
Gesellschaft fur Chirurgie. Kongress. 1996;113:262-264.
727. Konishi F, Okada M, Nagai H, Ozawa A, Kashiwagi H, Kanazawa K. Laparoscopic-assisted
colectomy with lymph node dissection for invasive carcinoma of the colon. Surgery today.
1996;26:882-889.
728.Kreis ME, Jehle EC, Haug V, et al. Functional results after transanal endoscopic microsurgery.
Diseases of the colon and rectum. 1996;39:1116-1121.
729. Lai DT, Fulham M, Stephen MS, et al. The role of whole-body positron emission tomography
with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Archives of surgery (Chicago, Ill. : 1960). 1996;131:703-707.
730. Leichman CG, Poplin E, Zalupski M, et al. A pilot trial of continuous infusion 5-fluorouracil
with levamisole for adjuvant therapy of colon cancer. The Journal of infusional chemotherapy.
1996;6:84-86.
731. Lupo L, Angelelli G, Pannarale O, Altomare D, Macarini L, Memeo V. Improved accuracy of
computed tomography in local staging of rectal cancer using water enema. International journal of
colorectal disease. 1996;11:60-64.
732. Lupton JR, Steinbach G, Chang WC, et al. Calcium supplementation modifies the relative
amounts of bile acids in bile and affects key aspects of human colon physiology. The Journal of
nutrition. 1996;126:1421-1428.
733. McCormack PM, Bains MS, Begg CB, et al. Role of video-assisted thoracic surgery in the
treatment of pulmonary metastases: results of a prospective trial. The Annals of thoracic surgery.
1996;62:213-216; discussion 216-217.
734. Miller K, Arrer E, Leitner C. Early detection of anastomotic leaks after low anterior resection
of the rectum. Diseases of the colon and rectum. 1996;39:1081-1085.
735. Mohiuddin M, Regine WF, Marks G. Prognostic significance of tumor fixation of rectal
carcinoma. Implications for adjunctive radiation therapy. Cancer. 1996;78:717-722.
736. Morlion BJ, Siedhoff HP, Joosten U, et al. [Immunomodulation after parenteral glutamine
administration in colorectal surgery]. Langenbecks Archiv fur Chirurgie. Supplement.
Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 1996;113:342-344.
737. Schatzkin A, Lanza E, Freedman LS, et al. The polyp prevention trial I: rationale, design,
recruitment, and baseline participant characteristics. Cancer epidemiology, biomarkers &
prevention : a publication of the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology. 1996;5:375-383.
738. Sofo L, Ratto C, Doglietto GB, et al. Intraoperative radiation therapy in integrated treatment
of rectal cancers. Results of phase II study. Diseases of the colon and rectum. 1996;39:1396-1403.
739. Steele RJ, Hershman MJ, Mortensen NJ, Armitage NC, Scholefield JH. Transanal endoscopic
microsurgery--initial experience from three centres in the United Kingdom. The British journal of
surgery. 1996;83:207-210.
740. Tartter PI. Postoperative stay associated with prognosis of patients with colorectal cancer.
Annals of surgery. 1996;223:351-356.
741. Ushveridze DG, Simonov NN, Barchuk AS, et al. [Organization of urgent surgical treatment
for complicated colonic cancers in a large industrial city]. Voprosy onkologii. 1996;42:89-92.
742. Wenisch C, Narzt E, Sessler DI, et al. Mild intraoperative hypothermia reduces production of
reactive oxygen intermediates by polymorphonuclear leukocytes. Anesthesia and analgesia.
1996;82:810-816.
743. Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal
carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Diseases of the colon
and rectum. 1996;39:969-976.
744. Yoshida K, Sugino T, Bolodeoku J, et al. Detection of exfoliated carcinoma cells in colonic
luminal washings by identification of deranged patterns of expression of the CD44 gene. Journal
of clinical pathology. 1996;49:300-305.
745. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal
Cancer Trial. The New England journal of medicine. 1997;336:980-987.
746. Adams WJ, Morris DL. Pilot study--cimetidine enhances lymphocyte infiltration of human
colorectal carcinoma: results of a small randomized control trial. Cancer. 1997;80:15-21.
747. Alberts DS, Einspahr J, Ritenbaugh C, et al. The effect of wheat bran fiber and calcium
supplementation on rectal mucosal proliferation rates in patients with resected adenomatous
colorectal polyps. Cancer epidemiology, biomarkers & prevention : a publication of the American
Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
1997;6:161-169.
748. Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as
combined treatment in rectal cancer. Final results of a phase III study of the European
Organization for Research and Treatment of Cancer. The British journal of surgery.
1997;84:352-357.
749. Bohm B, Schwenk W, Grundel K, Junghans T, Muller JM. [Value of laparoscopic technique
in primary colorectal carcinoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
1997;68:231-236.
750. Carli F, Halliday D. Continuous epidural blockade arrests the postoperative decrease in
muscle protein fractional synthetic rate in surgical patients. Anesthesiology. 1997;86:1033-1040.
751. Carli F, Webster JD, Halliday D. A nitrogen-free hypocaloric diet and recombinant human
growth hormone stimulate postoperative protein synthesis: fasted and fed leucine kinetics in the
surgical patient. Metabolism: clinical and experimental. 1997;46:796-800.
752. Carli F, Webster JD, Halliday D. Growth hormone modulates amino acid oxidation in the
surgical patient: leucine kinetics during the fasted and fed state using moderate nitrogenous and
caloric diet and recombinant human growth hormone. Metabolism: clinical and experimental.
1997;46:23-28.
753. Cepowicz D, Dadan H, Okulczyk B, Stocki W, Gryko M, Juchnicki K. [Clinical-morphologic
evaluation of treatment results for rectal cancer using Dixon's method]. Wiadomosci lekarskie
(Warsaw, Poland : 1960). 1997;50 Suppl 1 Pt 1:135-138.
754. Croce E, Azzola M, Russo R, Golia M, Olmi S. Laparoscopic colectomy: the absolute need
for a standard operative technique. JSLS : Journal of the Society of Laparoendoscopic Surgeons /
Society of Laparoendoscopic Surgeons. 1997;1:217-224.
755. De Salvo L, Razzetta F, Cagnazzo A, Tassone U, Arezzo A, Mattioli FP. [Comparison of
colorectal mechanical suture techniques]. Annali italiani di chirurgia. 1997;68:381-384.
756. Drews M, Malinger S, Krokowicz P, Marciniak R, Koscinski T. [Personal experiments in
treating rectal rumors with the TEM technique]. Wiadomosci lekarskie (Warsaw, Poland : 1960).
1997;50 Suppl 1 Pt 1:122-126.
757. Giralt J, Rubio D, Maldonado X, et al. Fluorouracil and high-dose leucovorin with
radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study. Acta oncologica
(Stockholm, Sweden). 1997;36:51-54.
758. Goh YC, Eu KW, Seow-Choen F. Early postoperative results of a prospective series of
laparoscopic vs. Open anterior resections for rectosigmoid cancers. Diseases of the colon and
rectum. 1997;40:776-780.
759. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B. Short-term
preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and
Oncology. 1997;43:133-137.
760. Hartsell PA, Frazee RC, Harrison JB, Smith RW. Early postoperative feeding after elective
colorectal surgery. Archives of surgery (Chicago, Ill. : 1960). 1997;132:518-520; discussion
520-511.
761. Hay JM, Fingerhut A, Paquet JC, Flamant Y. Management of the pelvic space with or without
omentoplasty after abdominoperineal resection for carcinoma of the rectum: a prospective
multicenter study. The French Association for Surgical Research. The European journal of surgery
= Acta chirurgica. 1997;163:199-206.
762. Heiss MM, Fasol-Merten K, Allgayer H, et al. Influence of autologous blood transfusion on
natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox sanguinis.
1997;73:237-245.
763. Heiss MM, Fraunberger P, Delanoff C, et al. Modulation of immune response by blood
transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal
cancer surgery. Shock (Augusta, Ga.). 1997;8:402-408.
764. Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE. Influence of hospital- and
surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative
radiotherapy. The British journal of surgery. 1997;84:657-663.
765. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is
associated with increased incidence of bacterial infection after colorectal surgery: a prospective
study. Transfusion. 1997;37:126-134.
766. Iishi H, Tatsuta M, Kitamura S, Narahara H, Iseki K, Ishiguro S. Endoscopic resection of
large
sessile
colorectal
polyps
using
a
submucosal
saline
injection
technique.
Hepato-gastroenterology. 1997;44:698-702.
767. Inaba Y, Arai Y, Takeuchi Y, et al. [Enhancement pattern of hepatic metastases from
colorectal cancer on CT arteriography]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta
radiologica. 1997;57:483-486.
768. Isbister WH. Colorectal surgery in the elderly: an audit of surgery in octogenarians. The
Australian and New Zealand journal of surgery. 1997;67:557-561.
769. Izvekova OV, Bershchanskaia AM, Firsov EF, Pan'shin GA. [Radiation pathomorphism after
a single large-fractionated preoperative irradiation of rectal cancer (electron microscopic study)].
Arkhiv patologii. 1997;59:37-41.
770. Kazi N, Radvany R, Oldham T, et al. Immunomodulatory effect of beta-carotene on T
lymphocyte subsets in patients with resected colonic polyps and cancer. Nutrition and cancer.
1997;28:140-145.
771. Krupski W, Zlomaniec J, Bryc S, Zlomaniec G. [The value of CT examination for diagnosis
of postoperative colonic cancer recurrences using bi-contrast and mono-contrast enema and air].
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina. 1997;52:129-139.
772. Lin MT, Saito H, Fukushima R, et al. Preoperative total parenteral nutrition influences
postoperative systemic cytokine responses after colorectal surgery. Nutrition (Burbank, Los
Angeles County, Calif.). 1997;13:8-12.
773. Lippert H, Gastinger I. [Results of a multicenter study in colon surgery for quality
assessment]. Zentralblatt fur Chirurgie. 1997;122:18-19.
774. Lundby L, Jensen VJ, Overgaard J, Laurberg S. Long-term colorectal function after
postoperative radiotherapy for colorectal cancer. Lancet. 1997;350:564.
775. Minsky BD, Cohen AM, Enker WE, et al. Preoperative 5-FU, low-dose leucovorin, and
radiation therapy for locally advanced and unresectable rectal cancer. International journal of
radiation oncology, biology, physics. 1997;37:289-295.
776. Mitsuishi K, Umeno T, Tanaka S, et al. [Study of preoperative combination therapy with UFT
+ CDDP in patients with gastric and colorectal cancer--concomitant effects based on the
thymidylate synthase inhibitory rat]. Gan to kagaku ryoho. Cancer & chemotherapy.
1997;24:1119-1124.
777. Mollen RM, Damhuis RA, Coebergh JW. Local recurrence and survival in patients with
rectal cancer, diagnosed 1981-86: a community hospital-based study in the south-east Netherlands.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology
and the British Association of Surgical Oncology. 1997;23:20-23.
778. Nitti D, Wils J, Sahmoud T, et al. Final results of a phase III clinical trial on adjuvant
intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC
GITCCG 1983-1987). European Organization for Research and Treatment of Cancer.
Gastrointestinal Tract Cancer Cooperative Group. European journal of cancer (Oxford, England :
1990). 1997;33:1209-1215.
779. Pakkastie TE, Ovaska JT, Pekkala ES, Luukkonen PE, Jarvinen HJ. A randomised study of
colostomies in low colorectal anastomoses. The European journal of surgery = Acta chirurgica.
1997;163:929-933.
780. Pazdur R. Phase II study of UFT plus leucovorin in colorectal cancer. Oncology. 1997;54
Suppl 1:19-23.
781. Rutten HJ, Nijhuis PH. Prevention of wound infection in elective colorectal surgery by local
application of a gentamicin-containing collagen sponge. The European journal of surgery.
Supplement. : = Acta chirurgica. Supplement. 1997:31-35.
782. Said S, Muller JM. TEM--minimal invasive therapy of rectal cancer? Swiss surgery =
Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera. 1997;3:248-254.
783. Stage JG, Schulze S, Moller P, et al. Prospective randomized study of laparoscopic versus
open colonic resection for adenocarcinoma. The British journal of surgery. 1997;84:391-396.
784. Tada M, Inoue H, Yabata E, Okabe S, Endo M. Feasibility of the transparent cap-fitted
colonoscope for screening and mucosal resection. Diseases of the colon and rectum.
1997;40:618-621.
785. Takahashi K, Mori T, Yasuno M. [The outcome of the postoperative radiotherapy of
autonomic nerve preserving operation for lower rectal cancer]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1997;24:1682-1685.
786. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative
radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment
of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. The British
journal of surgery. 1997;84:1130-1135.
787. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE. Combined modality
treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and
Oncology. 1997;44:277-282.
788. von Flue M, Hamel C, Harder F. Ileocecal interposition--functional outcome. Swiss surgery =
Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera. 1997;3:259-261.
789. Yabata E, Okabe S, Endo M. A prospective, randomized clinical trial of preoperative bowel
preparation for elective colorectal surgery--comparison among oral, systemic, and intraoperative
luminal antibacterial preparations. Journal of medical and dental sciences. 1997;44:75-80.
790. Akedo I, Ishikawa H, Nakamura T, et al. Three cases with familial adenomatous polyposis
diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid
(DHA)-concentrated fish oil capsules. Japanese journal of clinical oncology. 1998;28:762-765.
791. Bertoglio S, Percivale P, Schenone F, Peressini A, Murolo C, Badellino F. Role of
tumor-associated antigen expression in radioimmunoguided surgery for colorectal and breast
cancer. Seminars in surgical oncology. 1998;15:249-253.
792. Buchmann P, Bischofberger U, De Lorenzi D, Christen D. [Early postoperative nutrition after
laparoscopic and open colorectal resection]. Swiss surgery = Schweizer Chirurgie = Chirurgie
suisse = Chirurgia svizzera. 1998;4:146-155.
793. Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional
results after surgery for rectal cancer: results from a randomized study. Diseases of the colon and
rectum. 1998;41:543-549; discussion 549-551.
794. Delgado Gomis F, Bolufer Cano JM, Grau Cardona E, et al. Early results of laparoscopic
resection of colorectal cancer. Revista espanola de enfermedades digestivas : organo oficial de la
Sociedad Espanola de Patologia Digestiva. 1998;90:323-334.
795. Foley EF, Gaffey MJ, Frierson HF, Jr. The frequency and clinical significance of
neuroendocrine cells within stage III adenocarcinomas of the colon. Archives of pathology &
laboratory medicine. 1998;122:912-914.
796. Kapiteijn E, Marijnen CA, Colenbrander AC, et al. Local recurrence in patients with rectal
cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology
and the British Association of Surgical Oncology. 1998;24:528-535.
797. Kettelhack C, Hones C, Messinger D, Schlag PM. Randomized multicentre trial of the
influence of recombinant human erythropoietin on intraoperative and postoperative transfusion
need in anaemic patients undergoing right hemicolectomy for carcinoma. The British journal of
surgery. 1998;85:63-67.
798. Kockerling F, Reymond MA, Schneider C, et al. Prospective multicenter study of the quality
of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer. The
Laparoscopic Colorectal Surgery Study Group. Diseases of the colon and rectum.
1998;41:963-970.
799. Lacy AM, Delgado S, Garcia-Valdecasas JC, et al. Port site metastases and recurrence after
laparoscopic colectomy. A randomized trial. Surgical endoscopy. 1998;12:1039-1042.
800. Massari M, De Simone M, Cioffi U, Rosso L, Chiarelli M, Gabrielli F. Value and limits of
endorectal ultrasonography for preoperative staging of rectal carcinoma. Surgical laparoscopy &
endoscopy. 1998;8:438-444.
801. Meyskens FL, Jr., Gerner EW, Emerson S, et al. Effect of alpha-difluoromethylornithine on
rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer
prevention. Journal of the National Cancer Institute. 1998;90:1212-1218.
802. Milsom JW, Bohm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective,
randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer
surgery: a preliminary report. Journal of the American College of Surgeons. 1998;187:46-54;
discussion 54-45.
803. Morlion BJ, Stehle P, Wachtler P, et al. Total parenteral nutrition with glutamine dipeptide
after major abdominal surgery: a randomized, double-blind, controlled study. Annals of surgery.
1998;227:302-308.
804. Motamed S, Klubien K, Edwardes M, Mazza L, Carli F. Metabolic changes during recovery
in normothermic versus hypothermic patients undergoing surgery and receiving general anesthesia
and epidural local anesthetic agents. Anesthesiology. 1998;88:1211-1218.
805. Okuno K, Yasutomi M, Hida J, et al. Longterm effects of hepatic arterial interleukin-2-based
immunochemotherapy after potentially curative resection of colorectal liver metastases. Journal of
the American College of Surgeons. 1998;187:271-275.
806. Petersen S, Hellmich G, Baumann M, Herrmann T, Henke G, Ludwig K. [Brief preoperative
radiotherapy in surgical therapy of rectal carcinoma. Long-term results of a prospective
randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
1998;69:759-765.
807. Rajalakshmi T, Kini U. Colonic carcinomas masquerading as Crohn's colitis. Indian journal
of cancer. 1998;35:147-151.
808. Riethmuller G, Holz E, Schlimok G, et al. Monoclonal antibody therapy for resected Dukes' C
colorectal cancer: seven-year outcome of a multicenter randomized trial. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1998;16:1788-1794.
809. Schwenk W, Bohm B, Haase O, Junghans T, Muller JM. Laparoscopic versus conventional
colorectal resection: a prospective randomised study of postoperative ileus and early postoperative
feeding. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 1998;383:49-55.
810. Schwenk W, Bohm B, Muller JM. Postoperative pain and fatigue after laparoscopic or
conventional colorectal resections. A prospective randomized trial. Surgical endoscopy.
1998;12:1131-1136.
811. Schwenk W, Bohm B, Muller JM. [Influence of laparoscopic or conventional colorectal
resection on postoperative quality of life]. Zentralblatt fur Chirurgie. 1998;123:483-490.
812. Staib L, Braumuller H, Leeser C, et al. [1st successful immunization of pancreas and
colorectal carcinoma patients with CO17-1A-vaccine]. Langenbecks Archiv fur Chirurgie.
Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 1998;115:53-58.
813. Torralba JA, Robles R, Parrilla P, et al. Subtotal colectomy vs. intraoperative colonic
irrigation in the management of obstructed left colon carcinoma. Diseases of the colon and rectum.
1998;41:18-22.
814. Vecchio R, Latteri F, Di Martino M, Lanteri E, Cacciola E. [Preoperative treatment with
interleukin-2 in colorectal carcinoma]. Il Giornale di chirurgia. 1998;19:171-174.
815. Volpe CM, Abdel-Nabi HH, Kulaylat MN, Doerr RJ. Results of immunoscintigraphy using a
cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Annals of
surgical oncology. 1998;5:489-494.
816. Bellantone R, Bossola M, Carriero C, et al. Structured versus long-chain triglycerides: a
safety, tolerance, and efficacy randomized study in colorectal surgical patients. JPEN. Journal of
parenteral and enteral nutrition. 1999;23:123-127.
817. Benoist S, Panis Y, Denet C, Mauvais F, Mariani P, Valleur P. Optimal duration of urinary
drainage after rectal resection: a randomized controlled trial. Surgery. 1999;125:135-141.
818. Blomqvist L, Rubio C, Holm T, Machado M, Hindmarsh T. Rectal adenocarcinoma:
assessment of tumour involvement of the lateral resection margin by MRI of resected specimen.
The British journal of radiology. 1999;72:18-23.
819. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ. Serum YKL-40 and
colorectal cancer. British journal of cancer. 1999;79:1494-1499.
820. Debus ES, Sailer M, Geiger D, Dietz UA, Fuchs KH, Thiede A. Long-term results after 75
anastomoses in the upper extraperitoneal rectum with the biofragmentable anastomosis ring.
Digestive surgery. 1999;16:55-59.
821. Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for
rectal cancer: 681 consecutive cases from a specialty service. Annals of surgery.
1999;230:544-552; discussion 552-544.
822. Galizia G, Lieto E, Castellano P, et al. Comparison between the biofragmentable anastomosis
ring and stapled anastomoses in the extraperitoneal rectum: a prospective, randomized study.
International journal of colorectal disease. 1999;14:286-290.
823. Gatta G, Francisci S, Ponz de Leon M. The prevalence of colorectal cancer in Italy. Tumori.
1999;85:387-390.
824. Graham RA, Hackford AW, Wazer DE. Local excision of rectal carcinoma: a safe alternative
for more advanced tumors? Journal of surgical oncology. 1999;70:235-238.
825. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total
mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an
international analysis of 1411 patients. European journal of surgical oncology : the journal of the
European Society of Surgical Oncology and the British Association of Surgical Oncology.
1999;25:368-374.
826. Herrmann T, Petersen S, Hellmich G, Baumann M, Ludwig K. [Delayed toxicity of brief
preoperative irradiation and risk-adjusted postoperative radiotherapy of operative rectal carcinoma.
Results of a randomized prospective study]. Strahlentherapie und Onkologie : Organ der
Deutschen Rontgengesellschaft ... [et al]. 1999;175:430-436.
827. Ho YH, Tan M, Leong A, Eu KW, Nyam D, Seow-Choen F. Anal pressures impaired by
stapler insertion during colorectal anastomosis: a randomized, controlled trial. Diseases of the
colon and rectum. 1999;42:89-95.
828. Honda M, Tanaka Y, Matsuo Y, et al. [Antitumor effect of 5'-DFUR and PyNPase activity in
colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1999;26:939-943.
829. Huber FT, Herter B, Siewert JR. Colonic pouch vs. side-to-end anastomosis in low anterior
resection. Diseases of the colon and rectum. 1999;42:896-902.
830. Ishiguro A, Uno Y, Ishiguro Y, Munakata A, Morita T. Correlation of lifting versus non-lifting
and microscopic depth of invasion in early colorectal cancer. Gastrointestinal endoscopy.
1999;50:329-333.
831. Ishikura S, Ogino T, Ono M, et al. Preliminary results of pelvic autonomic nerve-preserving
surgery combined with intraoperative and postoperative radiation therapy for patients with low
rectal cancer. Japanese journal of clinical oncology. 1999;29:429-433.
832. Lee P, Oyama K, Homer L, Sullivan E. Effects of endorectal ultrasonography in the surgical
management of rectal adenomas and carcinomas. American journal of surgery. 1999;177:388-391.
833. Leung KL, Yiu RY, Lai PB, Lee JF, Thung KH, Lau WY. Laparoscopic-assisted resection of
colorectal carcinoma: five-year audit. Diseases of the colon and rectum. 1999;42:327-332;
discussion 332-323.
834. Lin JC, Wiechmann RJ, Szwerc MF, et al. Diagnostic and therapeutic video-assisted thoracic
surgery resection of pulmonary metastases. Surgery. 1999;126:636-641; discussion 641-632.
835. Melotti G, Tamborrino E, Lazzaretti MG, Bonilauri S, Mecheri F, Piccoli M. Laparoscopic
surgery for colorectal cancer. Seminars in surgical oncology. 1999;16:332-336.
836. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin
concentration at operation and during the postoperative period: reduced need for blood
transfusions
in
patients
undergoing
colorectal
surgery--prospective
double-blind
placebo-controlled study. World journal of surgery. 1999;23:30-35.
837. Richards ML, Caplan RH, Wickus GG, Lambert PJ, Kisken WA. The rapid low-dose (1
microgram) cosyntropin test in the immediate postoperative period: results in elderly subjects after
major abdominal surgery. Surgery. 1999;125:431-440.
838. Schwenk W, Bohm B, Witt C, Junghans T, Grundel K, Muller JM. Pulmonary function
following laparoscopic or conventional colorectal resection: a randomized controlled evaluation.
Archives of surgery (Chicago, Ill. : 1960). 1999;134:6-12; discussion 13.
839. Shibata T, Niinobu T, Shimano T, et al. [Microwave coagulation therapy under laparotomic
ischemia for multiple liver metastases of colorectal cancer]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1999;26:1760-1763.
840. Tsunoda A, Shibusawa M, Kusano M. Anorectal function after anterior resection with
side-to-side anastomosis for carcinoma of the rectum. Diseases of the colon and rectum.
1999;42:77-81.
841. Valverde A, Hay JM, Fingerhut A, et al. Senna vs polyethylene glycol for mechanical
preparation the evening before elective colonic or rectal resection: a multicenter controlled trial.
French Association for Surgical Research. Archives of surgery (Chicago, Ill. : 1960).
1999;134:514-519.
842. Vermorken JB, Claessen AM, van Tinteren H, et al. Active specific immunotherapy for stage
II and stage III human colon cancer: a randomised trial. Lancet. 1999;353:345-350.
843. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer:
technical considerations and outcomes. Diseases of the colon and rectum. 1999;42:1438-1448.
844. Wang S, Qi Q. [Influence of pre-operational medicated dachengqi granule on inflammatory
mediator in tumor patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi
= Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he
xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. 1999;19:337-339.
845. Yamamoto K, Kitamura K, Nishida S, et al. Iodine-131 human-mouse chimeric Fab
monoclonal antibody A7 guided surgery for colorectal cancer patients: a pilot study. Surgery today.
1999;29:190-193.
846. Young CJ, Solomon MJ, Eyers AA, et al. Evolution of the pelvic pouch procedure at one
institution: the first 100 cases. The Australian and New Zealand journal of surgery.
1999;69:438-442.
847. Arribas del Amo D, Ramirez Rodriguez JM, Aguilella Diago V, Elia Guedea M, Palacios
Fanlo MJ, Martinez Diez M. Transanal endoscopic surgery for rectal tumors. Revista espanola de
enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
2000;92:526-535.
848. Blomqvist L, Ohlsen H, Hindmarsh T, Jonsson E, Holm T. Local recurrence of rectal cancer:
MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed
tomography. European radiology. 2000;10:1383-1389.
849.Bozzetti F, Gavazzi C, Miceli R, et al. Perioperative total parenteral nutrition in malnourished,
gastrointestinal cancer patients: a randomized, clinical trial. JPEN. Journal of parenteral and
enteral nutrition. 2000;24:7-14.
850. Brivio F, Lissoni P, Gilardi R, et al. Abrogation of surgery-induced decline in circulating
dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.
Journal of biological regulators and homeostatic agents. 2000;14:200-203.
851. Calaluce R, Earnest DL, Heddens D, et al. Effects of piroxicam on prostaglandin E2 levels in
rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial. Cancer epidemiology,
biomarkers & prevention : a publication of the American Association for Cancer Research,
cosponsored by the American Society of Preventive Oncology. 2000;9:1287-1292.
852. Cascinu S, Ligi M, Del Ferro E, et al. Effects of calcium and vitamin supplementation on
colon cell proliferation in colorectal cancer. Cancer investigation. 2000;18:411-416.
853. Chow HH, Earnest DL, Clark D, et al. Effect of subacute ibuprofen dosing on rectal mucosal
prostaglandin E2 levels in healthy subjects with a history of resected polyps. Cancer epidemiology,
biomarkers & prevention : a publication of the American Association for Cancer Research,
cosponsored by the American Society of Preventive Oncology. 2000;9:351-356.
854. Delgado S, Lacy AM, Garcia Valdecasas JC, et al. Could age be an indication for
laparoscopic colectomy in colorectal cancer? Surgical endoscopy. 2000;14:22-26.
855. Durrant LG, Maxwell-Armstrong C, Buckley D, et al. A neoadjuvant clinical trial in
colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2000;6:422-430.
856. Gracia E, Targarona EM, Garriga J, Pujol J, Trias M. [Laparoscopic treatment of colorectal
polyps]. Gastroenterologia y hepatologia. 2000;23:224-227.
857. Harris JE, Ryan L, Hoover HC, Jr., et al. Adjuvant active specific immunotherapy for stage II
and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group
Study E5283. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 2000;18:148-157.
858. Hsu TC, Leu SC, Su CF, Huang PC, Tsai LF, Tsai SL. Assessment of intragastric pH value
changes after early nasogastric feeding. Nutrition (Burbank, Los Angeles County, Calif.).
2000;16:751-754.
859. Kim KM, Choi KY, Lee A, Kim BK. Lymphangioma of large intestine: report of ten cases
with endoscopic and pathologic correlation. Gastrointestinal endoscopy. 2000;52:255-259.
860. Kockerling F, Scheidbach H, Schneider C, et al. Laparoscopic abdominoperineal resection:
early postoperative results of a prospective study involving 116 patients. The Laparoscopic
Colorectal Surgery Study Group. Diseases of the colon and rectum. 2000;43:1503-1511.
861. Lammering G, Taher MM, Gruenagel HH, Borchard F, Porschen R. Alteration of DNA ploidy
status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal
cancer. Clinical cancer research : an official journal of the American Association for Cancer
Research. 2000;6:3215-3221.
862. Lechner P, Lind P, Goldenberg DM. Can postoperative surveillance with serial CEA
immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free
survival? Journal of the American College of Surgeons. 2000;191:511-518.
863. Leung KL, Lai PB, Ho RL, et al. Systemic cytokine response after laparoscopic-assisted
resection of rectosigmoid carcinoma: A prospective randomized trial. Annals of surgery.
2000;231:506-511.
864. Longo WE, Virgo KS, Johnson FE, et al. Risk factors for morbidity and mortality after
colectomy for colon cancer. Diseases of the colon and rectum. 2000;43:83-91.
865. Miettinen RP, Laitinen ST, Makela JT, Paakkonen ME. Bowel preparation with oral
polyethylene glycol electrolyte solution vs. no preparation in elective open colorectal surgery:
prospective, randomized study. Diseases of the colon and rectum. 2000;43:669-675; discussion
675-667.
866. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood
transfusion and postoperative infectious complications on prognosis after surgery for colorectal
cancer. Danish RANX05 Colorectal Cancer Study Group. The British journal of surgery.
2000;87:1553-1562.
867. Renzi C, Peticca L, Pescatori M. The use of relaxation techniques in the perioperative
management of proctological patients: preliminary results. International journal of colorectal
disease. 2000;15:313-316.
868. Rink AD, Goldschmidt D, Dietrich J, Nagelschmidt M, Vestweber KH. Negative side-effects
of retention sutures for abdominal wound closure. A prospective randomised study. The European
journal of surgery = Acta chirurgica. 2000;166:932-937.
869. Rosenthal DI, Haller DG, Saltz L, Semple D, Minsky BD. Postoperative radiation therapy for
rectal cancer combined with UFT/leucovorin. Oncology (Williston Park, N.Y.). 2000;14:59-62.
870. Schiedeck TH, Schwandner O, Baca I, et al. Laparoscopic surgery for the cure of colorectal
cancer: results of a German five-center study. Diseases of the colon and rectum. 2000;43:1-8.
871. Schwenk W, Jacobi C, Mansmann U, Bohm B, Muller JM. Inflammatory response after
laparoscopic and conventional colorectal resections - results of a prospective randomized trial.
Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2000;385:2-9.
872. Smith AJ, Nissan A, Lanouette NM, et al. Prokinetic effect of erythromycin after colorectal
surgery: randomized, placebo-controlled, double-blind study. Diseases of the colon and rectum.
2000;43:333-337.
873. Stocchi L, Nelson H, Young-Fadok TM, Larson DR, Ilstrup DM. Safety and advantages of
laparoscopic vs. open colectomy in the elderly: matched-control study. Diseases of the colon and
rectum. 2000;43:326-332.
874. Tanaka S, Haruma K, Oh EH, et al. Conditions of curability after endoscopic resection for
colorectal carcinoma with submucosally massive invasion. Oncology reports. 2000;7:783-788.
875. Abe T, Sakaguchi Y, Ohno S, et al. Apoptosis and p53 overexpression in human rectal cancer;
relationship
with
response
to
hyperthermo-chemo-radiotherapy.
Anticancer
research.
2001;21:2115-2120.
876. Andre T, Colin P, Louvet C, et al. Randomized adjuvant study comparing two schemes of
5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and
preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
Seminars in oncology. 2001;28:35-40.
877. Bauhofer A, Lorenz W, Stinner B, et al. Granulocyte-colony stimulating factor in the
prevention of postoperative infectious complications and sub-optimal recovery from operation in
patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a
controlled clinical trial developed by consensus of an international study group. Part two: design
of the study. Inflammation research : official journal of the European Histamine Research
Society ... [et al.]. 2001;50:187-205.
878. Begg AC, Janssen H, Sprong D, et al. Hypoxia and perfusion measurements in human
tumors--initial experience with pimonidazole and IUdR. Acta oncologica (Stockholm, Sweden).
2001;40:924-928.
879. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of
sentinel node analysis: a multicenter phase II trial. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology. 2001;19:1128-1136.
880. Bosset JF, Horiot JC, Hamers HP, et al. Postoperative pelvic radiotherapy with or without
elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical
trial of the EORTC Radiotherapy Group. Radiotherapy and oncology : journal of the European
Society for Therapeutic Radiology and Oncology. 2001;61:7-13.
881. Bozzetti F, Baticci F, Cozzaglio L, Biasi S, Facchetti G. Metabolic effects of intraportal
nutrition in humans. Nutrition (Burbank, Los Angeles County, Calif.). 2001;17:292-299.
882. Broll R, Duchrow M, Oevermann E, et al. p53 autoantibodies in sera of patients with a
colorectal
cancer
and
their
association
to
p53
protein
concentration
and
p53
immunohistochemistry in tumor tissue. International journal of colorectal disease. 2001;16:22-27.
883. Carli F, Trudel JL, Belliveau P. The effect of intraoperative thoracic epidural anesthesia and
postoperative analgesia on bowel function after colorectal surgery: a prospective, randomized trial.
Diseases of the colon and rectum. 2001;44:1083-1089.
884. De Kock M, Lavand'homme P, Waterloos H. 'Balanced analgesia' in the perioperative period:
is there a place for ketamine? Pain. 2001;92:373-380.
885. Delgado S, Lacy AM, Filella X, et al. Acute phase response in laparoscopic and open
colectomy in colon cancer: randomized study. Diseases of the colon and rectum. 2001;44:638-646.
886. Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an
[(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. The
Journal of surgical research. 2001;96:120-126.
887. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically
resectable uT3 rectal adenocarcinoma. International journal of radiation oncology, biology,
physics. 2001;49:987-995.
888. Gruessner U, Clemens M, Pahlplatz PV, Sperling P, Witte J, Rosen HR. Improvement of
perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after
abdominoperineal excision of rectal cancer. American journal of surgery. 2001;182:502-509.
889. Guadagni S, Fiorentini G, Palumbo G, et al. Hypoxic pelvic perfusion with mitomycin C
using a simplified balloon-occlusion technique in the treatment of patients with unresectable
locally recurrent rectal cancer. Archives of surgery (Chicago, Ill. : 1960). 2001;136:105-112.
890. Herman RM, Richter P, Walega P, Popiela T. Anorectal sphincter function and rectal barostat
study in patients following transanal endoscopic microsurgery. International journal of colorectal
disease. 2001;16:370-376.
891. Ho YH, Seow-Choen F, Tan M. Colonic J-pouch function at six months versus straight
coloanal anastomosis at two years: randomized controlled trial. World journal of surgery.
2001;25:876-881.
892. Holm T, Johansson H, Rutqvist LE, Cedermark B. Tumour location and the effects of
preoperative radiotherapy in the treatment of rectal cancer. The British journal of surgery.
2001;88:839-843.
893. Hunerbein M, Totkas S, Moesta KT, Ulmer C, Handke T, Schlag PM. The role of transrectal
ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery.
2001;129:164-169.
894. Lorenz W, Stinner B, Bauhofer A, et al. Granulocyte-colony stimulating factor in the
prevention of postoperative infectious complications and sub-optimal recovery from operation in
patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a
controlled clinical trial developed by consensus of an international study group. Part one: rationale
and hypothesis. Inflammation research : official journal of the European Histamine Research
Society ... [et al.]. 2001;50:115-122.
895. Machowska B, Duda K. [Does intravenous administration of magnesium have an effect on
postoperative analgesia?]. Folia medica Cracoviensia. 2001;42:255-262.
896. Mannaerts GH, Rutten HJ, Martijn H, Groen GJ, Hanssens PE, Wiggers T. Abdominosacral
resection for primary irresectable and locally recurrent rectal cancer. Diseases of the colon and
rectum. 2001;44:806-814.
897. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma
characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology.
2001;120:1077-1083.
898. Marusch F, Gastinger I, Schneider C, et al. Experience as a factor influencing the indications
for laparoscopic colorectal surgery and the results. Surgical endoscopy. 2001;15:116-120.
899. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the
results achieved in patients with rectal cancer. The British journal of surgery. 2001;88:1397-1402.
900. Marusch F, Koch A, Schmidt U, et al. Effect of caseload on the short-term outcome of colon
surgery: results of a multicenter study. International journal of colorectal disease.
2001;16:362-369.
901. Mels AK, Statius Muller MG, van Leeuwen PA, et al. Immune-stimulating effects of
low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients
operated on for primary colorectal carcinoma. The British journal of surgery. 2001;88:539-544.
902. Msika S, Deroide G, Kianmanesh R, et al. Harmonic scalpel in laparoscopic colorectal
surgery. Diseases of the colon and rectum. 2001;44:432-436.
903. Nakagoe T, Sawai T, Tsuji T, Ayabe H. Use of minilaparotomy in the treatment of colonic
cancer. The British journal of surgery. 2001;88:831-836.
904. Nelson H. Laparoscopic colectomy for colon cancer--a trial update. Swiss surgery =
Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera. 2001;7:248-251.
905. Ordemann J, Jacobi CA, Schwenk W, Stosslein R, Muller JM. Cellular and humoral
inflammatory response after laparoscopic and conventional colorectal resections. Surgical
endoscopy. 2001;15:600-608.
906. Staib L, Birebent B, Somasundaram R, et al. Immunogenicity of recombinant GA733-2E
antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
International journal of cancer. Journal international du cancer. 2001;92:79-87.
907. Stinner B, Bauhofer A, Lorenz W, et al. Granulocyte-colony stimulating factor in the
prevention of postoperative infectious complications and sub-optimal recovery from operation in
patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a
controlled clinical trial developed by consensus of an international study group. Part three:
individual patient, complication algorithm and quality manage. Inflammation research : official
journal of the European Histamine Research Society ... [et al.]. 2001;50:233-248.
908. Suzuki H, Ikeda K. Endoscopic mucosal resection and full thickness resection with complete
defect closure for early gastrointestinal malignancies. Endoscopy. 2001;33:437-439.
909. Tang CL, Eu KW, Tai BC, Soh JG, MacHin D, Seow-Choen F. Randomized clinical trial of
the effect of open versus laparoscopically assisted colectomy on systemic immunity in patients
with colorectal cancer. The British journal of surgery. 2001;88:801-807.
910. Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J.
Leukocyte-depletion of blood components does not significantly reduce the risk of infectious
complications. Results of a double-blinded, randomized study. International journal of colorectal
disease. 2001;16:147-153.
911. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid
supplementation improves the immunometabolic host response and outcome after colorectal
resection for cancer. Surgery. 2002;132:805-814.
912. Braga M, Vignali A, Gianotti L, et al. Laparoscopic versus open colorectal surgery: a
randomized trial on short-term outcome. Annals of surgery. 2002;236:759-766; disscussion 767.
913. Braga M, Vignali A, Zuliani W, et al. Metabolic and functional results after laparoscopic
colorectal surgery: a randomized, controlled trial. Diseases of the colon and rectum.
2002;45:1070-1077.
914. Brivio F, Lissoni P, Rovelli F, et al. Effects of IL-2 preoperative immunotherapy on
surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12
decline. Hepato-gastroenterology. 2002;49:385-387.
915. Champault GG, Barrat C, Raselli R, Elizalde A, Catheline JM. Laparoscopic versus open
surgery for colorectal carcinoma: a prospective clinical trial involving 157 cases with a mean
follow-up of 5 years. Surgical laparoscopy, endoscopy & percutaneous techniques. 2002;12:88-95.
916. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal
squamous intraepithelial lesions: a prospective study. Diseases of the colon and rectum.
2002;45:453-458.
917. Church JM. Warm water irrigation for dealing with spasm during colonoscopy: simple,
inexpensive, and effective. Gastrointestinal endoscopy. 2002;56:672-674.
918. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ. High serum
YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer.
2002;95:267-274.
919. Furst A, Burghofer K, Hutzel L, Jauch KW. Neorectal reservoir is not the functional principle
of the colonic J-pouch: the volume of a short colonic J-pouch does not differ from a straight
coloanal anastomosis. Diseases of the colon and rectum. 2002;45:660-667.
920. Galizia G, Lieto E, De Vita F, et al. Circulating levels of interleukin-10 and interleukin-6 in
gastric and colon cancer patients before and after surgery: relationship with radicality and outcome.
Journal of interferon & cytokine research : the official journal of the International Society for
Interferon and Cytokine Research. 2002;22:473-482.
921. Heah SM, Seow-Choen F, Eu KW, Ho YH, Tang CL. Prospective, randomized trial
comparing sigmoid vs. descending colonic J-pouch after total rectal excision. Diseases of the
colon and rectum. 2002;45:322-328.
922. Hole DJ, McArdle CS. Impact of socioeconomic deprivation on outcome after surgery for
colorectal cancer. The British journal of surgery. 2002;89:586-590.
923. Killingback M, Barron P, Dent O. Elective resection and anastomosis for colorectal cancer: a
prospective audit of mortality and morbidity 1976-1998. ANZ journal of surgery.
2002;72:689-698.
924. Kitagawa Y, Nishizawa S, Sano K, et al. Whole-body (18)F-fluorodeoxyglucose positron
emission tomography in patients with head and neck cancer. Oral surgery, oral medicine, oral
pathology, oral radiology, and endodontics. 2002;93:202-207.
925. Kubota T, Watanabe M, Otani Y, Kitajima M, Fukushiuma M. Different pathways of
5-fluorouracil metabolism after continuous venous or bolus injection in patients with colon
carcinoma: possible predictive value of thymidylate synthetase mRNA and ribonucleotide
reductase for 5-fluorouracil sensitivity. Anticancer research. 2002;22:3537-3540.
926. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus
open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet.
2002;359:2224-2229.
927. Lattermann R, Carli F, Wykes L, Schricker T. Epidural blockade modifies perioperative
glucose production without affecting protein catabolism. Anesthesiology. 2002;97:374-381.
928. Law WL, Chu KW, Choi HK. Randomized clinical trial comparing loop ileostomy and loop
transverse colostomy for faecal diversion following total mesorectal excision. The British journal
of surgery. 2002;89:704-708.
929. Liang JT, Shieh MJ, Chen CN, Cheng YM, Chang KJ, Wang SM. Prospective evaluation of
laparoscopy-assisted colectomy versus laparotomy with resection for management of complex
polyps of the sigmoid colon. World journal of surgery. 2002;26:377-383.
930. Litvak DA, Wood TF, Tsioulias GJ, et al. Systemic irinotecan and regional floxuridine after
hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases. Annals of
surgical oncology. 2002;9:148-155.
931. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and
water balance on recovery of gastrointestinal function after elective colonic resection: a
randomised controlled trial. Lancet. 2002;359:1812-1818.
932. Lotem M, Peretz T, Drize O, et al. Autologous cell vaccine as a post operative adjuvant
treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint
Committee on Cancer. British journal of cancer. 2002;86:1534-1539.
933. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after
short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal
cancer: report of a multicenter randomized trial. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology. 2002;20:817-825.
934. Marusch F, Koch A, Schmidt U, et al. Value of a protective stoma in low anterior resections
for rectal cancer. Diseases of the colon and rectum. 2002;45:1164-1171.
935. Marusch F, Koch A, Schmidt U, et al. Early postoperative results of surgery for rectal
carcinoma as a function of the distance of the tumor from the anal verge: results of a multicenter
prospective evaluation. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie.
2002;387:94-100.
936. Marusch F, Koch A, Schmidt U, et al. Impact of age on the short-term postoperative outcome
of patients undergoing surgery for colorectal carcinoma. International journal of colorectal disease.
2002;17:177-184.
937. Marusch F, Koch A, Schmidt U, et al. ["Colon-/rectal carcinoma" prospective studies as
comprehensive surgical quality assurance]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen
Medizen. 2002;73:138-145; discussion 145-136.
938. Marusch F, Koch A, Schmidt U, et al. [Which factors are responsible for postoperative
mortality in colorectal cancer patients?]. Zentralblatt fur Chirurgie. 2002;127:614-621.
939. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital
after adjustment for case-mix and deprivation. British journal of cancer. 2002;86:331-335.
940. Munemoto
Y,
Iida
Y,
Abe
J,
et
al.
Significance
of
postoperative
adjuvant
immunochemotherapy after curative resection of colorectal cancers: Association between host or
tumor factors and survival. International journal of oncology. 2002;20:403-411.
941. Nair SK, Morse M, Boczkowski D, et al. Induction of tumor-specific cytotoxic T
lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Annals of
surgery. 2002;235:540-549.
942. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural
success and complications of large-scale screening colonoscopy. Gastrointestinal endoscopy.
2002;55:307-314.
943. Neudecker J, Junghans T, Ziemer S, Raue W, Schwenk W. Effect of laparoscopic and
conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized
clinical trial. International journal of colorectal disease. 2002;17:426-429.
944. Nielsen HJ, Christensen IJ, Moesgaard F, Kehlet H. Ranitidine as adjuvant treatment in
colorectal cancer. The British journal of surgery. 2002;89:1416-1422.
945. Perez J, Taura P, Rueda J, et al. Role of dopamine in renal dysfunction during laparoscopic
surgery. Surgical endoscopy. 2002;16:1297-1301.
946. Polliand C, Barrat C, Raselli R, Elizalde A, Champault G. [Colorectal cancer: 74 patients
treated by laparoscopic resection with a mean follow-up of 5 years]. Annales de chirurgie.
2002;127:690-696.
947. Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following
laparoscopically assisted and conventional open mesorectal resection for cancer. The British
journal of surgery. 2002;89:1551-1556.
948. Rouanet P, Saint-Aubert B, Lemanski C, et al. Restorative and nonrestorative surgery for low
rectal cancer after high-dose radiation: long-term oncologic and functional results. Diseases of the
colon and rectum. 2002;45:305-313; discussion 313-305.
949. Sailer M, Fuchs KH, Fein M, Thiede A. Randomized clinical trial comparing quality of life
after
straight
and
pouch
coloanal
reconstruction.
The
British
journal
of
surgery.
2002;89:1108-1117.
950. Scheidbach H, Schneider C, Huegel O, et al. Laparoscopic sigmoid resection for cancer:
curative resection and preliminary medium-term results. Diseases of the colon and rectum.
2002;45:1641-1647.
951. Scheidbach H, Schneider C, Konradt J, et al. Laparoscopic abdominoperineal resection and
anterior resection with curative intent for carcinoma of the rectum. Surgical endoscopy.
2002;16:7-13.
952. Schricker T, Wykes L, Eberhart L, Lattermann R, Mazza L, Carli F. The anabolic effect of
epidural blockade requires energy and substrate supply. Anesthesiology. 2002;97:943-951.
953. Song JX, Qing SH, Huang XC, Qi DL. Effect of parenteral nutrition with L-arginine
supplementation on postoperative immune function in patients with colorectal cancer. Di 1 jun yi
da xue xue bao = Academic journal of the first medical college of PLA. 2002;22:545-547.
954. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G. Short-term quality-of-life outcomes
following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.
JAMA : the journal of the American Medical Association. 2002;287:321-328.
955. Wemyss-Holden SA, Berry DP, Robertson GS, Dennison AR, De La MHP, Maddern GJ.
Electrolytic ablation as an adjunct to liver resection: Safety and efficacy in patients. ANZ journal
of surgery. 2002;72:589-593.
956. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential
resection margin following total mesorectal excision for rectal cancer. The British journal of
surgery. 2002;89:327-334.
957. Araujo SE, da Silva eSousa AH, Jr., de Campos FG, et al. Conventional approach x
laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant
chemoradiation: results of a prospective randomized trial. Revista do Hospital das Clinicas.
2003;58:133-140.
958. Chu DZ, Chansky K, Alberts DS, et al. Adenoma recurrences after resection of colorectal
carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot
study. Annals of surgical oncology. 2003;10:870-875.
959. Costantini M, Sciallero S, Giannini A, et al. Interobserver agreement in the histologic
diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study
(SMAC). Journal of clinical epidemiology. 2003;56:209-214.
960. Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Fairey AS. A
randomized trial of exercise and quality of life in colorectal cancer survivors. European journal of
cancer care. 2003;12:347-357.
961. Donckier V, Van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission
tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency
ablation for liver metastases. Journal of surgical oncology. 2003;84:215-223.
962. Dunker MS, Ten Hove T, Bemelman WA, Slors JF, Gouma DJ, Van Deventer SJ.
Interleukin-6, C-reactive protein, and expression of human leukocyte antigen-DR on peripheral
blood mononuclear cells in patients after laparoscopic vs. conventional bowel resection: a
randomized study. Diseases of the colon and rectum. 2003;46:1238-1244.
963. Furst A, Suttner S, Agha A, Beham A, Jauch KW. Colonic J-pouch vs. coloplasty following
resection of distal rectal cancer: early results of a prospective, randomized, pilot study. Diseases of
the colon and rectum. 2003;46:1161-1166.
964. Hasegawa H, Kabeshima Y, Watanabe M, Yamamoto S, Kitajima M. Randomized controlled
trial of laparoscopic versus open colectomy for advanced colorectal cancer. Surgical endoscopy.
2003;17:636-640.
965. Hildebrandt U, Kessler K, Plusczyk T, Pistorius G, Vollmar B, Menger MD. Comparison of
surgical stress between laparoscopic and open colonic resections. Surgical endoscopy.
2003;17:242-246.
966. Hildebrandt U, Plusczyk T, Kessler K, Menger MD. Single-surgeon surgery in laparoscopic
colonic resection. Diseases of the colon and rectum. 2003;46:1640-1645.
967. James RD, Donaldson D, Gray R, Northover JM, Stenning SP, Taylor I. Randomized clinical
trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). The British
journal of surgery. 2003;90:1200-1212.
968. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer
with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases
recorded at 18 institutions. Diseases of the colon and rectum. 2003;46:S22-31.
969. Leung KL, Tsang KS, Ng MH, et al. Lymphocyte subsets and natural killer cell cytotoxicity
after laparoscopically assisted resection of rectosigmoid carcinoma. Surgical endoscopy.
2003;17:1305-1310.
970. Liang JT, Lai HS, Huang KC, et al. Comparison of medial-to-lateral versus traditional
lateral-to-medial laparoscopic dissection sequences for resection of rectosigmoid cancers:
randomized controlled clinical trial. World journal of surgery. 2003;27:190-196.
971. Machado M, Nygren J, Goldman S, Ljungqvist O. Similar outcome after colonic pouch and
side-to-end anastomosis in low anterior resection for rectal cancer: a prospective randomized trial.
Annals of surgery. 2003;238:214-220.
972. Marijnen CA, Nagtegaal ID, Kapiteijn E, et al. Radiotherapy does not compensate for
positive resection margins in rectal cancer patients: report of a multicenter randomized trial.
International journal of radiation oncology, biology, physics. 2003;55:1311-1320.
973. Marusch F, Koch A, Schmidt U, et al. [Importance of rectal extirpation for the therapy
concept of low rectal cancers]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
2003;74:341-351; discussion 351-342.
974. Meyerhardt JA, Catalano PJ, Schrag D, et al. Association of hospital procedure volume and
outcomes in patients with colon cancer at high risk for recurrence. Annals of internal medicine.
2003;139:649-657.
975. Morse MA, Nair SK, Mosca PJ, et al. Immunotherapy with autologous, human dendritic cells
transfected with carcinoembryonic antigen mRNA. Cancer investigation. 2003;21:341-349.
976. Neary P, Makin GB, White TJ, et al. Transanal endoscopic microsurgery: a viable operative
alternative
in
selected
2003;10:1106-1111.
patients
with
rectal
lesions.
Annals
of
surgical
oncology.
977. Neudecker J, Junghans T, Ziemer S, Raue W, Schwenk W. Prospective randomized trial to
determine the influence of laparoscopic and conventional colorectal resection on intravasal
fibrinolytic capacity. Surgical endoscopy. 2003;17:73-77.
978. Ohwada S, Kawate S, Ikeya T, et al. Adjuvant therapy with protein-bound polysaccharide K
and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial.
Diseases of the colon and rectum. 2003;46:1060-1068.
979. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and
radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Annals of
surgical oncology. 2003;10:1059-1069.
980. Pimentel JM, Duarte A, Gregorio C, Souto P, Patricio J. Transverse coloplasty pouch and
colonic J-pouch for rectal cancer--a comparative study. Colorectal disease : the official journal of
the Association of Coloproctology of Great Britain and Ireland. 2003;5:465-470.
981. Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II
trial of capecitabine, oxaliplatin, and radiation for rectal cancer. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 2003;21:3098-3104.
982. Rodgers MS, Collinson R, Desai S, Stubbs RS, McCall JL. Risk of dissemination with biopsy
of colorectal liver metastases. Diseases of the colon and rectum. 2003;46:454-458; discussion
458-459.
983. Saini A, Norman AR, Cunningham D, et al. Twelve weeks of protracted venous infusion of
fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant
treatment in colorectal cancer. British journal of cancer. 2003;88:1859-1865.
984. Scheidbach H, Schneider C, Hugel O, et al. Oncological quality and preliminary long-term
results in laparoscopic colorectal surgery. Surgical endoscopy. 2003;17:903-910.
985. Sklow B, Read T, Birnbaum E, Fry R, Fleshman J. Age and type of procedure influence the
choice of patients for laparoscopic colectomy. Surgical endoscopy. 2003;17:923-929.
986. Vlad L, Osian G, Branda H, et al. Radiofrequency by open surgical approach in the treatment
of hepatic tumours: early experience with 14 cases. Romanian journal of gastroenterology.
2003;12:113-118.
987. Wein A, Riedel C, Bruckl W, et al. Neoadjuvant treatment with weekly high-dose
5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable
liver metastases of colorectal cancer. Oncology. 2003;64:131-138.
988. Whynes DK, Frew EJ, Manghan CM, Scholefield JH, Hardcastle JD. Colorectal cancer,
screening and survival: the influence of socio-economic deprivation. Public health.
2003;117:389-395.
989. Wu FP, Boelens PG, van Leeuwen PA, et al. Effects of major liver resection, with or without
recombinant bactericidal/permeability-increasing protein (rBPI21), on the angiogenic profile of
patients with metastatic colorectal carcinoma. Journal of surgical oncology. 2003;84:137-142.
990. Wu FP, Sietses C, von Blomberg BM, van Leeuwen PA, Meijer S, Cuesta MA. Systemic and
peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer
patients: a prospective, randomized trial. Diseases of the colon and rectum. 2003;46:147-155.
991. Zhou ZG, Wang Z, Yu YY, et al. Laparoscopic total mesorectal excision of low rectal cancer
with preservation of anal sphincter: a report of 82 cases. World journal of gastroenterology : WJG.
2003;9:1477-1481.
992. A comparison of laparoscopically assisted and open colectomy for colon cancer. The New
England journal of medicine. 2004;350:2050-2059.
993. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as
adjuvant treatment for colon cancer. The New England journal of medicine. 2004;350:2343-2351.
994. Ates E, Yilmaz S, Erkasap S, et al. Perioperative immunonutrition ameliorates the
postoperative immune depression in patients with gastrointestinal system cancer (prospective
clinical study in 42 patients). Acta gastro-enterologica Belgica. 2004;67:250-254.
995. Berdah SV, Barthet M, Emungania O, et al. [Two stage videoassisted restorative
proctocolectomy. Early experience of 12 cases]. Annales de chirurgie. 2004;129:332-336.
996. Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors
of recurrence. Diseases of the colon and rectum. 2004;47:323-333.
997. Capussotti L, Massucco P, Muratore A, Amisano M, Bima C, Zorzi D. Laparoscopy as a
prognostic factor in curative resection for node positive colorectal cancer: results for a
single-institution nonrandomized prospective trial. Surgical endoscopy. 2004;18:1130-1135.
998. Carne PW, Frye JN, Kennedy-Smith A, et al. Local invasion of the bladder with colorectal
cancers: surgical management and patterns of local recurrence. Diseases of the colon and rectum.
2004;47:44-47.
999. Chung HW, Chung JB, Park SW, Song SY, Kang JK, Park CI. Comparison of hydrocolonic
sonograpy accuracy in preoperative staging between colon and rectal cancer. World journal of
gastroenterology : WJG. 2004;10:1157-1161.
1000.
Feo CV, Romanini B, Sortini D, et al. Early oral feeding after colorectal resection: a
randomized controlled study. ANZ journal of surgery. 2004;74:298-301.
1001.
Gambacorta MA, Valentini V, Morganti AG, et al. Chemoradiation with raltitrexed
(Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study.
International journal of radiation oncology, biology, physics. 2004;60:130-138.
1002.
Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation,
apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected
Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 2004;22:1572-1582.
1003.
Hautmann S, Felix-Chun KH, Currlin E, et al. [Cystectomy for indications other than
bladder cancer]. Der Urologe. Ausg. A. 2004;43:172-177.
1004.
Hsu TC, Su CF, Leu SC, Huang PC, Wang TE, Chu CH. Omeprazole is more effective
than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after
colon resection for cancer. American journal of surgery. 2004;187:20-23.
1005.
Hyodo M, Sekiguchi C, Ohdaira T, Chiba H, Ohtsuka S, Nagai H. Gasless
laparoscopy-assisted colon surgery utilizing mini-laparotomy and a subcutaneous abdominal wall
lift system. Hepato-gastroenterology. 2004;51:1011-1014.
1006.
Ishikawa H, Fujii H, Koyama F, et al. Long-term results of high-dose extracorporeal and
endocavitary radiation therapy followed by abdominoperineal resection for distal rectal cancer.
Surgery today. 2004;34:510-517.
1007.
Kaiser AM, Kang JC, Chan LS, Vukasin P, Beart RW, Jr. Laparoscopic-assisted vs. open
colectomy for colon cancer: a prospective randomized trial. Journal of laparoendoscopic &
advanced surgical techniques. Part A. 2004;14:329-334.
1008.
Kang JC, Chung MH, Chao PC, et al. Hand-assisted laparoscopic colectomy vs open
colectomy: a prospective randomized study. Surgical endoscopy. 2004;18:577-581.
1009.
Karube H, Masuda H, Takayama T. Usefulness of bipolar scissors for rectal cancer
surgery with autonomic nerve preservation. Hepato-gastroenterology. 2004;51:990-993.
1010.
Kitajima K, Fujimori T, Fujii S, et al. Correlations between lymph node metastasis and
depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese
collaborative study. Journal of gastroenterology. 2004;39:534-543.
1011.
Law WL, Chu KW, Tung HM. Early outcomes of 100 patients with laparoscopic
resection for rectal neoplasm. Surgical endoscopy. 2004;18:1592-1596.
1012.
Lei WZ, Zhao GP, Cheng Z, Li K, Zhou ZG. Gastrointestinal decompression after
excision and anastomosis of lower digestive tract. World journal of gastroenterology : WJG.
2004;10:1998-2001.
1013.
Leung KL, Kwok SP, Lam SC, et al. Laparoscopic resection of rectosigmoid carcinoma:
prospective randomised trial. Lancet. 2004;363:1187-1192.
1014.
Lin CY, Bai DJ, Yuan HY, et al. Perioperative cimetidine administration promotes
peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal
cancer: Results of a randomized controlled clinical trial. World journal of gastroenterology : WJG.
2004;10:136-142.
1015.
Lu CH, Chao PC, Borel CO, et al. Preincisional intravenous pentoxifylline attenuating
perioperative cytokine response, reducing morphine consumption, and improving recovery of
bowel function in patients undergoing colorectal cancer surgery. Anesthesia and analgesia.
2004;99:1465-1471; table of contents.
1016.
Meyer F, Marusch F, Koch A, et al. Emergency operation in carcinomas of the left colon:
value of Hartmann's procedure. Techniques in coloproctology. 2004;8 Suppl 1:s226-229.
1017.
Meyer L, Bereuter M, Marusch F, et al. Perineal wound closure after abdomino-perineal
excision of the rectum. Techniques in coloproctology. 2004;8 Suppl 1:s230-234.
1018.
Mintz Y, Weiss YG, Rivkind AI. Effects of intravenous fluid restriction on postoperative
complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded
multicenter trial. Annals of surgery. 2004;240:386; author reply 386-388.
1019.
Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum
CA19-9 play a practical role in the management of patients with colorectal cancer? Diseases of the
colon and rectum. 2004;47:227-232.
1020.
Mynster T, Nielsen HJ, Harling H, Bulow S. Blood loss and transfusion after total
mesorectal excision and conventional rectal cancer surgery. Colorectal disease : the official journal
of the Association of Coloproctology of Great Britain and Ireland. 2004;6:452-457.
1021.
Nagy A, Kovacs T, Bognar J, Mohos E, Loderer Z. [Parastomal hernia repair and
prevention with PHSL type mesh after abdomino-perineal rectum extirpation]. Zentralblatt fur
Chirurgie. 2004;129:149-152.
1022.
Pacelli F, Di Giorgio A, Papa V, et al. Preoperative radiotherapy combined with
intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal
cancer. Diseases of the colon and rectum. 2004;47:170-179.
1023.
Romano G, Cocchiara G, Calderone F, et al. [Endoscopic treatment of colorectal polyps
in a digestive endoscopy outpatient department]. Chirurgia italiana. 2004;56:669-673.
1024.
Rose J, Schneider C, Yildirim C, Geers P, Scheidbach H, Kockerling F. Complications in
laparoscopic colorectal surgery: results of a multicentre trial. Techniques in coloproctology.
2004;8 Suppl 1:s25-28.
1025.
Saito N, Ono M, Sugito M, et al. Early results of intersphincteric resection for patients
with very low rectal cancer: an active approach to avoid a permanent colostomy. Diseases of the
colon and rectum. 2004;47:459-466.
1026.
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative
chemoradiotherapy for rectal cancer. The New England journal of medicine. 2004;351:1731-1740.
1027.
Schricker T, Meterissian S, Wykes L, Eberhart L, Lattermann R, Carli F. Postoperative
protein sparing with epidural analgesia and hypocaloric dextrose. Annals of surgery.
2004;240:916-921.
1028.
Soop M, Carlson GL, Hopkinson J, et al. Randomized clinical trial of the effects of
immediate enteral nutrition on metabolic responses to major colorectal surgery in an enhanced
recovery protocol. The British journal of surgery. 2004;91:1138-1145.
1029.
Ullenhag GJ, Frodin JE, Jeddi-Tehrani M, et al. Durable carcinoembryonic antigen
(CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients
vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2004;10:3273-3281.
1030.
Ulrich A, Z'Graggen K, Schmied B, Weitz J, Buchler MW. [The transverse coloplasty
pouch after low anterior resection: early postoperative results]. Der Chirurg; Zeitschrift fur alle
Gebiete der operativen Medizen. 2004;75:430-435.
1031.
Vignali A, Braga M, Zuliani W, Frasson M, Radaelli G, Di Carlo V. Laparoscopic
colorectal surgery modifies risk factors for postoperative morbidity. Diseases of the colon and
rectum. 2004;47:1686-1693.
1032.
Wu FP, Hoekman K, Sietses C, et al. Systemic and peritoneal angiogenic response after
laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial.
Diseases of the colon and rectum. 2004;47:1670-1674.
1033.
Wu WX, Sun YM, Hua YB, Shen LZ. Laparoscopic versus conventional open resection
of rectal carcinoma: A clinical comparative study. World journal of gastroenterology : WJG.
2004;10:1167-1170.
1034.
Wulf J, Kramer K, van Aaken C, et al. Outcome of postoperative treatment for rectal
cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality
control analysis in six institutions in North Bavaria (Germany). Strahlentherapie und Onkologie :
Organ der Deutschen Rontgengesellschaft ... [et al]. 2004;180:5-14.
1035.
Zhou ZG, Hu M, Li Y, et al. Laparoscopic versus open total mesorectal excision with
anal sphincter preservation for low rectal cancer. Surgical endoscopy. 2004;18:1211-1215.
1036.
Alves A, Panis Y, Mathieu P, Kwiatkowski F, Slim K, Mantion G. Mortality and
morbidity after surgery of mid and low rectal cancer. Results of a French prospective multicentric
study. Gastroenterologie clinique et biologique. 2005;29:509-514.
1037.
Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K. Postoperative
mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective
multicenter study. Archives of surgery (Chicago, Ill. : 1960). 2005;140:278-283, discussion 284.
1038.
Bujko K, Nowacki MP, Kepka L, Oledzki J, Bebenek M, Kryj M. Postoperative
complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial
comparing short-term radiotherapy vs chemoradiation. Colorectal disease : the official journal of
the Association of Coloproctology of Great Britain and Ireland. 2005;7:410-416.
1039.
Chandrasekaran TV, Morgan RN, Mason RA, Mangat PS, Watkins AJ, Carr ND.
Nutrient induced thermogenesis during major colorectal excision--a pilot study. Colorectal
disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
2005;7:74-78.
1040.
Chaudhri S, Brown L, Hassan I, Horgan AF. Preoperative intensive, community-based
vs. traditional stoma education: a randomized, controlled trial. Diseases of the colon and rectum.
2005;48:504-509.
1041.
Chen R, Cai JL, Zhou B, Jiang AF. [Effect of immune-enhanced enteral diet on
postoperative immunological function in patients with colorectal cancer]. Zhonghua wei chang
wai ke za zhi = Chinese journal of gastrointestinal surgery. 2005;8:328-330.
1042.
Chi P, Lin HM, Chen YC, Xu ZB. [Feasibility of lymphadenectomy with skeletonization
in extended right hemicolectomy by hand-assisted laparoscopic surgery]. Zhonghua wei chang wai
ke za zhi = Chinese journal of gastrointestinal surgery. 2005;8:410-412.
1043.
Christodoulakis M, Tsiftsis DD. Preoperative epoetin alfa in colorectal surgery: a
randomized, controlled study. Annals of surgical oncology. 2005;12:718-725.
1044.
De Kock M, Lavand'homme P, Waterloos H. The short-lasting analgesia and long-term
antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery. Anesthesia
and analgesia. 2005;101:566-572, table of contents.
1045.
Engel J, Kerr J, Eckel R, et al. Influence of hospital volume on local recurrence and
survival in a population sample of rectal cancer patients. European journal of surgical oncology :
the journal of the European Society of Surgical Oncology and the British Association of Surgical
Oncology. 2005;31:512-520.
1046.
Espin-Basany E, Sanchez-Garcia JL, Lopez-Cano M, et al. Prospective, randomised
study on antibiotic prophylaxis in colorectal surgery. Is it really necessary to use oral antibiotics?
International journal of colorectal disease. 2005;20:542-546.
1047.
Gastinger I, Marusch F, Steinert R, Wolff S, Koeckerling F, Lippert H. Protective
defunctioning stoma in low anterior resection for rectal carcinoma. The British journal of surgery.
2005;92:1137-1142.
1048.
Haase O, Schwenk W, Hermann C, Muller JM. Guided imagery and relaxation in
conventional colorectal resections: a randomized, controlled, partially blinded trial. Diseases of
the colon and rectum. 2005;48:1955-1963.
1049.
Hartung G, Hofheinz RD, Dencausse Y, et al. Adjuvant therapy with edrecolomab versus
observation in stage II colon cancer: a multicenter randomized phase III study. Onkologie.
2005;28:347-350.
1050.
Hladik P, Vizd'a J, Hadzi Nikolov D, Dvorak J, Voboril Z. Radio-guided sentinel node
detection during the surgical treatment of rectal cancer. Nuclear medicine communications.
2005;26:977-982.
1051.
Hu X, Li HZ, Zhang J, An WD, Zhang CJ. [Evaluation of the minimal invasiveness of
laparoscopic operation for colorectal carcinoma]. Zhonghua wei chang wai ke za zhi = Chinese
journal of gastrointestinal surgery. 2005;8:404-406.
1052.
Ishida H, Nakada H, Yokoyama M, et al. Minilaparotomy approach for colonic cancer:
initial experience of 54 cases. Surgical endoscopy. 2005;19:316-320.
1053.
Jayne DG, Brown JM, Thorpe H, Walker J, Quirke P, Guillou PJ. Bladder and sexual
function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus
open technique. The British journal of surgery. 2005;92:1124-1132.
1054.
Jiang JK, Yang SH, Lin JK. Transabdominal anastomosis after low anterior resection: A
prospective, randomized, controlled trial comparing long-term results between side-to-end
anastomosis and colonic J-pouch. Diseases of the colon and rectum. 2005;48:2100-2108;
discussion 2108-2110.
1055.
Kawaguchi T, Kusumoto M, Maeshima A, Tateishi U, Suzuki K, Moriyama N.
High-resolution computed tomography appearances of surgically resected pulmonary metastases
from colorectal cancer, with histopathologic correlation. Radiation medicine. 2005;23:418-426.
1056.
Kim JC, Kim TW, Kim JH, et al. Preoperative concurrent radiotherapy with capecitabine
before total mesorectal excision in locally advanced rectal cancer. International journal of
radiation oncology, biology, physics. 2005;63:346-353.
1057.
Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R. Intensified concurrent
chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with
locally advanced rectal cancer. British journal of cancer. 2005;92:1215-1220.
1058.
Kuhry E, Bonjer HJ, Haglind E, et al. Impact of hospital case volume on short-term
outcome after laparoscopic operation for colonic cancer. Surgical endoscopy. 2005;19:687-692.
1059.
Lamberti C, Sauerbruch T, Glasmacher A. Adjuvant capecitabine is at least as effective
as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. Cancer
treatment reviews. 2005;31:648-652.
1060.
Laurent A, Parc Y, McNamara D, Parc R, Tiret E. Colonic J-pouch-anal anastomosis for
rectal cancer: a prospective, randomized study comparing handsewn vs. stapled anastomosis.
Diseases of the colon and rectum. 2005;48:729-734.
1061.
Lavand'homme P, De Kock M, Waterloos H. Intraoperative epidural analgesia combined
with ketamine provides effective preventive analgesia in patients undergoing major digestive
surgery. Anesthesiology. 2005;103:813-820.
1062.
Link KH, Kornmann M, Staib L, Redenbacher M, Kron M, Beger HG. Increase of
survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a
randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with
interferon-alpha. Annals of surgery. 2005;242:178-187.
1063.
Lundby L, Krogh K, Jensen VJ, et al. Long-term anorectal dysfunction after
postoperative radiotherapy for rectal cancer. Diseases of the colon and rectum. 2005;48:1343-1349;
discussion 1349-1352; author reply 1352.
1064.
Machado M, Nygren J, Goldman S, Ljungqvist O. Functional and physiologic
assessment of the colonic reservoir or side-to-end anastomosis after low anterior resection for
rectal cancer: a two-year follow-up. Diseases of the colon and rectum. 2005;48:29-36.
1065.
Marusch F, Koch A, Schmidt U, et al. The impact of the risk factor "age" on the early
postoperative results of surgery for colorectal carcinoma and its significance for perioperative
management. World journal of surgery. 2005;29:1013-1021; discussion 1021-1012.
1066.
Neudecker J, Junghans T, Raue W, Ziemer S, Schwenk W. Fibrinolytic capacity in
peritoneal fluid after laparoscopic and conventional colorectal resection: data from a randomized
controlled trial. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie.
2005;390:523-527.
1067.
Nowacki MP, Rutkowski A, Oledzki J, Chwalinski M. Prospective, randomized trial
examining the role of gentamycin-containing collagen sponge in the reduction of postoperative
morbidity in rectal cancer patients: early results and surprising outcome at 3-year follow-up.
International journal of colorectal disease. 2005;20:114-120.
1068.
Ram E, Sherman Y, Weil R, Vishne T, Kravarusic D, Dreznik Z. Is mechanical bowel
preparation mandatory for elective colon surgery? A prospective randomized study. Archives of
surgery (Chicago, Ill. : 1960). 2005;140:285-288.
1069.
Renwick AA, Bokey EL, Chapuis PH, et al. Effect of supervised surgical training on
outcomes after resection of colorectal cancer. The British journal of surgery. 2005;92:631-636.
1070.
Robles R, Marin C, Fernandez JA, et al. [Toward zero mortality in liver resection.
Presentation of 200 consecutive cases]. Cirugia espanola. 2005;78:19-27.
1071.
Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression
after preoperative chemoradiotherapy for rectal cancer. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 2005;23:8688-8696.
1072.
Schricker T, Wykes L, Eberhart L, Carli F, Meterissian S. Randomized clinical trial of
the anabolic effect of hypocaloric parenteral nutrition after abdominal surgery. The British journal
of surgery. 2005;92:947-953.
1073.
Sobrero A, Frassineti G, Falcone A, et al. Adjuvant sequential methotrexate -->
5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage
II colon cancer. British journal of cancer. 2005;92:24-29.
1074.
Stuckle CA, Haegele KF, Jendreck M, et al. [Improvements in detection of rectal cancer
recurrence by multiplanar reconstruction]. Der Radiologe. 2005;45:930-934, 936.
1075.
Suehiro T, Matsumata T, Shikada Y, Sugimachi K. The effect of the herbal medicines
dai-kenchu-to
and
keishi-bukuryo-gan
on
bowel movement
after
colorectal
surgery.
Hepato-gastroenterology. 2005;52:97-100.
1076.
Svendsen MN, Werther K, Christensen IJ, Basse L, Nielsen HJ. Influence of open versus
laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its
soluble receptor 1 (sVEGFR1). Inflammation research : official journal of the European Histamine
Research Society ... [et al.]. 2005;54:458-463.
1077.
Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR. Prospective evaluation
of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable
colorectal liver metastases. The British journal of surgery. 2005;92:362-369.
1078.
Tsunoda A, Shibusawa M, Takata M, Hiratsuka K, Shida K, Kusano M. Early oral
feeding should be resumed following the resolution of gastric ileus. Hepato-gastroenterology.
2005;52:775-779.
1079.
Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III
colon cancer. The New England journal of medicine. 2005;352:2696-2704.
1080.
Ulrich A, Z'Graggen K, Weitz J, Buchler MW. Functional results of the colon J-pouch
versus transverse coloplasty pouch in Heidelberg. Recent results in cancer research. Fortschritte
der Krebsforschung. Progres dans les recherches sur le cancer. 2005;165:205-211.
1081.
Veldkamp R, Kuhry E, Hop WC, et al. Laparoscopic surgery versus open surgery for
colon cancer: short-term outcomes of a randomised trial. The lancet oncology. 2005;6:477-484.
1082.
Wichmann MW, Huttl TP, Winter H, et al. Immunological effects of laparoscopic vs
open colorectal surgery: a prospective clinical study. Archives of surgery (Chicago, Ill. : 1960).
2005;140:692-697.
1083.
Widder J, Herbst F, Dobrowsky W, et al. Preoperative short-term radiation therapy (25
Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). British journal of cancer.
2005;92:1209-1214.
1084.
Zhao G, Xiao G, Huang MX, Long HK. [Effect of laparoscopic radical operation on
systemic immunity in patients with colorectal cancer]. Zhonghua wei chang wai ke za zhi =
Chinese journal of gastrointestinal surgery. 2005;8:407-409.
1085.
Zhou ZX, Shao YF, Zhao P, Bai XF, Wang B. [Application of sigmoid coloplasty in
super-lower anastomosis]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal
surgery. 2005;8:306-308.
1086.
Arteaga-Gonzalez I, Martin-Malagon A, Fernandez EM, et al. The use of preoperative
endoscopic tattooing in laparoscopic colorectal cancer surgery for endoscopically advanced
tumors: a prospective comparative clinical study. World journal of surgery. 2006;30:605-611.
1087.
Bauhofer A, Lorenz W, Koller M, et al. Evaluation of the McPeek postoperative
outcome score in three trials. Langenbeck's archives of surgery / Deutsche Gesellschaft fur
Chirurgie. 2006;391:418-427.
1088.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M.
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with
preoperative conventionally fractionated chemoradiation for rectal cancer. The British journal of
surgery. 2006;93:1215-1223.
1089.
Cavaliere F, Valle M, De Simone M, et al. 120 peritoneal carcinomatoses from
colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a
S.I.T.I.L.O. multicentric study. In vivo (Athens, Greece). 2006;20:747-750.
1090.
Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkotter U. Pre-emptive
antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels
after elective colorectal surgery: a prospective randomised pilot study. Langenbeck's archives of
surgery / Deutsche Gesellschaft fur Chirurgie. 2006;391:187-194.
1091.
Chun HK, Choi D, Kim MJ, et al. Preoperative staging of rectal cancer: comparison of
3-T high-field MRI and endorectal sonography. AJR. American journal of roentgenology.
2006;187:1557-1562.
1092.
Daoud M, Gadea V, Radulescu E. [Considerations about neoplastic intestinal occlusion].
Chirurgia (Bucharest, Romania : 1990). 2006;101:319-323.
1093.
Feng B, Zheng MH, Mao ZH, et al. Clinical advantages of laparoscopic colorectal
cancer surgery in the elderly. Aging clinical and experimental research. 2006;18:191-195.
1094.
Frasson M, Braga M, Vignali A, et al. [Laparoscopic-assisted versus open surgery for
colorectal cancer: postoperative morbidity in a single center randomized trial]. Minerva chirurgica.
2006;61:283-292.
1095.
Garcia-Botello SA, Garcia-Granero E, Lillo R, Lopez-Mozos F, Millan M, Lledo S.
Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen
administration on the colorectal anastomosis. The British journal of surgery. 2006;93:698-706.
1096.
Hirayama I, Suzuki M, Ide M, Asao T, Kuwano H. Gum-chewing stimulates bowel
motility after surgery for colorectal cancer. Hepato-gastroenterology. 2006;53:206-208.
1097.
Holt PR, Bresalier RS, Ma CK, et al. Calcium plus vitamin D alters preneoplastic
features of colorectal adenomas and rectal mucosa. Cancer. 2006;106:287-296.
1098.
Hong X, Ye TH, Zhang XH, Ren HZ, Huang YG, Bu YF. Changes of interleukin-6 and
related factors as well as gastric intramucosal pH during colorectal and orthopaedic surgical
procedures. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih / Chinese
Academy of Medical Sciences. 2006;21:57-61.
1099.
Houborg KB, Jensen MB, Rasmussen P, Gandrup P, Schroll M, Laurberg S.
Postoperative physical training following colorectal surgery: a randomised, placebo-controlled
study. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and
the Scandinavian Surgical Society. 2006;95:17-22.
1100.
Hsu TC, Su CF, Huang PC, Lu SC, Tsai SL. Comparison of tolerance and change of
intragastric pH between early nasogastric and nasojejunal feeding following resection of
colorectal cancer. Clinical nutrition (Edinburgh, Scotland). 2006;25:681-686.
1101.
Jin J, Li YX, Liu YP, et al. [Phase I study of postoperative concurrent chemoradiation
with capecitabine as adjuvant treatment for stage II/III operable rectal cancer]. Zhonghua zhong
liu za zhi [Chinese journal of oncology]. 2006;28:393-396.
1102.
Junghans T, Raue W, Haase O, Neudecker J, Schwenk W. [Value of laparoscopic surgery
in elective colorectal surgery with "fast-track"-rehabilitation]. Zentralblatt fur Chirurgie.
2006;131:298-303.
1103.
King PM, Blazeby JM, Ewings P, et al. The influence of an enhanced recovery
programme on clinical outcomes, costs and quality of life after surgery for colorectal cancer.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and
Ireland. 2006;8:506-513.
1104.
Kremer A, Holdenrieder S, Stieber P, Wilkowski R, Nagel D, Seidel D. Nucleosomes in
colorectal cancer patients during radiochemotherapy. Tumour biology : the journal of the
International Society for Oncodevelopmental Biology and Medicine. 2006;27:235-242.
1105.
Kuo CP, Jao SW, Chen KM, et al. Comparison of the effects of thoracic epidural
analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel
function in patients undergoing colonic surgery. British journal of anaesthesia. 2006;97:640-646.
1106.
Liang H, Yang CX, Li H, Liu HZ, Wang HB. [Effects of preoperative acute
hypervolemic hemodilution on hypercoagulability of patients with colon cancer]. Ai zheng =
Aizheng = Chinese journal of cancer. 2006;25:1256-1260.
1107.
Maschuw K, Kress R, Ramaswamy A, Braun I, Langer P, Gerdes B. Short-term
preoperative radiotherapy in rectal cancer patients leads to a reduction of the detectable number of
lymph nodes in resection specimens. Langenbeck's archives of surgery / Deutsche Gesellschaft fur
Chirurgie. 2006;391:364-368.
1108.
Matsuda A, Furukawa K, Takasaki H, et al. Preoperative oral immune-enhancing
nutritional supplementation corrects TH1/TH2 imbalance in patients undergoing elective surgery
for colorectal cancer. Diseases of the colon and rectum. 2006;49:507-516.
1109.
Matthiessen P, Hallbook O, Rutegard J, Sjodahl R. Population-based study of risk
factors for postoperative death after anterior resection of the rectum. The British journal of surgery.
2006;93:498-503.
1110.
Navarro M, Dotor E, Rivera F, et al. A Phase II study of preoperative radiotherapy and
concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for
resectable locally advanced rectal cancer. International journal of radiation oncology, biology,
physics. 2006;66:201-205.
1111.
Noblett SE, Watson DS, Huong H, Davison B, Hainsworth PJ, Horgan AF. Pre-operative
oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal disease :
the official journal of the Association of Coloproctology of Great Britain and Ireland.
2006;8:563-569.
1112.
Norager CB, Jensen MB, Madsen MR, Qvist N, Laurberg S. Effect of darbepoetin alfa
on physical function in patients undergoing surgery for colorectal cancer. A randomized,
double-blind, placebo-controlled study. Oncology. 2006;71:212-220.
1113.
O'Boyle KP, Coatsworth S, Anthony G, et al. Effects of desialylation of ovine
submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated
Tn. Cancer immunity. 2006;6:5.
1114.
Ohwada S, Sato Y, Izumi M, et al. Preoperative tegafur suppositories for resectable
rectal cancer: phase II trial. Diseases of the colon and rectum. 2006;49:1602-1610.
1115.
Oosterling SJ, Mels AK, Geijtenbeek TB, et al. Preoperative granulocyte/macrophage
colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with
lymphocytes in colorectal cancer patients. Immunobiology. 2006;211:641-649.
1116.
Ortiz H, Ciga MA, Oteiza F, Armendariz P, de Miguel M, Marzo J. [Introduction of
laparoscopy in the treatment of rectal cancer in a coloproctology unit]. Cirugia espanola.
2006;79:160-166.
1117.
Ptok H, Steinert R, Meyer F, et al. [Long-term oncological results after laparoscopic,
converted and primary open procedures for rectal carcinoma. Results of a multicenter
observational study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
2006;77:709-717.
1118.
Quah HM, Samad A, Neathey AJ, Hay DJ, Maw A. Does gum chewing reduce
postoperative ileus following open colectomy for left-sided colon and rectal cancer? A prospective
randomized controlled trial. Colorectal disease : the official journal of the Association of
Coloproctology of Great Britain and Ireland. 2006;8:64-70.
1119.
Rimaitis K, Pavalkis D. Does epidural anaesthesia and analgesia really improves
surgical outcome after colorectal cancer surgery? Acta chirurgica Iugoslavica. 2006;53:85-89.
1120.
Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with
colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized,
controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 2006;24:386-393.
1121.
Sakamoto K, Machi J, Prygrocki M, et al. Comparison of characteristics and survival of
colorectal cancer between Japanese-Americans in Hawaii and native Japanese in Japan. Diseases
of the colon and rectum. 2006;49:50-57.
1122.
Sakata H, Iwakiri R, Ootani A, et al. A pilot randomized control study to evaluate
endoscopic resection using a ligation device for rectal carcinoid tumors. World journal of
gastroenterology : WJG. 2006;12:4026-4028.
1123.
Schafer HH, Vivaldi C, Holscher AH. [Local excision with transanal endoscopic
microsurgery (TEM) after endoscopic R1/R2-polypectomy of pT1 "low-risk" carcinomas of the
rectum]. Zeitschrift fur Gastroenterologie. 2006;44:647-650.
1124.
Schwenk W, Neudecker J, Raue W, Haase O, Muller JM. "Fast-track" rehabilitation after
rectal cancer resection. International journal of colorectal disease. 2006;21:547-553.
1125.
Slim K, Panis Y, Alves A, Kwiatkowski F, Mathieu P, Mantion G. Predicting
postoperative mortality in patients undergoing colorectal surgery. World journal of surgery.
2006;30:100-106.
1126.
Soran A, Harlak A, Wilson JW, et al. Diverticular disease in patients with colon cancer:
subgroup analysis of national surgical adjuvant breast and bowel project protocol C-06. Clinical
colorectal cancer. 2006;6:140-145.
1127.
Svanfeldt M, Thorell A, Nygren J, Ljungqvist O. Postoperative parenteral nutrition
while proactively minimizing insulin resistance. Nutrition (Burbank, Los Angeles County, Calif.).
2006;22:457-464.
1128.
Tang CL, Jayne DG, Seow-Choen F, Ng YY, Eu KW, Mustapha N. A randomized
controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following
abdominal surgery. Annals of surgery. 2006;243:449-455.
1129.
Vermeulen J, Lange JF, van der Harst E. Impaired anastomotic healing after preoperative
radiotherapy followed by anterior resection for treatment of rectal carcinoma. South African
journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie. 2006;44:12, 14-16.
1130.
Wang Z, Chen JX, Wang PZ. [Effect of compound branch chain amino acid injection on
nutritional support in patients after radical resection for colorectal cancer]. Zhonghua wei chang
wai ke za zhi = Chinese journal of gastrointestinal surgery. 2006;9:399-401.
1131.
Wu AW, Gu J, Wang J. [Effect of total mesorectal excision and preoperative
chemoradiotherapy on local recurrence in rectal cancer]. Zhonghua wei chang wai ke za zhi =
Chinese journal of gastrointestinal surgery. 2006;9:207-209.
1132.
Zanon C, Bortolini M, Chiappino I, et al. Cytoreductive surgery combined with
intraperitoneal chemohyperthermia for the treatment of advanced colon cancer. World journal of
surgery. 2006;30:2025-2032.
1133.
Zhou T, Wu XT, Zhou YJ, Huang X, Fan W, Li YC. Early removing gastrointestinal
decompression and early oral feeding improve patients' rehabilitation after colorectostomy. World
journal of gastroenterology : WJG. 2006;12:2459-2463.
1134.
Aballea S, Boler A, Craig A, Wasan H. An economic evaluation of oxaliplatin for the
adjuvant treatment of colon cancer in the United Kingdom (UK). European journal of cancer
(Oxford, England : 1990). 2007;43:1687-1693.
1135.
Alves A, Panis Y, Mantion G, Slim K, Kwiatkowski F, Vicaut E. The AFC score:
validation of a 4-item predicting score of postoperative mortality after colorectal resection for
cancer or diverticulitis: results of a prospective multicenter study in 1049 patients. Annals of
surgery. 2007;246:91-96.
1136.
Amemiya T, Oda K, Ando M, et al. Activities of daily living and quality of life of
elderly patients after elective surgery for gastric and colorectal cancers. Annals of surgery.
2007;246:222-228.
1137.
Bageacu S, Kaczmarek D, Lacroix M, Dubois J, Forest J, Porcheron J. Cryosurgery for
resectable and unresectable hepatic metastases from colorectal cancer. European journal of
surgical oncology : the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 2007;33:590-596.
1138.
Bauhofer A, Plaul U, Torossian A, et al. Perioperative prophylaxis with granulocyte
colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved
recovery: A randomized, controlled trial. Surgery. 2007;141:501-510.
1139.
Borisov DB, Levin AV, Vyl'iurov IV, Sokolov AV, Nedashkovskii EV. [Efficiency of
preemptive intravenous paracetamol analgesia in abdominal surgery]. Anesteziologiia i
reanimatologiia. 2007:38-40.
1140.
Braga M, Frasson M, Vignali A, Zuliani W, Capretti G, Di Carlo V. Laparoscopic
resection in rectal cancer patients: outcome and cost-benefit analysis. Diseases of the colon and
rectum. 2007;50:464-471.
1141.
Chung CC, Ng DC, Tsang WW, et al. Hand-assisted laparoscopic versus open right
colectomy: a randomized controlled trial. Annals of surgery. 2007;246:728-733.
1142.
Corso OH, Morris RG, Hewett PJ, Karatassas A. Safety of 96-hour incision-site
continuous infusion of ropivacaine for postoperative analgesia after bowel cancer resection.
Therapeutic drug monitoring. 2007;29:57-63.
1143.
Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of
radiation-induced diarrhea. World journal of gastroenterology : WJG. 2007;13:912-915.
1144.
Emura F, Saito Y, Taniguchi M, Fujii T, Tagawa K, Yamakado M. Further validation of
magnifying chromocolonoscopy for differentiating colorectal neoplastic polyps in a health
screening center. Journal of gastroenterology and hepatology. 2007;22:1722-1727.
1145.
Finco C, Magnanini P, Sarzo G, et al. Prospective randomized study on perioperative
enteral
immunonutrition
in
laparoscopic
colorectal
surgery.
Surgical
endoscopy.
2007;21:1175-1179.
1146.
Fujita S, Saito N, Yamada T, et al. Randomized, multicenter trial of antibiotic
prophylaxis in elective colorectal surgery: single dose vs 3 doses of a second-generation
cephalosporin without metronidazole and oral antibiotics. Archives of surgery (Chicago, Ill. :
1960). 2007;142:657-661.
1147.
Hubner M, Hahnloser D, Hetzer F, Muller MK, Clavien PA, Demartines N. A
prospective randomized comparison of two instruments for dissection and vessel sealing in
laparoscopic colorectal surgery. Surgical endoscopy. 2007;21:592-594.
1148.
Hurlstone DP, Hunter MD, Sanders DS, Thomson M, Cross SS. Olympus Lucera
high-resolution vascular ectasia mapping in combination with the type V crypt pattern for the
invasive depth estimation and nodal disease estimation in Paris type II colorectal cancers: a
comparative prospective analysis to 20 MHz ultrasound. Journal of clinical gastroenterology.
2007;41:178-184.
1149.
Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Miki H. Colorectal
resection by a minilaparotomy approach vs. conventional operation for colon cancer. Results of a
prospective randomized trial. Hepato-gastroenterology. 2007;54:1970-1975.
1150.
Janson M, Lindholm E, Anderberg B, Haglind E. Randomized trial of health-related
quality of life after open and laparoscopic surgery for colon cancer. Surgical endoscopy.
2007;21:747-753.
1151.
Jung B, Lannerstad O, Pahlman L, Arodell M, Unosson M, Nilsson E. Preoperative
mechanical preparation of the colon: the patient's experience. BMC surgery. 2007;7:5.
1152.
Khoo CK, Vickery CJ, Forsyth N, Vinall NS, Eyre-Brook IA. A prospective randomized
controlled trial of multimodal perioperative management protocol in patients undergoing elective
colorectal resection for cancer. Annals of surgery. 2007;245:867-872.
1153.
Kim JC, Takahashi K, Yu CS, et al. Comparative outcome between chemoradiotherapy
and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Annals of surgery. 2007;246:754-762.
1154.
Kirman I, Belizon A, Balik E, et al. Perioperative sargramostim (recombinant human
GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing
minimally invasive surgery. European journal of surgical oncology : the journal of the European
Society of Surgical Oncology and the British
Association of Surgical
Oncology.
2007;33:1169-1176.
1155.
Liang JT, Huang KC, Lai HS, Lee PH, Sun CT. Oncologic results of laparoscopic D3
lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
Annals of surgical oncology. 2007;14:1980-1990.
1156.
Liang JT, Lai HS, Lee PH. Laparoscopic pelvic autonomic nerve-preserving surgery for
patients with lower rectal cancer after chemoradiation therapy. Annals of surgical oncology.
2007;14:1285-1287.
1157.
Liang JT, Lai HS, Lee PH, Huang KC. Comparison of functional and surgical outcomes
of laparoscopic-assisted colonic J-pouch versus straight reconstruction after total mesorectal
excision for lower rectal cancer. Annals of surgical oncology. 2007;14:1972-1979.
1158.
Neufeld D, Bugyev N, Grankin M, et al. Specimen length as a perioperative surrogate
marker for adequate lymphadenectomy in colon cancer: the surgeon's role. International surgery.
2007;92:155-160.
1159.
Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ.
Association between venous thromboembolism and perioperative allogeneic transfusion. Archives
of surgery (Chicago, Ill. : 1960). 2007;142:126-132; discussion 133.
1160.
Oguz M, Kerem M, Bedirli A, et al. L-alanin-L-glutamine supplementation improves the
outcome after colorectal surgery for cancer. Colorectal disease : the official journal of the
Association of Coloproctology of Great Britain and Ireland. 2007;9:515-520.
1161.
Pan YF, Zhang XH, Jia XJ, et al. [Laparoscopic abdominoperineal resection for low
rectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2007;10:253-256.
1162.
Pechlivanides G, Gouvas N, Tsiaoussis J, et al. Lymph node clearance after total
mesorectal excision for rectal cancer: laparoscopic versus open approach. Digestive diseases
(Basel, Switzerland). 2007;25:94-99.
1163.
Pietsch AP, Fietkau R, Klautke G, Foitzik T, Klar E. Effect of neoadjuvant
chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer
patients. International journal of colorectal disease. 2007;22:1311-1317.
1164.
Ptok H, Marusch F, Meyer F, et al. Oncological outcome of local vs radical resection of
low-risk pT1 rectal cancer. Archives of surgery (Chicago, Ill. : 1960). 2007;142:649-655;
discussion 656.
1165.
Rao SX, Zeng MS, Xu JM, et al. Assessment of T staging and mesorectal fascia status
using high-resolution MRI in rectal cancer with rectal distention. World journal of
gastroenterology : WJG. 2007;13:4141-4146.
1166.
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and
synchronous liver metastases: a multi-institutional analysis. Annals of surgical oncology.
2007;14:3481-3491.
1167.
Rhomberg W, Hammer J, Sedlmayer F, Eiter H, Seewald D, Schneider B. Irradiation
with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal
cancer. Results of a small randomized multicenter study. Strahlentherapie und Onkologie : Organ
der Deutschen Rontgengesellschaft ... [et al]. 2007;183:380-384.
1168.
Rink AD, Haaf F, Knupper N, Vestweber KH. Prospective randomised trial comparing
ileocaecal interposition and colon-J-pouch as rectal replacement after total mesorectal excision.
International journal of colorectal disease. 2007;22:153-160.
1169.
Saito Y, Uraoka T, Matsuda T, et al. Endoscopic treatment of large superficial colorectal
tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointestinal
endoscopy. 2007;66:966-973.
1170.
Saltz LB, Niedzwiecki D, Hollis D, et al. Irinotecan fluorouracil plus leucovorin is not
superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer:
results of CALGB 89803. Journal of clinical oncology : official journal of the American Society of
Clinical Oncology. 2007;25:3456-3461.
1171.
Sanders G, Arthur CH, Hosie KB, Lambert AW. Is patient outcome affected by the
administration of intravenous fluid during bowel preparation for colonic surgery? Annals of the
Royal College of Surgeons of England. 2007;89:487-489.
1172.
Scheidbach H, Schubert D, Hugel O, et al. Results of laparoscopic surgery for colorectal
cancer in palliative intent: short-term end points in 331 patients in comparison with procedures in
benign indications. Surgical laparoscopy, endoscopy & percutaneous techniques. 2007;17:79-82.
1173.
Schiller DE, Cummings BJ, Rai S, et al. Outcomes of salvage surgery for squamous cell
carcinoma of the anal canal. Annals of surgical oncology. 2007;14:2780-2789.
1174.
Schricker T, Wykes L, Carvalho G, et al. Perioperative amino acid supplementation of
hypocaloric glucose does not impair glucose metabolism after surgery. Metabolism: clinical and
experimental. 2007;56:1508-1513.
1175.
Seike K, Koda K, Saito N, et al. Laser Doppler assessment of the influence of division at
the root of the inferior mesenteric artery on anastomotic blood flow in rectosigmoid cancer surgery.
International journal of colorectal disease. 2007;22:689-697.
1176.
Skanberg J, Lundholm K, Haglind E. Effects of blood transfusion with leucocyte
depletion on length of hospital stay, respiratory assistance and survival after curative surgery for
colorectal cancer. Acta oncologica (Stockholm, Sweden). 2007;46:1123-1130.
1177.
Szynglarewicz B, Matkowski R, Kasprzak P, et al. Sphincter-preserving R0 total
mesorectal excision with resection of internal genitalia combined with pre- or postoperative
chemoradiation for T4 rectal cancer in females. World journal of gastroenterology : WJG.
2007;13:2339-2343.
1178.
Tanaka S, Saito K, Ito T, et al. CDX2 as a useful marker of colorectal adenocarcinoma
metastases to lung in pre-operative biopsy specimens. Oncology reports. 2007;18:87-92.
1179.
Taqi A, Hong X, Mistraletti G, Stein B, Charlebois P, Carli F. Thoracic epidural
analgesia facilitates the restoration of bowel function and dietary intake in patients undergoing
laparoscopic colon resection using a traditional, nonaccelerated, perioperative care program.
Surgical endoscopy. 2007;21:247-252.
1180.
Veenhof AA, Kropman RH, Engel AF, et al. Preoperative radiation therapy for locally
advanced rectal cancer: a comparison between two different time intervals to surgery. International
journal of colorectal disease. 2007;22:507-513.
1181.
Willeke F, Horisberger K, Kraus-Tiefenbacher U, et al. A phase II study of capecitabine
and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant
treatment of locally advanced rectal cancer. British journal of cancer. 2007;96:912-917.
1182.
Wiriyakosol S, Kongdan Y, Euanorasetr C, Wacharachaisurapol N, Lertsithichai P.
Randomized controlled trial of bisacodyl suppository versus placebo for postoperative ileus after
elective colectomy for colon cancer. Asian journal of surgery / Asian Surgical Association.
2007;30:167-172.
1183.
Xu JM, Zhong YS, Zhu DX, et al. [Application of the protocol of enhanced recovery
after surgery in colorectal surgery]. Zhonghua wei chang wai ke za zhi = Chinese journal of
gastrointestinal surgery. 2007;10:238-244.
1184.
Yang L, Yu YY, Zhou ZG, et al. Quality of life outcomes following laparoscopic total
mesorectal excision for low rectal cancers: a clinical control study. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 2007;33:575-579.
1185.
Yao YF, Yang Z, Li ZF, Gu J. Immunoscintigraphy of local recurrent rectal cancer with
99mTc-labeled anti-CEA monoclonal antibody CL58. World journal of gastroenterology : WJG.
2007;13:1841-1846.
1186.
Yoshida S, Tanaka S, Hirata M, et al. Optical biopsy of GI lesions by reflectance-type
laser-scanning confocal microscopy. Gastrointestinal endoscopy. 2007;66:144-149.
1187.
Allardyce RA, Bagshaw PF, Frampton CM, et al. Australian and New Zealand study
comparing laparoscopic and open surgeries for colon cancer in adults: organization and conduct.
ANZ journal of surgery. 2008;78:840-847.
1188.
An GQ, Zhao XL, Gao YC, Wang GY, Yu YM. [Effects of preoperative carbohydrate
loading on the changes in serum tumor necrosis factor receptors 1 and 2 and insulin resistance in
patients of colon carcinoma]. Zhonghua yi xue za zhi. 2008;88:2041-2044.
1189.
Arteaga Gonzalez I, Lopez-Tomassetti Fernandez EM, Hernandez Pinero Y, et al.
Effectiveness of colorectal laparoscopic surgery on patients at high anesthetic risk: an intervention
cohort study. International journal of colorectal disease. 2008;23:101-106.
1190.
Augestad KM, Vonen B, Aspevik R, et al. Should the surgeon or the general practitioner
(GP) follow up patients after surgery for colon cancer? A randomized controlled trial protocol
focusing on quality of life, cost-effectiveness and serious clinical events. BMC health services
research. 2008;8:137.
1191.
Auman JT, Church R, Lee SY, Watson MA, Fleshman JW, McLeod HL. Celecoxib
pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression
alterations suggestive of diminished cellular proliferation. European journal of cancer (Oxford,
England : 1990). 2008;44:1754-1760.
1192.
Baik SH, Kim NK, Lee KY, et al. Factors influencing pathologic results after total
mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Annals of surgical
oncology. 2008;15:721-728.
1193.
Ballonoff A, Kavanagh B, McCarter M, et al. Preoperative capecitabine and accelerated
intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. American
journal of clinical oncology. 2008;31:264-270.
1194.
Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on
pharmacological preconditioning in liver surgery using a volatile anesthetic. Annals of surgery.
2008;248:909-918.
1195.
Bilimoria KY, Bentrem DJ, Merkow RP, et al. Laparoscopic-assisted vs. open colectomy
for cancer: comparison of short-term outcomes from 121 hospitals. Journal of gastrointestinal
surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008;12:2001-2009.
1196.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders
after rectal cancer surgery with and without preoperative radiation therapy. The British journal of
surgery. 2008;95:206-213.
1197.
Chude GG, Rayate NV, Patris V, et al. Defunctioning loop ileostomy with low anterior
resection for distal rectal cancer: should we make an ileostomy as a routine procedure? A
prospective randomized study. Hepato-gastroenterology. 2008;55:1562-1567.
1198.
de Castro SM, van Eijck CH, Rutten JP, et al. Pancreas-preserving total duodenectomy
versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and
polyps in the duodenum. The British journal of surgery. 2008;95:1380-1386.
1199.
Elkord E, Dangoor A, Drury NL, et al. An MVA-based vaccine targeting the oncofetal
antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases. Journal
of immunotherapy (Hagerstown, Md. : 1997). 2008;31:820-829.
1200.
Esnaola NF, Stewart AK, Feig BW, Skibber JM, Rodriguez-Bigas MA. Age-, race-, and
ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care
study from the national cancer data base. Annals of surgical oncology. 2008;15:3036-3047.
1201.
Fujii M, Takayama T, Kochi M. Clinical identification of colorectal cancer patients
benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial. Journal of cancer
research and clinical oncology. 2008;134:1319-1323.
1202.
Fuks D, Pessaux P, Tuech JJ, et al. Management of patients with carcinoma of the right
colon invading the duodenum or pancreatic head. International journal of colorectal disease.
2008;23:477-481.
1203.
Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al. cT3N0 rectal cancer: potential
overtreatment with preoperative chemoradiotherapy is warranted. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 2008;26:368-373.
1204.
Hata F, Sasaki K, Hirata K, Yamamitsu S, Shirasaka T. Efficacy of a continuous venous
infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable
colorectal cancer: a prospective randomized trial. Surgery today. 2008;38:623-632.
1205.
Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally
recurrent rectal cancer. Diseases of the colon and rectum. 2008;51:284-291.
1206.
Hewett PJ, Allardyce RA, Bagshaw PF, et al. Short-term outcomes of the Australasian
randomized clinical study comparing laparoscopic and conventional open surgical treatments for
colon cancer: the ALCCaS trial. Annals of surgery. 2008;248:728-738.
1207.
Hoensch H, Groh B, Edler L, Kirch W. Prospective cohort comparison of flavonoid
treatment in patients with resected colorectal cancer to prevent recurrence. World journal of
gastroenterology : WJG. 2008;14:2187-2193.
1208.
Horisberger K, Hofheinz RD, Palma P, et al. Tumor response to neoadjuvant
chemoradiation in rectal cancer: predictor for surgical morbidity? International journal of
colorectal disease. 2008;23:257-264.
1209.
Jin J, Li YX, Wang JW, et al. Phase I study of oxaliplatin in combination with
capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.
International journal of radiation oncology, biology, physics. 2008;72:671-677.
1210.
Kacar S, Varilsuha C, Gurkan A, Karaca C. Pre-operative radiochemotherapy for rectal
cancer.
A
prospective
randomized
trial
comparing
pre-operative
vs.
postoperative
radiochemotherapy in rectal cancer patients. Acta chirurgica Belgica. 2008;108:518-523.
1211.
Kube R, Ptok H, Steinert R, et al. [Clinical value of laparoscopic surgery for colon
cancer]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2008;79:1145-1150.
1212.
Kurome M, Kato J, Nawa T, et al. Risk factors for high-grade dysplasia or carcinoma in
colorectal adenoma cases treated with endoscopic polypectomy. European journal of
gastroenterology & hepatology. 2008;20:111-117.
1213.
Lacy AM, Delgado S, Castells A, et al. The long-term results of a randomized clinical
trial of laparoscopy-assisted versus open surgery for colon cancer. Annals of surgery.
2008;248:1-7.
1214.
Liang B, Wang S, Ye YJ, et al. Impact of postoperative omega-3 fatty acid-supplemented
parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients.
World journal of gastroenterology : WJG. 2008;14:2434-2439.
1215.
Liu Z, Wang XD, Li L. [Perioperative fast track programs enhance the postoperative
recovery after rectal carcinoma resection]. Zhonghua wei chang wai ke za zhi = Chinese journal of
gastrointestinal surgery. 2008;11:551-553.
1216.
Lohsiriwat V, Lohsiriwat D. Comparison of immediate surgical outcomes between
posterior pelvic exenteration and standard resection for primary rectal cancer: a matched
case-control study. World journal of gastroenterology : WJG. 2008;14:2414-2417.
1217.
Masaki T, Takayama M, Matsuoka H, et al. Intraoperative radiotherapy for oncological
and function-preserving surgery in patients with advanced lower rectal cancer. Langenbeck's
archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2008;393:173-180.
1218.
Meyskens FL, Jr., McLaren CE, Pelot D, et al. Difluoromethylornithine plus sulindac for
the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind
trial. Cancer prevention research (Philadelphia, Pa.). 2008;1:32-38.
1219.
Michalek-Sauberer A, Kozek-Langenecker SA, Heinzl H, Deusch E, Chiari A. Median
effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia
administered via a spinal catheter for brachytherapy of the lower abdomen. Regional anesthesia
and pain medicine. 2008;33:4-9.
1220.
Milanov NO, Pugaev AV, Achkasov EE, Alekperov SF, Kalachev OA. [Extended,
combined, and concurrent surgery in patients with neoplastic obturation large bowel obstruction].
Vestnik Rossiiskoi akademii meditsinskikh nauk / Rossiiskaia akademiia meditsinskikh nauk.
2008:18-24.
1221.
Nakao M, Hata J, Manabe N, et al. Evaluation of colon cancer vascularity by flash echo
imaging. Scandinavian journal of gastroenterology. 2008;43:223-228.
1222.
Narita K, Tsunoda A, Takenaka K, Watanabe M, Nakao K, Kusano M. Effect of
mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for
carcinoma. Diseases of the colon and rectum. 2008;51:1692-1695.
1223.
Ng SS, Leung KL, Lee JF, et al. Laparoscopic-assisted versus open abdominoperineal
resection for low rectal cancer: a prospective randomized trial. Annals of surgical oncology.
2008;15:2418-2425.
1224.
Paulson EC, Mitra N, Sonnad S, et al. National Cancer Institute designation predicts
improved outcomes in colorectal cancer surgery. Annals of surgery. 2008;248:675-686.
1225.
Posner MC, Niedzwiecki D, Venook AP, et al. A phase II prospective multi-institutional
trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer
hepatic metastases: cancer and leukemia group B study 89903. Annals of surgical oncology.
2008;15:158-164.
1226.
Ramacciato G, D'Angelo F, Aurello P, et al. [Right hemicolectomy for colon cancer: a
prospective randomised study comparing laparoscopic vs. open technique]. Chirurgia italiana.
2008;60:1-7.
1227.
Rodel C, Arnold D, Hipp M, et al. Phase I-II trial of cetuximab, capecitabine, oxaliplatin,
and radiotherapy as preoperative treatment in rectal cancer. International journal of radiation
oncology, biology, physics. 2008;70:1081-1086.
1228.
Rosenthal DI, Catalano PJ, Haller DG, et al. Phase I study of preoperative radiation
therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and
postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
International journal of radiation oncology, biology, physics. 2008;72:108-113.
1229.
Salerno G, Chandler I, Wotherspoon A, Thomas K, Moran B, Brown G. Sites of surgical
wasting in the abdominoperineal specimen. The British journal of surgery. 2008;95:1147-1154.
1230.
Scabini S, Rimini E, Romairone E, et al. Total mesorectal excision with radiofrequency
in rectal cancer. Minerva chirurgica. 2008;63:289-292.
1231.
Schieman C, MacLean AR, Buie WD, Rudmik LR, Ghali WA, Dixon E. Does surgeon
fatigue influence outcomes after anterior resection for rectal cancer? American journal of surgery.
2008;195:684-687; discussion 687-688.
1232.
Schricker T, Meterissian S, Lattermann R, et al. Anticatabolic effects of avoiding
preoperative fasting by intravenous hypocaloric nutrition: a randomized clinical trial. Annals of
surgery. 2008;248:1051-1059.
1233.
Shukla PJ, Siddachari R, Ahire S, et al. Postoperative deep vein thrombosis in patients
with colorectal cancer. Indian journal of gastroenterology : official journal of the Indian Society of
Gastroenterology. 2008;27:71-73.
1234.
Singh RK, Dharmasena D, Virgo KS, Tyson SE, Grossmann EM, Johnson FE.
Proctectomy for rectal cancer in patients with prior spinal cord injury. Surgical oncology.
2008;17:313-316.
1235.
Taieb J, Puig PL, Bedenne L. Cetuximab plus FOLFOX-4 for fully resected stage III
colon carcinoma: scientific background and the ongoing PETACC-8 trial. Expert review of
anticancer therapy. 2008;8:183-189.
1236.
Targarona EM, Balague C, Pernas JC, et al. Can we predict immediate outcome after
laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features
after 3-dimensional reconstruction of the pelvic anatomy. Annals of surgery. 2008;247:642-649.
1237.
Williams NS, Murphy J, Knowles CH. Anterior Perineal PlanE for Ultra-low Anterior
Resection of the Rectum (the APPEAR technique): a prospective clinical trial of a new procedure.
Annals of surgery. 2008;247:750-758.
1238.
Wong SK, Jalaludin BB, Morgan MJ, et al. Tumor pathology and long-term survival in
emergency colorectal cancer. Diseases of the colon and rectum. 2008;51:223-230.
1239.
Zhou BJ, Song WQ, Yan QH, et al. Ultrasonically activated scalpel versus monopolar
electrocautery shovel in laparoscopic total mesorectal excision for rectal cancer. World journal of
gastroenterology : WJG. 2008;14:4065-4069.
1240.
Achiam MP, Holst Andersen LP, Klein M, Chabanova E, Thomsen HS, Rosenberg J.
Preoperative evaluation of synchronous colorectal cancer using MR colonography. Academic
radiology. 2009;16:790-797.
1241.
Amitai MM, Fidder H, Avidan B, et al. Contrast-enhanced CT colonography with
64-slice MDCT compared to endoscopic colonoscopy in the follow-up of patients after colorectal
cancer resection. Clinical imaging. 2009;33:433-438.
1242.
Bach SP, Hill J, Monson JR, et al. A predictive model for local recurrence after transanal
endoscopic microsurgery for rectal cancer. The British journal of surgery. 2009;96:280-290.
1243.
Bernstein TE, Endreseth BH, Romundstad P, Wibe A. Circumferential resection margin
as a prognostic factor in rectal cancer. The British journal of surgery. 2009;96:1348-1357.
1244.
Bockhorn M, Sotiropoulos G, Neuhaus J, et al. Prognostic impact of intrahepatic
lymphatic and microvascular involvement in cases of colorectal liver metastases. International
journal of colorectal disease. 2009;24:845-850.
1245.
Braumann C, Guenther N, Wendling P, et al. Multimodal perioperative rehabilitation in
elective conventional resection of colonic cancer: results from the German Multicenter Quality
Assurance Program 'Fast-Track Colon II'. Digestive surgery. 2009;26:123-129.
1246.
Braun KP, Braun V, Brookman-Amissah S, et al. [Treatment of rectal carcinoma:
satisfaction of general practitioners with surgical clinics]. Der Chirurg; Zeitschrift fur alle Gebiete
der operativen Medizen. 2009;80:1147-1151.
1247.
Brisinda G, Vanella S, Cadeddu F, et al. End-to-end versus end-to-side stapled
anastomoses after anterior resection for rectal cancer. Journal of surgical oncology. 2009;99:75-79.
1248.
Cheung HY, Chung CC, Tsang WW, Wong JC, Yau KK, Li MK. Endolaparoscopic
approach vs conventional open surgery in the treatment of obstructing left-sided colon cancer: a
randomized controlled trial. Archives of surgery (Chicago, Ill. : 1960). 2009;144:1127-1132.
1249.
Cheung HY, Chung CC, Wong JC, Yau KK, Li MK. Laparoscopic rectal cancer surgery
with and without neoadjuvant chemo-irradiation: a comparative study. Surgical endoscopy.
2009;23:147-152.
1250.
Chouillard E, Ata T, De Jonghe B, et al. Staged laparoscopic adjuvant intraperitoneal
chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a
preliminary experience. Surgical endoscopy. 2009;23:363-369.
1251.
Cohen ME, Bilimoria KY, Ko CY, Richards K, Hall BL. Variability in length of stay
after colorectal surgery: assessment of 182 hospitals in the national surgical quality improvement
program. Annals of surgery. 2009;250:901-907.
1252.
Ding KF, Chen R, Zhang JL, et al. Laparoscopic surgery for the curative treatment of
rectal cancer: results of a Chinese three-center case-control study. Surgical endoscopy.
2009;23:854-861.
1253.
Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of
preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after
colorectal cancer surgery. The British journal of surgery. 2009;96:1122-1128.
1254.
Ellebaek Pedersen M, Qvist N, Bisgaard C, Kelly U, Bernhard A, Moller Pedersen S.
Peritoneal microdialysis. Early diagnosis of anastomotic leakage after low anterior resection for
rectosigmoid cancer. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical
Society and the Scandinavian Surgical Society. 2009;98:148-154.
1255.
Elshazly WG, Farouk M, Samy M. Preoperative concomitant radiotherapy with oral
capecitabine in advanced rectal cancer within 6 cm from anal verge. International journal of
colorectal disease. 2009;24:401-407.
1256.
Feo CV, Lanzara S, Sortini D, et al. Fast track postoperative management after elective
colorectal surgery: a controlled trail. The American surgeon. 2009;75:1247-1251.
1257.
Fokstuen T, Holm T, Glimelius B. Postoperative morbidity and mortality in relation to
leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and
Oncology. 2009;93:293-297.
1258.
Gollins SW, Myint S, Susnerwala S, et al. Preoperative downstaging chemoradiation
with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a
phase I trial (NWCOG-2). British journal of cancer. 2009;101:924-934.
1259.
Gonzalez QH, Rodriguez-Zentner HA, Moreno-Berber JM, et al. Laparoscopic versus
open total mesorectal excision: a nonrandomized comparative prospective trial in a tertiary center
in Mexico City. The American surgeon. 2009;75:33-38.
1260.
Hendry PO, Hausel J, Nygren J, et al. Determinants of outcome after colorectal
resection within an enhanced recovery programme. The British journal of surgery.
2009;96:197-205.
1261.
Herbst A, Wallner M, Rahmig K, et al. Methylation of helicase-like transcription factor
in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
European journal of gastroenterology & hepatology. 2009;21:565-569.
1262.
Horisberger K, Treschl A, Mai S, et al. Cetuximab in combination with capecitabine,
irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II
MARGIT trial. International journal of radiation oncology, biology, physics. 2009;74:1487-1493.
1263.
Ionescu D, Iancu C, Ion D, et al. Implementing fast-track protocol for colorectal surgery:
a prospective randomized clinical trial. World journal of surgery. 2009;33:2433-2438.
1264.
Kacar S, Varilsuha C, Gurkan A, Karaca C. Pre-operative radiochemotherapy for rectal
cancer.
A
prospective
randomized
trial
comparing
pre-operative
vs.
postoperative
radiochemotherapy in rectal cancer patients. Acta chirurgica Belgica. 2009;109:701-707.
1265.
Keilholz L, Mese M, Henneking K, Willner J. Effect of total mesorectal excision on the
outcome of rectal cancer after standardized postoperative radiochemotherapy: do randomized
studies translate into clinical routine? Strahlentherapie und Onkologie : Organ der Deutschen
Rontgengesellschaft ... [et al]. 2009;185:364-370.
1266.
Kim JY, Kim NK, Sohn SK, et al. Prognostic value of postoperative CEA clearance in
rectal cancer patients with high preoperative CEA levels. Annals of surgical oncology.
2009;16:2771-2778.
1267.
Kube R, Mroczkowski P, Steinert R, et al. [Anastomotic leakage following bowel
resections for colon cancer: multivariate analysis of risk factors]. Der Chirurg; Zeitschrift fur alle
Gebiete der operativen Medizen. 2009;80:1153-1159.
1268.
Kumara HM, Feingold D, Kalady M, et al. Colorectal resection is associated with
persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro
endothelial cell growth, migration, and invasion. Annals of surgery. 2009;249:973-977.
1269.
Lange MM, Marijnen CA, Maas CP, et al. Risk factors for sexual dysfunction after
rectal cancer treatment. European journal of cancer (Oxford, England : 1990). 2009;45:1578-1588.
1270.
Lee SD, Lim SB. D3 lymphadenectomy using a medial to lateral approach for curable
right-sided colon cancer. International journal of colorectal disease. 2009;24:295-300.
1271.
Lee WS, Lee WY, Chun HK, Yun SH, Cho YB, Yun HR. Curved cutter stapler vs. linear
stapler in rectal cancer surgery: a pilot prospective randomized study. International journal of
colorectal disease. 2009;24:1327-1332.
1272.
Manikhas GM, Akhytin VA, Fridman M, Solomennikov AV, Palkanova MS. [Effect of
enterosorption on immunologic parameters of patients with colorectal cancer in the postoperative
period]. Voprosy onkologii. 2009;55:66-71.
1273.
Martinez-Fernandez A, Garcia-Albeniz X, Pineda E, et al. Serum matrilysin levels
predict outcome in curatively resected colorectal cancer patients. Annals of surgical oncology.
2009;16:1412-1420.
1274.
Miyajima N, Fukunaga M, Hasegawa H, Tanaka J, Okuda J, Watanabe M. Results of a
multicenter study of 1,057 cases of rectal cancer treated by laparoscopic surgery. Surgical
endoscopy. 2009;23:113-118.
1275.
Morino M, Parini U, Allaix ME, Monasterolo G, Brachet Contul R, Garrone C. Male
sexual and urinary function after laparoscopic total mesorectal excision. Surgical endoscopy.
2009;23:1233-1240.
1276.
Neudecker J, Klein F, Bittner R, Carus T, Stroux A, Schwenk W. Short-term outcomes
from a prospective randomized trial comparing laparoscopic and open surgery for colorectal
cancer. The British journal of surgery. 2009;96:1458-1467.
1277.
Nieuwenhuis DH, Draaisma WA, Verberne GH, van Overbeeke AJ, Consten EC.
Transanal endoscopic operation for rectal lesions using two-dimensional visualization and
standard endoscopic instruments: a prospective cohort study and comparison with the literature.
Surgical endoscopy. 2009;23:80-86.
1278.
Olszyna-Serementa M, Kolodziejczyk M, Sprawka A, Nasierowska-Guttmejer A, Bujko
K. The quality of pathological reports of postoperative specimens in rectal cancer: an audit from
the Mazovia region. Polish journal of pathology : official journal of the Polish Society of
Pathologists. 2009;60:130-133.
1279.
Papadima A, Boutsikou M, Lagoudianakis EE, et al. Lymphocyte apoptosis after major
abdominal surgery is not influenced by anesthetic technique: a comparative study of general
anesthesia versus combined general and epidural analgesia. Journal of clinical anesthesia.
2009;21:414-421.
1280.
Park CM, Lee WY, Cho YB, et al. Sodium hyaluronate-based bioresorbable membrane
(Seprafilm) reduced early postoperative intestinal obstruction after lower abdominal surgery for
colorectal cancer: the preliminary report. International journal of colorectal disease.
2009;24:305-310.
1281.
Petersen M, Kockerling F, Lippert H, Scheidbach H. Laparoscopically assisted reversal
of Hartmann procedure. Surgical laparoscopy, endoscopy & percutaneous techniques.
2009;19:48-51.
1282.
Rittler P, Kuppinger D, Krick M, et al. Differential regulation of protein synthesis in
hepatic and intestinal tissues by amino acids: studies in patients recovering from major abdominal
operations. Surgery. 2009;146:113-121.
1283.
Rodriguez-Zentner HA, Tapia-Cid de Leon H, Alonso M, et al. [Factors associated with
survival in liver resection for metastatic colorectal carcinoma]. Revista de gastroenterologia de
Mexico. 2009;74:12-17.
1284.
Sato T, Takayama T, Fujii M, et al. Systemic use of antibiotics does not prevent
postoperative infection in elective colorectal surgery: a randomized controlled trial. Journal of
infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
2009;15:34-38.
1285.
Scheidbach H, Ptok H, Schubert D, et al. Palliative stoma creation: comparison of
laparoscopic vs conventional procedures. Langenbeck's archives of surgery / Deutsche
Gesellschaft fur Chirurgie. 2009;394:371-374.
1286.
Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus
selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and
NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
1287.
Serra-Aracil X, Bombardo-Junca J, Moreno-Matias J, et al. Randomized, controlled,
prospective trial of the use of a mesh to prevent parastomal hernia. Annals of surgery.
2009;249:583-587.
1288.
Shalhoub J, Naughton P, Lau N, et al. Concurrent colorectal malignancy and abdominal
aortic aneurysm: a multicentre experience and review of the literature. European journal of
vascular and endovascular surgery : the official journal of the European Society for Vascular
Surgery. 2009;37:544-556.
1289.
Shantha Kumara HM, Cabot JC, Hoffman A, et al. Minimally invasive colon resection is
associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels
during the early postoperative period. Surgical endoscopy. 2009;23:694-699.
1290.
Shantha Kumara HM, Kirman I, Feingold D, et al. Perioperative GMCSF limits the
proangiogenic plasma protein changes associated with colorectal cancer resection. European
journal of surgical oncology : the journal of the European Society of Surgical Oncology and the
British Association of Surgical Oncology. 2009;35:295-301.
1291.
Sillah K, Griffiths EA, Pritchard SA, et al. Clinical impact of tumour involvement of the
anastomotic doughnut in oesophagogastric cancer surgery. Annals of the Royal College of
Surgeons of England. 2009;91:195-200.
1292.
Stamenkovic D, Geric V, Djordjevic M, et al. Subarachnoid morphine, bupivacaine and
fentanyl as part of combined spinal-epidural analgesia for low anterior resection. A prospective,
randomised, double-blind clinical trial. Anaesthesia and intensive care. 2009;37:552-560.
1293.
Stender MT, Frokjaer JB, Larsen TB, Lundbye-Christensen S, Thorlacius-Ussing O.
Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal
cancer patients: a clinical, prospective cohort study with one-year follow-up. Diseases of the colon
and rectum. 2009;52:446-451.
1294.
Togashi K, Hewett DG, Radford-Smith GL, Francis L, Leggett BA, Appleyard MN. The
use of indigocarmine spray increases the colonoscopic detection rate of adenomas. Journal of
gastroenterology. 2009;44:826-833.
1295.
Tsikitis VL, Malireddy K, Green EA, et al. Postoperative surveillance recommendations
for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2009;27:3671-3676.
1296.
Vignali A, Di Palo S, Orsenigo E, Ghirardelli L, Radaelli G, Staudacher C. Effect of
prednisolone on local and systemic response in laparoscopic vs. open colon surgery: a randomized,
double-blind, placebo-controlled trial. Diseases of the colon and rectum. 2009;52:1080-1088.
1297.
Wang T, Cui Y, Huang WS, et al. The role of postoperative colonoscopic surveillance
after radical surgery for colorectal cancer: a prospective, randomized clinical study.
Gastrointestinal endoscopy. 2009;69:609-615.
1298.
Wang ZD, Wu ZY, Li Y, Wu WL, Lin F. [Clinical efficacy comparison between
laparoscopy and open radical resection for 191 advanced colorectal cancer patients]. Zhonghua
wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2009;12:368-370.
1299.
Wille-Jorgensen P, Pilsgaard B, Moller P. Reconstruction of the pelvic floor with a
biological mesh after abdominoperineal excision for rectal cancer. International journal of
colorectal disease. 2009;24:323-325.
1300.
Yamada S, Shinoto M, Shigeo Y, et al. [Current status and perspective of heavy ion
beam therapy for patients with pelvic recurrence after primarily resected rectal cancer]. Gan to
kagaku ryoho. Cancer & chemotherapy. 2009;36:1263-1266.
1301.
Yamada T, Tamura S, Onishi S, Hiroi M. A comparison of magnifying
chromoendoscopy versus histopathology of forceps biopsy specimen in the diagnosis of minute
flat adenoma of the colon. Digestive diseases and sciences. 2009;54:2002-2008.
1302.
Yamamoto S, Fukunaga M, Miyajima N, Okuda J, Konishi F, Watanabe M. Impact of
conversion on surgical outcomes after laparoscopic operation for rectal carcinoma: a retrospective
study of 1,073 patients. Journal of the American College of Surgeons. 2009;208:383-389.
1303.
Yasunaga H, Matsuyama Y, Ohe K. Effects of hospital and surgeon volumes on
operating times, postoperative complications, and length of stay following laparoscopic colectomy.
Surgery today. 2009;39:955-961.
1304.
Ychou M, Raoul JL, Douillard JY, et al. A phase III randomised trial of LV5FU2 +
irinotecan
versus
LV5FU2
alone
in
adjuvant
high-risk
colon
cancer
(FNCLCC
Accord02/FFCD9802). Annals of oncology : official journal of the European Society for Medical
Oncology / ESMO. 2009;20:674-680.
1305.
Zhou PH, Yao LQ, Qin XY. Endoscopic submucosal dissection for colorectal epithelial
neoplasm. Surgical endoscopy. 2009;23:1546-1551.
1306.
Alberts SR, Roh MS, Mahoney MR, et al. Alternating systemic and hepatic artery
infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer
Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP)
phase II intergroup trial, N9945/CI-66. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2010;28:853-858.
1307.
Allardyce RA, Bagshaw PF, Frampton CM, et al. Australasian Laparoscopic Colon
Cancer Study shows that elderly patients may benefit from lower postoperative complication rates
following laparoscopic versus open resection. The British journal of surgery. 2010;97:86-91.
1308.
Bianco MA, Cipolletta L, Rotondano G, Buffoli F, Gizzi G, Tessari F. Prevalence of
nonpolypoid colorectal neoplasia: an Italian multicenter observational study. Endoscopy.
2010;42:279-285.
1309.
Borda Martin A, Martinez-Penuela JM, Munoz-Navas M, Borda Celaya F, Jimenez
Perez J, Carretero Ribon C. [Do metachronous colorectal adenomas show proximal shift?].
Gastroenterologia y hepatologia. 2010;33:419-424.
1310.
Boye K, Nesland JM, Sandstad B, Maelandsmo GM, Flatmark K. Nuclear S100A4 is a
novel prognostic marker in colorectal cancer. European journal of cancer (Oxford, England :
1990). 2010;46:2919-2925.
1311.
Braga M, Frasson M, Zuliani W, Vignali A, Pecorelli N, Di Carlo V. Randomized
clinical trial of laparoscopic versus open left colonic resection. The British journal of surgery.
2010;97:1180-1186.
1312.
Bretagnol F, Panis Y, Rullier E, et al. Rectal cancer surgery with or without bowel
preparation: The French GRECCAR III multicenter single-blinded randomized trial. Annals of
surgery. 2010;252:863-868.
1313.
Campagnacci R, Patrizi A, Piangatelli C, Rimini M, Guerrieri M. A flexible concept of
fast track surgery for laparoscopic colorectal resections. Minerva chirurgica. 2010;65:609-617.
1314.
Celentano V, Fabbrocile G, Luglio G, Antonelli G, Tarquini R, Bucci L. Prospective
study of sexual dysfunction in men with rectal cancer: feasibility and results of nerve sparing
surgery. International journal of colorectal disease. 2010;25:1441-1445.
1315.
De Palma GD, Staibano S, Siciliano S, et al. In vivo characterisation of superficial
colorectal neoplastic lesions with high-resolution probe-based confocal laser endomicroscopy in
combination with video-mosaicing: a feasibility study to enhance routine endoscopy. Digestive
and liver disease : official journal of the Italian Society of Gastroenterology and the Italian
Association for the Study of the Liver. 2010;42:791-797.
1316.
Gagliardi G, Pucciarelli S, Asteria CR, et al. A nationwide audit of the use of
radiotherapy for rectal cancer in Italy. Techniques in coloproctology. 2010;14:229-235.
1317.
Garlipp B, Ptok H, Schmidt U, Meyer F, Gastinger I, Lippert H. Neoadjuvant
chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative
bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of
the Quality Assurance in Rectal Cancer Surgery multicenter observational trial. Langenbeck's
archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2010;395:1031-1038.
1318.
Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant
chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial
ACCORD 12/0405-Prodige 2. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2010;28:1638-1644.
1319.
Gianotti L, Morelli L, Galbiati F, et al. A randomized double-blind trial on perioperative
administration of probiotics in colorectal cancer patients. World journal of gastroenterology : WJG.
2010;16:167-175.
1320.
Gomez Sanchez MB, Garcia-Talavera Espin NV, Sanchez Alvarez C, et al.
[Perioperative nutritional support in patients with colorectal neoplasms]. Nutricion hospitalaria.
2010;25:797-805.
1321.
Gort M, Otter R, Plukker JT, Broekhuis M, Klazinga NS. Actionable indicators for short
and long term outcomes in rectal cancer. European journal of cancer (Oxford, England : 1990).
2010;46:1808-1814.
1322.
Hirose M, Fukui H, Igarashi Y, et al. Detection of desmoplastic reaction in biopsy
specimens is useful for predicting the depth of invasion of early colorectal cancer: a Japanese
collaborative study. Journal of gastroenterology. 2010;45:1212-1218.
1323.
Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L. Preoperative synbiotic bowel
conditioning for elective colorectal surgery. Wiener klinische Wochenschrift. 2010;122 Suppl
2:26-30.
1324.
Huerta S, Hrom J, Gao X, et al. Tissue microarray constructs to predict a response to
chemoradiation in rectal cancer. Digestive and liver disease : official journal of the Italian Society
of Gastroenterology and the Italian Association for the Study of the Liver. 2010;42:679-684.
1325.
Ishida H, Ishiguro T, Ohsawa T, et al. Curative colectomy via minilaparotomy approach
without utilizing specific instruments. Techniques in coloproctology. 2010;14:153-159.
1326.
Jaskolka JD, Kachura JR, Hwang DM, et al. Pathologic assessment of radiofrequency
ablation of pulmonary metastases. Journal of vascular and interventional radiology : JVIR.
2010;21:1689-1696.
1327.
Jiang ZM, Wilmore DW, Wang XR, et al. Randomized clinical trial of intravenous
soybean oil alone versus soybean oil plus fish oil emulsion after gastrointestinal cancer surgery.
The British journal of surgery. 2010;97:804-809.
1328.
Kaska M, Grosmanova T, Havel E, et al. The impact and safety of preoperative oral or
intravenous carbohydrate administration versus fasting in colorectal surgery--a randomized
controlled trial. Wiener klinische Wochenschrift. 2010;122:23-30.
1329.
Kawamura YJ, Tokumitsu A, Mizokami K, Sasaki J, Tsujinaka S, Konishi F. First alert
for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA
19-9 should be included in surveillance programs. Clinical colorectal cancer. 2010;9:48-51.
1330.
Kornmann M, Staib L, Wiegel T, et al. Adjuvant chemoradiotherapy of advanced
resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with
folinic acid or with interferon-alpha. British journal of cancer. 2010;103:1163-1172.
1331.
Kube R, Granowski D, Stubs P, et al. Surgical practices for malignant left colonic
obstruction in Germany. European journal of surgical oncology : the journal of the European
Society of Surgical Oncology and the British Association of Surgical Oncology. 2010;36:65-71.
1332.
Kupcsulik P, Nagy A, Lazar G, et al. [CS circular staplers for rectal surgery--a
multicenter prospective study]. Magyar sebeszet. 2010;63:62-66.
1333.
Li J, Chen R, Xu YQ, et al. Impact of a laparoscopic resection on the quality of life in
rectal cancer patients: results of 135 patients. Surgery today. 2010;40:917-922.
1334.
Lin C, Charlton ME, Meza JL, Enke CA, Loberiza FR, Jr. Temporal and regional
variations in the use of preoperative radiation therapy for rectal cancer. American journal of
clinical oncology. 2010;33:443-447.
1335.
Liu L, Herrinton LJ, Hornbrook MC, Wendel CS, Grant M, Krouse RS. Early and late
complications among long-term colorectal cancer survivors with ostomy or anastomosis. Diseases
of the colon and rectum. 2010;53:200-212.
1336.
Lloyd GM, Kirby R, Hemingway DM, Keane FB, Miller AS, Neary P. The RAPID
protocol enhances patient recovery after both laparoscopic and open colorectal resections. Surgical
endoscopy. 2010;24:1434-1439.
1337.
Lou Z, Zhang W, Mei ZB, et al. [Integrity evaluation of resected mesentery specimen
after total mesorectal excision by methylene blue perfusion via superior rectal artery]. Zhonghua
wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2010;13:148-150.
1338.
Ludwig K, Viscusi ER, Wolff BG, Delaney CP, Senagore A, Techner L. Alvimopan for
the management of postoperative ileus after bowel resection: characterization of clinical benefit by
pooled responder analysis. World journal of surgery. 2010;34:2185-2190.
1339.
Madbouly KM, Hussein A, Omar W, Farid M. Regenerated oxidized cellulose
reinforcement of low rectal anastomosis: do we still need diversion? Diseases of the colon and
rectum. 2010;53:889-895.
1340.
Maggiori L, Rullier E, Meyer C, Portier G, Faucheron JL, Panis Y. Randomized
controlled trial of pelvic calcium alginate following rectal cancer surgery. The British journal of
surgery. 2010;97:479-484.
1341.
Matthiessen P, Lindgren R, Hallbook O, Rutegard J, Sjodahl R. Symptomatic
anastomotic leakage diagnosed after hospital discharge following low anterior resection for rectal
cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great
Britain and Ireland. 2010;12:e82-87.
1342.
Meng ZQ, Garcia MK, Chiang JS, et al. Electro-acupuncture to prevent prolonged
postoperative ileus: a randomized clinical trial. World journal of gastroenterology : WJG.
2010;16:104-111.
1343.
Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology,
management and prognosis of colorectal cancer with lung metastases: a 30-year population-based
study. Gut. 2010;59:1383-1388.
1344.
Nyasavajjala SM, Shaw AG, Khan AQ, Brown SR, Lund JN. Neoadjuvant
chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? Colorectal disease :
the official journal of the Association of Coloproctology of Great Britain and Ireland.
2010;12:33-36.
1345.
Pandazi A, Kapota E, Matsota P, Paraskevopoulou P, Dervenis C, Kostopanagiotou G.
Preincisional versus postincisional administration of parecoxib in colorectal surgery: effect on
postoperative pain control and cytokine response. A randomized clinical trial. World journal of
surgery. 2010;34:2463-2469.
1346.
Pappalardo G, Spoletini D, Nunziale A, Manna E, De Lucia F, Frattaroli FM. [The
surgical tratment of the subperitoneal rectal cancer]. Annali italiani di chirurgia. 2010;81:255-263;
discussion 283.
1347.
Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of
preoperative radiotherapy regimens for rectal cancer. The British journal of surgery.
2010;97:580-587.
1348.
Pigazzi A, Luca F, Patriti A, et al. Multicentric study on robotic tumor-specific
mesorectal excision for the treatment of rectal cancer. Annals of surgical oncology.
2010;17:1614-1620.
1349.
Pulitano C, Castillo F, Aldrighetti L, et al. What defines 'cure' after liver resection for
colorectal metastases? Results after 10 years of follow-up. HPB : the official journal of the
International Hepato Pancreato Biliary Association. 2010;12:244-249.
1350.
Rosenberg R, Engel J, Bruns C, et al. The prognostic value of lymph node ratio in a
population-based collective of colorectal cancer patients. Annals of surgery. 2010;251:1070-1078.
1351.
Roth AD, Tejpar S, Delorenzi M, et al. Prognostic role of KRAS and BRAF in stage II
and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993,
SAKK 60-00 trial. Journal of clinical oncology : official journal of the American Society of
Clinical Oncology. 2010;28:466-474.
1352.
Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111
colorectal endoscopic submucosal dissections (with video). Gastrointestinal endoscopy.
2010;72:1217-1225.
1353.
Scabini S, Rimini E, Romairone E, et al. Colon and rectal surgery for cancer without
mechanical bowel preparation: one-center randomized prospective trial. World journal of surgical
oncology. 2010;8:35.
1354.
Shantha Kumara HM, Grieco MJ, Yan X, et al. Minimally invasive colorectal resection
for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may
transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and
Ang-2). Surgical endoscopy. 2010;24:2581-2587.
1355.
Shelygin YA, Chernyshov SV, Rybakov EG. Stapled ileostomy closure results in
reduction of postoperative morbidity. Techniques in coloproctology. 2010;14:19-23.
1356.
Simunovic M, Coates A, Goldsmith CH, et al. The cluster-randomized Quality Initiative
in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery. CMAJ : Canadian
Medical Association journal = journal de l'Association medicale canadienne. 2010;182:1301-1306.
1357.
Stephens RJ, Thompson LC, Quirke P, et al. Impact of short-course preoperative
radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council
CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2010;28:4233-4239.
1358.
Takeuchi Y, Uedo N, Ishihara R, et al. Efficacy of an endo-knife with a water-jet
function (Flushknife) for endoscopic submucosal dissection of superficial colorectal neoplasms.
The American journal of gastroenterology. 2010;105:314-322.
1359.
Takiguchi N, Nagata M, Soda H, et al. Multicenter randomized comparison of LigaSure
versus conventional surgery for gastrointestinal carcinoma. Surgery today. 2010;40:1050-1054.
1360.
Tulchinsky H, Kashtan H, Rabau M, Wasserberg N. Evaluation of the NiTi Shape
Memory BioDynamix ColonRing in colorectal anastomosis: first in human multi-center study.
International journal of colorectal disease. 2010;25:1453-1458.
1361.
Wang XD, Ouyang SR, Lv DH, Liu D, Li L. [Use of inflammatory factors combined
with multi-slice spiral computer tomography for preoperative staging and operative strategy in
colon cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2010;13:732-736.
1362.
Wang ZG, Wang Q, Wang WJ, Qin HL. Randomized clinical trial to compare the effects
of preoperative oral carbohydrate versus placebo on insulin resistance after colorectal surgery. The
British journal of surgery. 2010;97:317-327.
1363.
Watanabe M, Murakami M, Nakao K, Asahara T, Nomoto K, Tsunoda A. Randomized
clinical trial of the influence of mechanical bowel preparation on faecal microflora in patients
undergoing colonic cancer resection. The British journal of surgery. 2010;97:1791-1797.
1364.
Willett CG, Duda DG, Ancukiewicz M, et al. A safety and survival analysis of
neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with
standard chemoradiation in locally advanced rectal cancer. The oncologist. 2010;15:845-851.
1365.
Xia Y, Yang Z, Chen HQ, Qin HL. [Effect of bowel preparation with probiotics on
intestinal barrier after surgery for colorectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese
journal of gastrointestinal surgery. 2010;13:528-531.
1366.
Yang P, Feng X, Niu LJ, Yang DJ, Huang WQ, Huang XQ. [Effects of preoperative oral
glucose on perioperative insulin resistance and plasma proteins of intestinal surgery]. Zhonghua
wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2010;13:814-817.
1367.
Zhang JW, Du P, Chen DW, Cui L, Ying CM. [Effect of viable Bifidobacterium
supplement on the immune status and inflammatory response in patients undergoing resection for
colorectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2010;13:40-43.
1368.
Zhao BY, Li GX, Wang YN, Hu YF, He W, Yu J. [Peritoneal structural injury in
laparoscopic versus open radical resection for colorectal cancer: a prospective controlled study].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2010;13:193-196.
1369.
Aimaq R, Akopian G, Kaufman HS. Surgical site infection rates in laparoscopic versus
open colorectal surgery. The American surgeon. 2011;77:1290-1294.
1370.
Alcantara M, Serra-Aracil X, Falco J, Mora L, Bombardo J, Navarro S. Prospective,
controlled, randomized study of intraoperative colonic lavage versus stent placement in
obstructive left-sided colonic cancer. World journal of surgery. 2011;35:1904-1910.
1371.
Baik SH, Gincherman M, Mutch MG, Birnbaum EH, Fleshman JW. Laparoscopic vs
open resection for patients with rectal cancer: comparison of perioperative outcomes and
long-term survival. Diseases of the colon and rectum. 2011;54:6-14.
1372.
Bertani E, Chiappa A, Biffi R, et al. Comparison of oral polyethylene glycol plus a large
volume glycerine enema with a large volume glycerine enema alone in patients undergoing
colorectal surgery for malignancy: a randomized clinical trial. Colorectal disease : the official
journal of the Association of Coloproctology of Great Britain and Ireland. 2011;13:e327-334.
1373.
Bharti N, Kumar P, Bala I, Gupta V. The efficacy of a novel approach to transversus
abdominis plane block for postoperative analgesia after colorectal surgery. Anesthesia and
analgesia. 2011;112:1504-1508.
1374.
Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, et al. (124)I-huA33 antibody PET of
colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2011;52:1173-1180.
1375.
Conradi LC, Bleckmann A, Schirmer M, et al. Thymidylate synthase as a prognostic
biomarker for locally advanced rectal cancer after multimodal treatment. Annals of surgical
oncology. 2011;18:2442-2452.
1376.
Cui J, Zhang JL, Wang S, Sun ZQ, Jiang XL. [A preliminary study of stenting followed
by laparoscopic surgery for obstructing left-sided colon cancer]. Zhonghua wei chang wai ke za
zhi = Chinese journal of gastrointestinal surgery. 2011;14:40-43.
1377.
Dag A, Colak T, Turkmenoglu O, Gundogdu R, Aydin S. A randomized controlled trial
evaluating early versus traditional oral feeding after colorectal surgery. Clinics (Sao Paulo, Brazil).
2011;66:2001-2005.
1378.
de Jong MC, van Vledder MG, Ribero D, et al. Therapeutic efficacy of combined
intraoperative ablation and resection for colorectal liver metastases: an international,
multi-institutional analysis. Journal of gastrointestinal surgery : official journal of the Society for
Surgery of the Alimentary Tract. 2011;15:336-344.
1379.
Duldulao MP, Lee W, Le M, et al. Surgical complications and pathologic complete
response after neoadjuvant chemoradiation in locally advanced rectal cancer. The American
surgeon. 2011;77:1281-1285.
1380.
Flatmark K, Borgen E, Nesland JM, et al. Disseminated tumour cells as a prognostic
biomarker in colorectal cancer. British journal of cancer. 2011;104:1434-1439.
1381.
Garcia-Botello S, Canovas de Lucas R, Tornero C, et al. [Implementation of a
perioperative multimodal rehabilitation protocol in elective colorectal surgery. A prospective
randomised controlled study]. Cirugia espanola. 2011;89:159-166.
1382.
Gollins S, Sun Myint A, Haylock B, et al. Preoperative chemoradiotherapy using
concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced
rectal cancer: impact on long-term clinical outcomes. Journal of clinical oncology : official journal
of the American Society of Clinical Oncology. 2011;29:1042-1049.
1383.
Guo MG, Feng Y, Zheng Q, et al. Comparison of self-expanding metal stents and urgent
surgery for left-sided malignant colonic obstruction in elderly patients. Digestive diseases and
sciences. 2011;56:2706-2710.
1384.
Haga Y, Wada Y, Ikenaga M, Takeuchi H, Ikejiri K. Evaluation of modified estimation
of physiologic ability and surgical stress in colorectal carcinoma surgery. Diseases of the colon
and rectum. 2011;54:1293-1300.
1385.
Hara M, Sato M, Takahashi H, Takayama S, Takeyama H. Accuracy of monitoring
serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is
limited to only the first postoperative year. Surgery today. 2011;41:1357-1362.
1386.
Kaltoft B, Gogenur I, Rosenberg J. Reduced length of stay and convalescence in
laparoscopic vs open sigmoid resection with traditional care: a double blinded randomized clinical
trial. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain
and Ireland. 2011;13:e123-130.
1387.
Kang J, Min BS, Park YA, et al. Risk factor analysis of postoperative complications
after robotic rectal cancer surgery. World journal of surgery. 2011;35:2555-2562.
1388.
Kim JS, Hur H, Min BS, Lee KY, Chung HC, Kim NK. Inflammatory and tumor
stimulating
responses
after
laparoscopic
sigmoidectomy.
Yonsei
medical
journal.
2011;52:635-642.
1389.
Lauprecht AE, Wenger FA, El Fadil O, Walz MK, Groeben H. Levobupivacaine plasma
concentrations following major liver resection. Journal of anesthesia. 2011;25:369-375.
1390.
Leong QM, Son DN, Cho JS, et al. Robot-assisted intersphincteric resection for low
rectal cancer: technique and short-term outcome for 29 consecutive patients. Surgical endoscopy.
2011;25:2987-2992.
1391.
Li K, Zhou Z, Chen Z, Zhang Y, Wang C. "Fast Track" nasogastric decompression of
rectal cancer surgery. Frontiers of medicine. 2011;5:306-309.
1392.
Liang JT. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for
patients with low rectal cancer after concurrent chemoradiation therapy. Annals of surgical
oncology. 2011;18:153-159.
1393.
Liang X, Hou S, Liu H, et al. Effectiveness and safety of laparoscopic resection versus
open surgery in patients with rectal cancer: a randomized, controlled trial from China. Journal of
laparoendoscopic & advanced surgical techniques. Part A. 2011;21:381-385.
1394.
Limburg PJ, Mahoney MR, Ziegler KL, et al. Randomized phase II trial of sulindac,
atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer prevention
research (Philadelphia, Pa.). 2011;4:259-269.
1395.
Liu LJ, Shi XH, Xu XD, Gong HF, Fu CG, Wang H. Laparoscopic-assisted ileal
pouch-rectal muscle sheath anastomosis for the treatment of familial adenomatous polyposis.
International journal of colorectal disease. 2011;26:1051-1057.
1396.
Lo SF, Wang YT, Wu LY, Hsu MY, Chang SC, Hayter M. Multimedia education
programme for patients with a stoma: effectiveness evaluation. Journal of advanced nursing.
2011;67:68-76.
1397.
Matsuoka H, Maeda K, Katsuno H, et al. Recovery of upper gastrointestinal bowel
movement after rectosigmoid cancer surgery: a pilot transit analysis. International surgery.
2011;96:281-285.
1398.
Mayo NE, Feldman L, Scott S, et al. Impact of preoperative change in physical function
on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery.
2011;150:505-514.
1399.
Moronczyk DA, Krasnodebski IW. Implementation of the fast track surgery in patients
undergoing the colonic resection: own experience. Polski przeglad chirurgiczny. 2011;83:482-487.
1400.
Moselli NM, Baricocchi E, Ribero D, Sottile A, Suita L, Debernardi F. Intraoperative
epidural analgesia prevents the early proinflammatory response to surgical trauma. Results from a
prospective randomized clinical trial of intraoperative epidural versus general analgesia. Annals of
surgical oncology. 2011;18:2722-2731.
1401.
Niedzwiecki D, Bertagnolli MM, Warren RS, et al. Documenting the natural history of
patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant
treatment with edrecolomab or observation: results from CALGB 9581. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 2011;29:3146-3152.
1402.
Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC. Randomized phase 3 trial
comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally
advanced rectal cancer. Cancer. 2011;117:3703-3712.
1403.
Park JM, Suh SW, Kwak JM, Kim J, Kim SH. Three-port laparoscopy-assisted
colectomy for colorectal cancer using external traction with suspension suture. Surgical
laparoscopy, endoscopy & percutaneous techniques. 2011;21:e249-252.
1404.
Pascual M, Alonso S, Pares D, et al. Randomized clinical trial comparing inflammatory
and angiogenic response after open versus laparoscopic curative resection for colonic cancer. The
British journal of surgery. 2011;98:50-59.
1405.
Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor
response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2011;29:3753-3760.
1406.
Ptok H, Marusch F, Schmidt U, Gastinger I, Wenisch HJ, Lippert H. Risk adjustment as
basis for rational benchmarking: the example of colon carcinoma. World journal of surgery.
2011;35:196-205.
1407.
Ramirez JM, Aguilella V, Valencia J, et al. Transanal endoscopic microsurgery for rectal
cancer. Long-term oncologic results. International journal of colorectal disease. 2011;26:437-443.
1408.
Ramirez JM, Blasco JA, Roig JV, et al. Enhanced recovery in colorectal surgery: a
multicentre study. BMC surgery. 2011;11:9.
1409.
Rasic Z, Schwarz D, Adam VN, et al. Efficacy of antimicrobial triclosan-coated
polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal surgery.
Collegium antropologicum. 2011;35:439-443.
1410.
Reissfelder C, Timke C, Schmitz-Winnenthal H, et al. A randomized controlled trial to
investigate the influence of low dose radiotherapy on immune stimulatory effects in liver
metastases of colorectal cancer. BMC cancer. 2011;11:419.
1411.
Scheidbach H, Garlipp B, Oberlander H, Adolf D, Kockerling F, Lippert H. Conversion
in laparoscopic colorectal cancer surgery: impact on short- and long-term outcome. Journal of
laparoendoscopic & advanced surgical techniques. Part A. 2011;21:923-927.
1412.
Scholin J, Buunen M, Hop W, et al. Bowel obstruction after laparoscopic and open colon
resection for cancer: results of 5 years of follow-up in a randomized trial. Surgical endoscopy.
2011;25:3755-3760.
1413.
Shantha Kumara HM, Tohme ST, Kim IY, et al. Minimally invasive colorectal resection
is associated with a transient increase in plasma hepatocyte growth factor levels early after surgery
for colon cancer. Surgical innovation. 2011;18:254-258.
1414.
Shcherba SN, Polovinkin VV. [Use of Tachocomb for prevention of postoperative
lymphatic leaks in the abdomen]. Voprosy onkologii. 2011;57:269-270.
1415.
Shihab OC, How P, West N, et al. Can a novel MRI staging system for low rectal cancer
aid surgical planning? Diseases of the colon and rectum. 2011;54:1260-1264.
1416.
Singh R, Nordeen N, Mei SL, Kaffes A, Tam W, Saito Y. West meets East: preliminary
results of narrow band imaging with optical magnification in the diagnosis of colorectal lesions: a
multicenter Australian study using the modified Sano's classification. Digestive endoscopy :
official journal of the Japan Gastroenterological Endoscopy Society. 2011;23 Suppl 1:126-130.
1417.
Storli K, Sondenaa K, Furnes B, et al. Improved lymph node harvest from resected
colon cancer specimens did not cause upstaging from TNM stage II to III. World journal of
surgery. 2011;35:2796-2803.
1418.
Stucky CC, Pockaj BA, Novotny PJ, et al. Long-term follow-up and individual item
analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial
93-46-53 (INT 0146). Annals of surgical oncology. 2011;18:2422-2431.
1419.
Suzuki T, Sadahiro S, Maeda Y, Tanaka A, Okada K, Kamijo A. Optimal duration of
prophylactic antibiotic administration for elective colon cancer surgery: A randomized, clinical
trial. Surgery. 2011;149:171-178.
1420.
Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance
imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery
alone: a prospective, multicenter, European study. Annals of surgery. 2011;253:711-719.
1421.
Toyomasu Y, Mochiki E, Morita H, et al. Mosapride citrate improves postoperative ileus
of patients with colectomy. Journal of gastrointestinal surgery : official journal of the Society for
Surgery of the Alimentary Tract. 2011;15:1361-1367.
1422.
Ueno H, Mochizuki H, Shirouzu K, et al. Actual status of distribution and prognostic
impact of extramural discontinuous cancer spread in colorectal cancer. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 2011;29:2550-2556.
1423.
Varpe P, Huhtinen H, Rantala A, et al. Quality of life after surgery for rectal cancer with
special reference to pelvic floor dysfunction. Colorectal disease : the official journal of the
Association of Coloproctology of Great Britain and Ireland. 2011;13:399-405.
1424.
Veenhof AA, Sietses C, von Blomberg BM, et al. The surgical stress response and
postoperative immune function after laparoscopic or conventional total mesorectal excision in
rectal cancer: a randomized trial. International journal of colorectal disease. 2011;26:53-59.
1425.
Vlug MS, Wind J, Hollmann MW, et al. Laparoscopy in combination with fast track
multimodal management is the best perioperative strategy in patients undergoing colonic surgery:
a randomized clinical trial (LAFA-study). Annals of surgery. 2011;254:868-875.
1426.
Wang G, Jiang ZW, Xu J, et al. Fast-track rehabilitation program vs conventional care
after colorectal resection: a randomized clinical trial. World journal of gastroenterology : WJG.
2011;17:671-676.
1427.
Warschkow R, Steffen T, Thierbach J, Bruckner T, Lange J, Tarantino I. Risk factors for
anastomotic leakage after rectal cancer resection and reconstruction with colorectostomy. A
retrospective study with bootstrap analysis. Annals of surgical oncology. 2011;18:2772-2782.
1428.
Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Ulcerative
colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a
nationwide Japanese study. Inflammatory bowel diseases. 2011;17:802-808.
1429.
Xiao L, Zhang WB, Jiang PC, et al. Can transanal tube placement after anterior
resection for rectal carcinoma reduce anastomotic leakage rate? A single-institution prospective
randomized study. World journal of surgery. 2011;35:1367-1377.
1430.
Yamamoto T, Umegae S, Matsumoto K, Saniabadi AR. Peritoneal cytokines as early
markers of peritonitis following surgery for colorectal carcinoma: a prospective study. Cytokine.
2011;53:239-242.
1431.
Yu JC, Ge JN, Tang Y, et al. [Multicenter cross-sectional study of anemia in patients
with gastric and colorectal cancer before and after the operation]. Zhonghua wai ke za zhi
[Chinese journal of surgery]. 2011;49:53-56.
1432.
Zhang SY, Du YQ. [Effects of warming needle moxibustion on improvement of
gastrointestinal and immune function in patients with postoperation of colorectal cancer].
Zhongguo zhen jiu = Chinese acupuncture & moxibustion. 2011;31:513-517.
1433.
Zheng H, Zhang W, Ayanian JZ, Zaborski LB, Zaslavsky AM. Profiling hospitals by
survival of patients with colorectal cancer. Health services research. 2011;46:729-746.
1434.
Akagi Y, Shirouzu K, Fujita S, et al. Predicting oncologic outcomes by stratifying
mesorectal extension in patients with pT3 rectal cancer: a Japanese multi-institutional study.
International journal of cancer. Journal international du cancer. 2012;131:1220-1227.
1435.
Alberts SR, Sargent DJ, Nair S, et al. Effect of oxaliplatin, fluorouracil, and leucovorin
with or without cetuximab on survival among patients with resected stage III colon cancer: a
randomized trial. JAMA : the journal of the American Medical Association. 2012;307:1383-1393.
1436.
Avgoustou C, Penlidis P, Tsakpini A, Sioros C, Giannousis D. Compression anastomoses
in colon and rectal surgery with the NiTi ColonRing. Techniques in coloproctology.
2012;16:29-35.
1437.
Baig MN, Moftah M, Deasy J, McNamara DA, Cahill RA. Implementation and
usefulness of single-access laparoscopic segmental and total colectomy. Colorectal disease : the
official journal of the Association of Coloproctology of Great Britain and Ireland.
2012;14:1267-1275.
1438.
Belle S, Collet PH, Szyrach M, et al. Selective tissue elevation by pressure for
endoscopic mucosal resection of colorectal adenoma: first clinical trial. Surgical endoscopy.
2012;26:343-349.
1439.
Bertoglio S, Fabiani F, Negri PD, et al. The postoperative analgesic efficacy of
preperitoneal continuous wound infusion compared to epidural continuous infusion with local
anesthetics after colorectal cancer surgery: a randomized controlled multicenter study. Anesthesia
and analgesia. 2012;115:1442-1450.
1440.
Cai HK, He HF, Tian W, Zhou MQ, Hu Y, Deng YC. Colorectal cancer lymph node
staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro. World
journal of gastroenterology : WJG. 2012;18:6148-6154.
1441.
Cennamo V, Luigiano C, Manes G, et al. Colorectal stenting as a bridge to surgery
reduces morbidity and mortality in left-sided malignant obstruction: a predictive risk score-based
comparative study. Digestive and liver disease : official journal of the Italian Society of
Gastroenterology and the Italian Association for the Study of the Liver. 2012;44:508-514.
1442.
Champagne BJ, Papaconstantinou HT, Parmar SS, et al. Single-incision versus standard
multiport laparoscopic colectomy: a multicenter, case-controlled comparison. Annals of surgery.
2012;255:66-69.
1443.
Coe SG, Thomas C, Crook J, Ussui V, Diehl N, Wallace MB. Colorectal surveillance
interval assignment based on in vivo prediction of polyp histology: impact of endoscopic quality
improvement program. Gastrointestinal endoscopy. 2012;76:118-125 e111.
1444.
Davenport DL, Vargas HD, Kasten MW, Xenos ES. Timing and perioperative risk
factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer
resection. Clinical and applied thrombosis/hemostasis : official journal of the International
Academy of Clinical and Applied Thrombosis/Hemostasis. 2012;18:569-575.
1445.
Dipetrillo T, Pricolo V, Lagares-Garcia J, et al. Neoadjuvant bevacizumab, oxaliplatin,
5-fluorouracil, and radiation for rectal cancer. International journal of radiation oncology, biology,
physics. 2012;82:124-129.
1446.
Dong LR, Zhu YM, Xu Q, Cao CX, Zhang BZ. Clinical evaluation of extraperitoneal
colostomy without damaging the muscle layer of the abdominal wall. The Journal of international
medical research. 2012;40:1410-1416.
1447.
Drini M, Speer A, Dow C, Collier N, Bhathal P, Macrae FA. Management of duodenal
adenomatosis in FAP: single centre experience. Familial cancer. 2012;11:167-173.
1448.
Dvorak J, Sitorova V, Ryska A, et al. [Prognostic significance of changes of tumor
epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with
rectal
adenocarcinoma].
Strahlentherapie
und
Onkologie
:
Organ
der
Deutschen
Rontgengesellschaft ... [et al]. 2012;188:833-838.
1449.
Eckardt J, Licht PB. Thoracoscopic versus open pulmonary metastasectomy: a
prospective, sequentially controlled study. Chest. 2012;142:1598-1602.
1450.
Fiori E, Lamazza A, Schillaci A, et al. Palliative management for patients with subacute
obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting:
final results of a prospective randomized trial. American journal of surgery. 2012;204:321-326.
1451.
Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after
mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III
lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled,
non-inferiority trial. The lancet oncology. 2012;13:616-621.
1452.
Gong J, Shi DB, Li XX, Cai SJ, Guan ZQ, Xu Y. Short-term outcomes of laparoscopic
total mesorectal excision compared to open surgery. World journal of gastroenterology : WJG.
2012;18:7308-7313.
1453.
Gouvas N, Gogos-Pappas G, Tsimogiannis K, Tsimoyiannis E, Dervenis C, Xynos E.
Implementation of fast-track protocols in open and laparoscopic sphincter-preserving rectal cancer
surgery: a multicenter, comparative, prospective, non-randomized study. Digestive surgery.
2012;29:301-309.
1454.
Gupta N, Bansal A, Rao D, et al. Prevalence of advanced histological features in
diminutive and small colon polyps. Gastrointestinal endoscopy. 2012;75:1022-1030.
1455.
Gustafsson
UO,
Tiefenthal
M,
Thorell
A,
Ljungqvist
O,
Nygrens
J.
Laparoscopic-assisted and open high anterior resection within an ERAS protocol. World journal of
surgery. 2012;36:1154-1161.
1456.
He HF, Zhou MQ, Chen JQ, et al. Enhanced lymph node retrieval from colorectal cancer
resections using a simple lymphatic staining method. Hepato-gastroenterology. 2012;59:375-379.
1457.
Herrera-Gomez A, Orozco C, Ruiz-Molina JM, Tellez-Palacios D, Ortega-Gutierrez C,
Namendys-Silva SA. [Colorectal surgery in patients over 65 years of age]. Revista de
gastroenterologia de Mexico. 2012;77:119-124.
1458.
Hida K, Hasegawa S, Kinjo Y, et al. Open versus laparoscopic resection of primary
tumor for incurable stage IV colorectal cancer: a large multicenter consecutive patients cohort
study. Annals of surgery. 2012;255:929-934.
1459.
Homma K, Otaki Y, Sugawara M, Kobayashi M. Efficacy of novel SB knife Jr examined
in a multicenter study on colorectal endoscopic submucosal dissection. Digestive endoscopy :
official journal of the Japan Gastroenterological Endoscopy Society. 2012;24 Suppl 1:117-120.
1460.
Huscher CG, Mingoli A, Sgarzini G, et al. Standard laparoscopic versus single-incision
laparoscopic colectomy for cancer: early results of a randomized prospective study. American
journal of surgery. 2012;204:115-120.
1461.
Ikematsu H, Saito Y, Tanaka S, et al. The impact of narrow band imaging for colon
polyp detection: a multicenter randomized controlled trial by tandem colonoscopy. Journal of
gastroenterology. 2012;47:1099-1107.
1462.
Ishihara S, Watanabe T, Akahane T, et al. Tumor location is a prognostic factor in poorly
differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the
colon. International journal of colorectal disease. 2012;27:371-379.
1463.
Jang JH, Kang SB, Lee SM, Park JS, Kim DW, Ahn S. Randomized controlled trial of
tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery. World journal of
surgery. 2012;36:2730-2737.
1464.
Kennedy RH, Francis A, Dutton S, et al. EnROL: a multicentre randomised trial of
conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery
programme. BMC cancer. 2012;12:181.
1465.
Kim HH, Park SJ, Lee SH, et al. Efficacy of endoscopic submucosal resection with a
ligation device for removing small rectal carcinoid tumor compared with endoscopic mucosal
resection: analysis of 100 cases. Digestive endoscopy : official journal of the Japan
Gastroenterological Endoscopy Society. 2012;24:159-163.
1466.
Kim JC, Kim CW, Yoon YS, Lee HO, Park IJ. Levator-sphincter reinforcement after
ultralow anterior resection in patients with low rectal cancer: the surgical method and evaluation
of anorectal physiology. Surgery today. 2012;42:547-553.
1467.
Kolovrat M, Busic Z, Lovric Z, et al. Mechanical bowel preparation in colorectal
surgery. Collegium antropologicum. 2012;36:1343-1346.
1468.
Laghi L, Beghelli S, Spinelli A, et al. Irrelevance of microsatellite instability in the
epidemiology of sporadic pancreatic ductal adenocarcinoma. PloS one. 2012;7:e46002.
1469.
Latkauskas T, Pauzas H, Gineikiene I, et al. Initial results of a randomized controlled
trial comparing clinical and pathological downstaging of rectal cancer after preoperative
short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal
disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
2012;14:294-298.
1470.
Li JL, Ji JF, Cai Y, et al. Preoperative concomitant boost intensity-modulated
radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and
Oncology. 2012;102:4-9.
1471.
Loffler T, Rossion I, Bruckner T, et al. HAnd Suture Versus STApling for Closure of
Loop Ileostomy (HASTA Trial): results of a multicenter randomized trial (DRKS00000040).
Annals of surgery. 2012;256:828-835; discussion 835-826.
1472.
Ma CJ, Sun LC, Chen FM, et al. A double-blind randomized study comparing the
efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical
gastrointestinal tumor patients. Nutrition in clinical practice : official publication of the American
Society for Parenteral and Enteral Nutrition. 2012;27:410-415.
1473.
McKay GD, Morgan MJ, Wong SK, et al. Improved short-term outcomes of
laparoscopic versus open resection for colon and rectal cancer in an area health service: a
multicenter study. Diseases of the colon and rectum. 2012;55:42-50.
1474.
Mettke R, Schmidt A, Wolff S, et al. [Spleen injuries during colorectal carcinoma
surgery. Effect on the early postoperative result]. Der Chirurg; Zeitschrift fur alle Gebiete der
operativen Medizen. 2012;83:809-814.
1475.
Ng LW, Tung LM, Cheung HY, Wong JC, Chung CC, Li MK. Hand-assisted
laparoscopic versus total laparoscopic right colectomy: a randomized controlled trial. Colorectal
disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
2012;14:e612-617.
1476.
Ortiz H, Armendariz P, Kreisler E, et al. Influence of rescrubbing before laparotomy
closure on abdominal wound infection after colorectal cancer surgery: results of a multicenter
randomized clinical trial. Archives of surgery (Chicago, Ill. : 1960). 2012;147:614-620.
1477.
Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T. Randomized clinical trial on
preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2012;397:801-807.
1478.
Park JS, Choi GS, Park SY, Kim HJ, Ryuk JP. Randomized clinical trial of
robot-assisted versus standard laparoscopic right colectomy. The British journal of surgery.
2012;99:1219-1226.
1479.
Poon JT, Cheung CW, Fan JK, Lo OS, Law WL. Single-incision versus conventional
laparoscopic colectomy for colonic neoplasm: a randomized, controlled trial. Surgical endoscopy.
2012;26:2729-2734.
1480.
Poulsen M, Ovesen H. Is laparoscopic colorectal cancer surgery in obese patients
associated with an increased risk? Short-term results from a single center study of 425 patients.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary
Tract. 2012;16:1554-1558.
1481.
Ren L, Zhu D, Wei Y, et al. Enhanced Recovery After Surgery (ERAS) program
attenuates stress and accelerates recovery in patients after radical resection for colorectal cancer: a
prospective randomized controlled trial. World journal of surgery. 2012;36:407-414.
1482.
Schietroma M, Carlei F, Cecilia EM, Piccione F, Bianchi Z, Amicucci G. Colorectal
Infraperitoneal anastomosis: the effects of perioperative supplemental oxygen administration on
the anastomotic dehiscence. Journal of gastrointestinal surgery : official journal of the Society for
Surgery of the Alimentary Tract. 2012;16:427-434.
1483.
Sheng QS, Lin JJ, Chen WB, et al. Hand-assisted laparoscopic versus open right
hemicolectomy: short-term outcomes in a single institution from China. Surgical laparoscopy,
endoscopy & percutaneous techniques. 2012;22:267-271.
1484.
Staff C, Magnusson CG, Hojjat-Farsangi M, et al. Induction of IgM, IgA and IgE
antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein. Journal of
clinical immunology. 2012;32:855-865.
1485.
Sturm D, Vazdar L, Bagatin D, Sakic K, Hrgovic Z. Perioperative PAI-1 values in
surgically treated colorectal carcinoma patients under low molecular weight heparin
thromboprophylaxis. Minerva chirurgica. 2012;67:343-354.
1486.
Sulyok I, Fleischmann E, Stift A, et al. Effect of preoperative fever-range whole-body
hyperthermia on immunological markers in patients undergoing colorectal cancer surgery. British
journal of anaesthesia. 2012;109:754-761.
1487.
Sun PL, Li B, Ye QF. Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy
for locally advanced rectal cancer: results of a phase II study. International journal of colorectal
disease. 2012;27:1325-1332.
1488.
Tampellini M, Ottone A, Bellini E, et al. The role of lung metastasis resection in
improving outcome of colorectal cancer patients: results from a large retrospective study. The
oncologist. 2012;17:1430-1438.
1489.
Tan KY, Kawamura YJ, Tokomitsu A, Tang T. Assessment for frailty is useful for
predicting morbidity in elderly patients undergoing colorectal cancer resection whose
comorbidities are already optimized. American journal of surgery. 2012;204:139-143.
1490.
Tralhao JG, Abrantes AM, Hoti E, et al. Hepatic extraction fraction: interest of its
quantification in patients with hepatic tumours. Hepato-gastroenterology. 2012;59:1507-1511.
1491.
Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metastasectomy in colorectal
cancer: the PulMiCC trial. Thorax. 2012;67:185-187.
1492.
Tsutsumi S, Yajima R, Tabe Y, et al. The efficacy of fondaparinux for the prophylaxis of
venous thromboembolism after resection for colorectal cancer. Hepato-gastroenterology.
2012;59:2477-2479.
1493.
Ueno H, Mochizuki H, Shirouzu K, et al. Multicenter study for optimal categorization of
extramural tumor deposits for colorectal cancer staging. Annals of surgery. 2012;255:739-746.
1494.
Veenhof AA, Vlug MS, van der Pas MH, et al. Surgical stress response and
postoperative immune function after laparoscopy or open surgery with fast track or standard
perioperative care: a randomized trial. Annals of surgery. 2012;255:216-221.
1495.
Vlug MS, Bartels SA, Wind J, Ubbink DT, Hollmann MW, Bemelman WA. Which fast
track elements predict early recovery after colon cancer surgery? Colorectal disease : the official
journal of the Association of Coloproctology of Great Britain and Ireland. 2012;14:1001-1008.
1496.
Wang G, Jiang Z, Zhao K, et al. Immunologic response after laparoscopic colon cancer
operation within an enhanced recovery program. Journal of gastrointestinal surgery : official
journal of the Society for Surgery of the Alimentary Tract. 2012;16:1379-1388.
1497.
Wang G, Jiang ZW, Zhao K, et al. Fast track rehabilitation programme enhances
functional
recovery
after
laparoscopic
colonic
resection.
Hepato-gastroenterology.
2012;59:2158-2163.
1498.
Wang Q, Suo J, Jiang J, Wang C, Zhao YQ, Cao X. Effectiveness of fast-track
rehabilitation vs conventional care in laparoscopic colorectal resection for elderly patients: a
randomized trial. Colorectal disease : the official journal of the Association of Coloproctology of
Great Britain and Ireland. 2012;14:1009-1013.
1499.
Wang S, Wang ML, Li Y, Zhou YB, Wang DS. [Clinical study on risk factor associated
with gut flora change in patients with rectal cancer during perioperative period]. Zhonghua wei
chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2012;15:570-573.
1500.
West NP, Kobayashi H, Takahashi K, et al. Understanding optimal colonic cancer
surgery: comparison of Japanese D3 resection and European complete mesocolic excision with
central vascular ligation. Journal of clinical oncology : official journal of the American Society of
Clinical Oncology. 2012;30:1763-1769.
1501.
Wu YJ, Wu CT, Zhang XB, Ou WT, Huang P. [Clinical study of different bowel
preparations on changes of gut flora in patients undergoing colorectal resection]. Zhonghua wei
chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2012;15:574-577.
1502.
Yang D, He W, Zhang S, Chen H, Zhang C, He Y. Fast-track surgery improves
postoperative clinical recovery and immunity after elective surgery for colorectal carcinoma:
randomized controlled clinical trial. World journal of surgery. 2012;36:1874-1880.
1503.
Yang DJ, He WL, Zhang S, et al. [Fast track surgery accelerates the postoperative
rehabilitation and recovery of insulin sensitivity in elective operation for colorectal carcinoma: a
randomized controlled clinical trial]. Zhonghua wai ke za zhi [Chinese journal of surgery].
2012;50:870-874.
1504.
Yang DJ, Zhang S, He WL, et al. Fast track surgery accelerates the recovery of
postoperative insulin sensitivity. Chinese medical journal. 2012;125:3261-3265.
1505.
Yang DJ, Zhang S, He WL, et al. [Fast-track surgery accelerates the recovery of
postoperative humoral immune function in elective operation for colorectal carcinoma: a
randomized controlled clinical trial]. Zhonghua yi xue za zhi. 2012;92:1112-1115.
1506.
Yoshikawa K, Shimada M, Nishioka M, et al. The effects of the Kampo medicine
(Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following
laparoscopic colorectal resection. Surgery today. 2012;42:646-651.
1507.
Zhang JW, Du P, Gao J, Yang BR, Fang WJ, Ying CM. Preoperative probiotics decrease
postoperative infectious complications of colorectal cancer. The American journal of the medical
sciences. 2012;343:199-205.
1508.
Zhu DX, Wei Y, Ren L, et al. [Application of enhanced recovery program after
surgery(ERAS) in patients undergoing radical resection for colorectal cancer]. Zhonghua wei
chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2012;15:555-560.
1509.
Abbott AM, Grotz TE, Rueth NM, Hernandez Irizarry RC, Tuttle TM, Jakub JW.
Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two
academic centers. Annals of surgical oncology. 2013;20:340-345.
1510.
Ahn KY, Hur H, Kim DH, et al. The effects of inpatient exercise therapy on the length
of hospital stay in stages I-III colon cancer patients: randomized controlled trial. International
journal of colorectal disease. 2013;28:643-651.
1511.
Andersson J, Angenete E, Gellerstedt M, et al. Health-related quality of life after
laparoscopic and open surgery for rectal cancer in a randomized trial. The British journal of
surgery. 2013;100:941-949.
1512.
Asa Z, Greenberg R, Ghinea R, Inbar R, Wasserberg N, Avital S. Grading of
complications and risk factor evaluation in laparoscopic colorectal surgery. Surgical endoscopy.
2013;27:3748-3753.
1513.
Asoglu O, Balik E, Kunduz E, et al. Laparoscopic surgery for rectal cancer: outcomes in
513 patients. World journal of surgery. 2013;37:883-892.
1514.
Barendse RM, Dijkgraaf MG, Rolf UR, et al. Colorectal surgeons' learning curve of
transanal endoscopic microsurgery. Surgical endoscopy. 2013;27:3591-3602.
1515.
Biondo S, Frago R, Codina Cazador A, et al. Long-term functional results from a
randomized clinical study of transverse coloplasty compared with colon J-pouch after low anterior
resection for rectal cancer. Surgery. 2013;153:383-392.
1516.
Bondar GV, Basheev V, Sovpel OV, Sovpel IV. [Perspectives of development of the
cancer recti surgery]. Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukrainy, Naukove
tovarystvo khirurhiv Ukrainy. 2013:5-9.
1517.
Bos MM, Bakhshi-Raiez F, Dekker JW, de Keizer NF, de Jonge E. Outcomes of
intensive care unit admissions after elective cancer surgery. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 2013;39:584-592.
1518.
Boulind CE, Ewings P, Bulley SH, et al. Feasibility study of analgesia via epidural
versus continuous wound infusion after laparoscopic colorectal resection. The British journal of
surgery. 2013;100:395-402.
1519.
Buchs NC, Pugin F, Volonte F, Hagen ME, Morel P, Ris F. Robotic transanal endoscopic
microsurgery: technical details for the lateral approach. Diseases of the colon and rectum.
2013;56:1194-1198.
1520.
Bujko K, Nasierowska-Guttmejer A, Wyrwicz L, et al. Neoadjuvant treatment for
unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiotherapy
and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
2013;107:171-177.
1521.
Burke JP, Coffey JC, Boyle E, Keane F, McNamara DA. Early outcomes for rectal
cancer surgery in the republic of ireland following a national centralization program. Annals of
surgical oncology. 2013;20:3414-3421.
1522.
Calvo FA, Sole CV, Serrano J, et al. Postchemoradiation laparoscopic resection and
intraoperative electron-beam radiation boost in locally advanced rectal cancer: long-term
outcomes. Journal of cancer research and clinical oncology. 2013;139:1825-1833.
1523.
Cannon RM, Scoggins CR, Callender GG, Quillo A, McMasters KM, Martin RC, 2nd.
Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost
modeling. Annals of surgical oncology. 2013;20:2887-2892.
1524.
Chang K, Fakhoury M, Barnajian M, Tarta C, Bergamaschi R. Laparoscopic right colon
resection with intracorporeal anastomosis. Surgical endoscopy. 2013;27:1730-1736.
1525.
Chao HL, Miao SJ, Liu PF, et al. The beneficial effect of ST-36 (Zusanli) acupressure on
postoperative gastrointestinal function in patients with colorectal cancer. Oncology nursing forum.
2013;40:E61-68.
1526.
Chen YY, Liu ZH, Zhu K, Shi PD, Yin L. Transanal endoscopic microsurgery versus
laparoscopic
lower
anterior
resection
for
the
treatment
of
T1-2
rectal
cancers.
Hepato-gastroenterology. 2013;60:727-732.
1527.
Conradi LC, Styczen H, Sprenger T, et al. Frequency of HER-2 positivity in rectal
cancer and prognosis. The American journal of surgical pathology. 2013;37:522-531.
1528.
Deng G, Wong WD, Guillem J, et al. A phase II, randomized, controlled trial of
acupuncture
for
reduction
of
Postcolectomy
Ileus.
Annals
of
surgical
oncology.
2013;20:1164-1169.
1529.
Di Giorgio A, Cardi M, Biacchi D, et al. Depth of colorectal-wall invasion and
lymph-node involvement as major outcome factors influencing surgical strategy in patients with
advanced and recurrent ovarian cancer with diffuse peritoneal metastases. World journal of
surgical oncology. 2013;11:64.
1530.
Feroci F, Lenzi E, Baraghini M, et al. Fast-track surgery in real life: how patient factors
influence outcomes and compliance with an enhanced recovery clinical pathway after colorectal
surgery. Surgical laparoscopy, endoscopy & percutaneous techniques. 2013;23:259-265.
1531.
Floodeen H, Hallbook O, Rutegard J, Sjodahl R, Matthiessen P. Early and late
symptomatic anastomotic leakage following low anterior resection of the rectum for cancer: are
they different entities? Colorectal disease : the official journal of the Association of
Coloproctology of Great Britain and Ireland. 2013;15:334-340.
1532.
Francescutti V, Coates A, Thabane L, Goldsmith CH, Levine MN, Simunovic M.
Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer
(QIRC) trial. Canadian journal of surgery. Journal canadien de chirurgie. 2013;56:E148-153.
1533.
Ghazal AH, El-Shazly WG, Bessa SS, El-Riwini MT, Hussein AM. Colonic
endolumenal stenting devices and elective surgery versus emergency subtotal/total colectomy in
the management of malignant obstructed left colon carcinoma. Journal of gastrointestinal surgery :
official journal of the Society for Surgery of the Alimentary Tract. 2013;17:1123-1129.
1534.
Giessen C, Fischer von Weikersthal L, Laubender RP, et al. Evaluation of prognostic
factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial.
British journal of cancer. 2013;109:1428-1436.
1535.
Hartman RI, Chang CY, Wo JY, et al. Optimizing adjuvant treatment decisions for stage
t2 rectal cancer based on mesorectal node size: a decision analysis. Academic radiology.
2013;20:79-89.
1536.
Hesselager C, Vuong T, Pahlman L, et al. Short-term outcome after neoadjuvant
high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable
rectal cancer. Colorectal disease : the official journal of the Association of Coloproctology of
Great Britain and Ireland. 2013;15:662-666.
1537.
Kang J, Park MG, Hur H, Min BS, Lee KY, Kim NK. Safety and efficacy of the NiTi
Shape Memory Compression Anastomosis Ring (CAR/ColonRing) for end-to-end compression
anastomosis in anterior resection or low anterior resection. Surgical innovation. 2013;20:164-170.
1538.
Kneist W, Kauff DW, Juhre V, Hoffmann KP, Lang H. Is intraoperative neuromonitoring
associated with better functional outcome in patients undergoing open TME? Results of a
case-control study. European journal of surgical oncology : the journal of the European Society of
Surgical Oncology and the British Association of Surgical Oncology. 2013;39:994-999.
1539.
Kohne CH, Bedenne L, Carrato A, et al. A randomised phase III intergroup trial
comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus
5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: the Pan-European
Trial in Adjuvant Colon Cancer 2 study. European journal of cancer (Oxford, England : 1990).
2013;49:1868-1875.
1540.
Kojima M, Shimazaki H, Iwaya K, et al. Pathological diagnostic criterion of blood and
lymphatic vessel invasion in colorectal cancer: a framework for developing an objective
pathological diagnostic system using the Delphi method, from the Pathology Working Group of
the Japanese Society for Cancer of the Colon and Rectum. Journal of clinical pathology.
2013;66:551-558.
1541.
Lee CK, Shim JJ, Jang JY. Cold snare polypectomy vs. Cold forceps polypectomy using
double-biopsy technique for removal of diminutive colorectal polyps: a prospective randomized
study. The American journal of gastroenterology. 2013;108:1593-1600.
1542.
Lee SM, Kang SB, Jang JH, et al. Early rehabilitation versus conventional care after
laparoscopic rectal surgery: a prospective, randomized, controlled trial. Surgical endoscopy.
2013;27:3902-3909.
1543.
Leung AL, Cheung HY, Fok BK, Chung CC, Li MK, Tang CN. Prospective randomized
trial of hybrid NOTES colectomy versus conventional laparoscopic colectomy for left-sided
colonic tumors. World journal of surgery. 2013;37:2678-2682.
1544.
Li C, Carli F, Lee L, et al. Impact of a trimodal prehabilitation program on functional
recovery after colorectal cancer surgery: a pilot study. Surgical endoscopy. 2013;27:1072-1082.
1545.
Lidder P, Thomas S, Fleming S, Hosie K, Shaw S, Lewis S. A randomized placebo
controlled trial of preoperative carbohydrate drinks and early postoperative nutritional supplement
drinks in colorectal surgery. Colorectal disease : the official journal of the Association of
Coloproctology of Great Britain and Ireland. 2013;15:737-745.
1546.
Liu Y, Tao KX, Wang GB, et al. [Effect of enteral nutrition as replacement of traditional
bowel preparation on the intraperitoneal and intraluminal disseminated tumor cells, recurrence and
metastasis in patients with colorectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese
journal of gastrointestinal surgery. 2013;16:350-353.
1547.
Liu ZH, Huang MJ, Zhang XW, et al. The effects of perioperative probiotic treatment on
serum zonulin concentration and subsequent postoperative infectious complications after
colorectal cancer surgery: a double-center and double-blind randomized clinical trial. The
American journal of clinical nutrition. 2013;97:117-126.
1548.
Lujan J, Valero G, Biondo S, Espin E, Parrilla P, Ortiz H. Laparoscopic versus open
surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients. Surgical
endoscopy. 2013;27:295-302.
1549.
Maas HA, Lemmens VE, Nijhuis PH, de Hingh IH, Koning CC, Janssen-Heijnen ML.
Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75
years and older. European journal of surgical oncology : the journal of the European Society of
Surgical Oncology and the British Association of Surgical Oncology. 2013;39:1087-1093.
1550.
Manceau G, d'Annunzio E, Karoui M, et al. Elective subtotal colectomy with
ileosigmoid anastomosis for colon cancer preserves bowel function and quality of life. Colorectal
disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
2013;15:1078-1085.
1551.
Masci E, Viale E, Notaristefano C, et al. Endoscopic mucosal resection in high- and
low-volume centers: a prospective multicentric study. Surgical endoscopy. 2013;27:3799-3805.
1552.
Mori Y, Kudo S, Ikehara N, et al. Comprehensive diagnostic ability of endocytoscopy
compared with biopsy for colorectal neoplasms: a prospective randomized noninferiority trial.
Endoscopy. 2013;45:98-105.
1553.
Nakajima K, Takahashi S, Saito N, et al. Efficacy of the predicted operation time (POT)
strategy for synchronous colorectal liver metastasis (SCLM): feasibility study for staged resection
in patients with a long POT. Journal of gastrointestinal surgery : official journal of the Society for
Surgery of the Alimentary Tract. 2013;17:688-695.
1554.
Ng SS, Leung WW, Mak TW, et al. Electroacupuncture reduces duration of
postoperative ileus after laparoscopic surgery for colorectal cancer. Gastroenterology.
2013;144:307-313 e301.
1555.
Nielsen HJ, Jess P, Aldulaymi BH, et al. Early detection of recurrence after curative
resection for colorectal cancer - obstacles when using soluble biomarkers? Scandinavian journal of
gastroenterology. 2013;48:326-333.
1556.
Nurkin S, Kakarla VR, Ruiz DE, Cance WG, Tiszenkel HI. The role of faecal diversion
in low rectal cancer: a review of 1791 patients having rectal resection with anastomosis for cancer,
with and without a proximal stoma. Colorectal disease : the official journal of the Association of
Coloproctology of Great Britain and Ireland. 2013;15:e309-316.
1557.
Pappas-Gogos G, Tellis C, Lasithiotakis K, et al. Oxidative stress markers in
laparoscopic versus open colectomy for cancer: a double-blind randomized study. Surgical
endoscopy. 2013;27:2357-2365.
1558.
Park JW, Sohn DK, Park S, et al. Safety and efficacy of single-port colectomy for
sigmoid colon cancer: a phase II clinical trial. Journal of laparoendoscopic & advanced surgical
techniques. Part A. 2013;23:745-750.
1559.
Penninckx F, Kartheuser A, Van de Stadt J, et al. Outcome following laparoscopic and
open total mesorectal excision for rectal cancer. The British journal of surgery.
2013;100:1368-1375.
1560.
Pettersson D, Glimelius B, Iversen H, Johansson H, Holm T, Martling A. Impaired
postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm
III Trial. The British journal of surgery. 2013;100:969-975.
1561.
Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during
colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology.
2013;144:74-80 e71.
1562.
Ptok H, Ruppert R, Stassburg J, et al. Pretherapeutic MRI for decision-making regarding
selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric
prospective
observational
study.
Journal
of
magnetic
resonance
imaging
:
JMRI.
2013;37:1122-1128.
1563.
Qiao Y, Ren H, Huang Y, et al. [Impact of CCND1 A870G polymorphism on acute
adverse events in postoperative rectal cancer patients treated with adjuvant concurrent
chemoradiotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2013;35:268-272.
1564.
Repici A, Hassan C, Radaelli F, et al. Accuracy of narrow-band imaging in predicting
colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a
multicenter, prospective trial. Gastrointestinal endoscopy. 2013;78:106-114.
1565.
Saber A, Hokkam EN. Efficacy of protective tube cecostomy after restorative resection
for colorectal cancer: a randomized trial. International journal of surgery (London, England).
2013;11:350-353.
1566.
Scarpa M, Di Cristofaro L, Cortinovis M, et al. Minimally invasive surgery for
colorectal cancer: quality of life and satisfaction with care in elderly patients. Surgical endoscopy.
2013;27:2911-2920.
1567.
Schiessling S, Leowardi C, Kienle P, et al. Laparoscopic versus conventional ileoanal
pouch procedure in patients undergoing elective restorative proctocolectomy (LapConPouch
Trial)-a randomized controlled trial. Langenbeck's archives of surgery / Deutsche Gesellschaft fur
Chirurgie. 2013;398:807-816.
1568.
Schricker T, Wykes L, Meterissian S, et al. The anabolic effect of perioperative nutrition
depends on the patient's catabolic state before surgery. Annals of surgery. 2013;257:155-159.
1569.
Shcherba SN, Polovinkin VV. [A method for reducing suppurative septic complications
in the perineal wound after cylindrical extralevatory extirpation of the rectum in cancer patients].
Voprosy onkologii. 2013;59:132-133.
1570.
Simunovic M, Coates A, Smith A, Thabane L, Goldsmith CH, Levine MN. Uptake of an
innovation in surgery: observations from the cluster-randomized Quality Initiative in Rectal
Cancer trial. Canadian journal of surgery. Journal canadien de chirurgie. 2013;56:415-421.
1571.
Snijders HS, van den Broek CB, Wouters MW, et al. An increasing use of defunctioning
stomas after low anterior resection for rectal cancer. Is this the way to go? European journal of
surgical oncology : the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 2013;39:715-720.
1572.
Theodoropoulos GE, Papanikolaou IG, Karantanos T, Zografos G. Post-colectomy
assessment of gastrointestinal function: a prospective study on colorectal cancer patients.
Techniques in coloproctology. 2013;17:525-536.
1573.
Trastulli S, Desiderio J, Farinacci F, et al. Robotic right colectomy for cancer with
intracorporeal anastomosis: short-term outcomes from a single institution. International journal of
colorectal disease. 2013;28:807-814.
1574.
van den Broek CB, Vermeer TA, Bastiaannet E, Rutten HJ, van de Velde CJ, Marijnen
CA. Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal
cancer patients. European journal of cancer (Oxford, England : 1990). 2013;49:3131-3139.
1575.
van der Vorst JR, Schaafsma BE, Hutteman M, et al. Near-infrared fluorescence-guided
resection of colorectal liver metastases. Cancer. 2013;119:3411-3418.
1576.
Walter CJ, Maxwell-Armstrong C, Pinkney TD, et al. A randomised controlled trial of
the efficacy of ultrasound-guided transversus abdominis plane (TAP) block in laparoscopic
colorectal surgery. Surgical endoscopy. 2013;27:2366-2372.
1577.
Wang JH, King TM, Chang MC, Hsu CW. Drainage placement through the
extraperitoneal tunnel can prevent its postoperative dislodgement effectively in laparoscopic rectal
surgery. Surgical laparoscopy, endoscopy & percutaneous techniques. 2013;23:410-414.
1578.
Wang JP, Lin YD, Wang L, et al. [Effect of intermittent pneumatic compression on
coagulation function and deep venous hemodynamics of lower limbs after rectal cancer resection].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2013;16:739-743.
1579.
Wang W, Wang R, Wang Y, et al. Preoperative colonic lesion localization with charcoal
nanoparticle tattooing for laparoscopic colorectal surgery. Journal of biomedical nanotechnology.
2013;9:2123-2125.
1580.
Wang ZH, Zhong B, Xiang JY, Zhou YB, Wang DS. [Effect of early oral enteral
nutrition on clinical outcomes after colorectal cancer surgery]. Zhonghua wei chang wai ke za zhi
= Chinese journal of gastrointestinal surgery. 2013;16:735-738.
1581.
Wolff HA, Conradi LC, Beissbarth T, et al. Gender affects acute organ toxicity during
radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase
III trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology
and Oncology. 2013;108:48-54.
1582.
Yamamoto S, Ito M, Okuda J, et al. Laparoscopic surgery for stage 0/I rectal carcinoma:
short-term outcomes of a single-arm phase II trial. Annals of surgery. 2013;258:283-288.
1583.
Yang L, Huang XE, Zhou JN. Risk assessment on anastomotic leakage after rectal
cancer surgery: an analysis of 753 patients. Asian Pacific journal of cancer prevention : APJCP.
2013;14:4447-4453.
1584.
Young JM, Butow PN, Walsh J, et al. Multicenter randomized trial of centralized
nurse-led telephone-based care coordination to improve outcomes after surgical resection for
colorectal cancer: the CONNECT intervention. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology. 2013;31:3585-3591.
1585.
Zhao WT, Hu FL, Li YY, Li HJ, Luo WM, Sun F. Use of a transanal drainage tube for
prevention of anastomotic leakage and bleeding after anterior resection for rectal cancer. World
journal of surgery. 2013;37:227-232.
1586.
Boelens PG, Heesakkers FF, Luyer MD, et al. Reduction of postoperative ileus by early
enteral nutrition in patients undergoing major rectal surgery: prospective, randomized, controlled
trial. Annals of surgery. 2014;259:649-655.
1587.
Brown SR, Mathew R, Keding A, Marshall HC, Brown JM, Jayne DG. The impact of
postoperative complications on long-term quality of life after curative colorectal cancer surgery.
Annals of surgery. 2014;259:916-923.
1588.
Das P, Eng C, Rodriguez-Bigas MA, et al. Preoperative radiation therapy with
concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. International
journal of radiation oncology, biology, physics. 2014;88:301-305.
1589.
Halabi WJ, Kang CY, Nguyen VQ, et al. Epidural analgesia in laparoscopic colorectal
surgery: a nationwide analysis of use and outcomes. JAMA surgery. 2014;149:130-136.
1590.
Henneman D, van Bommel AC, Snijders A, et al. Ranking and rankability of hospital
postoperative mortality rates in colorectal cancer surgery. Annals of surgery. 2014;259:844-849.
1591.
Hu JJ, Liang JW, Wang Z, et al. Short-term outcomes of laparoscopically assisted
surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.
The Journal of surgical research. 2014;187:438-444.
1592.
Kashihara H, Shimada M, Kurita N, et al. Comparisons of inflammatory cytokines
expressions in drain after laparoscopic versus open surgery. Hepato-gastroenterology.
2014;61:379-381.
1593.
Ortiz H, Ciga MA, Armendariz P, et al. Multicentre propensity score-matched analysis
of conventional versus extended abdominoperineal excision for low rectal cancer. The British
journal of surgery. 2014;101:874-882.
1594.
Patel SA, Chen YH, Hornick JL, et al. Early-stage rectal cancer: clinical and pathologic
prognostic markers of time to local recurrence and overall survival after resection. Diseases of the
colon and rectum. 2014;57:449-459.
1595.
Sadahiro S, Suzuki T, Tanaka A, et al. Comparison between oral antibiotics and
probiotics as bowel preparation for elective colon cancer surgery to prevent infection: prospective
randomized trial. Surgery. 2014;155:493-503.
1596.
Schachschal G, Mayr M, Treszl A, et al. Endoscopic versus histological characterisation
of polyps during screening colonoscopy. Gut. 2014;63:458-465.
1597.
Sorensen LS, Thorlacius-Ussing O, Schmidt EB, et al. Randomized clinical trial of
perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery. The British
journal of surgery. 2014;101:33-42.
1598.
Tanaka A, Sadahiro S, Suzuki T, Okada K, Saito G. Randomized controlled trial
comparing subcuticular absorbable suture with conventional interrupted suture for wound closure
at elective operation of colon cancer. Surgery. 2014;155:486-492.
1599.
van Bree SH, Bemelman WA, Hollmann MW, et al. Identification of clinical outcome
measures for recovery of gastrointestinal motility in postoperative ileus. Annals of surgery.
2014;259:708-714.
1600.
Waits SA, Fritze D, Banerjee M, et al. Developing an argument for bundled
interventions to reduce surgical site infection in colorectal surgery. Surgery. 2014;155:602-606.
1601.
Williams JP, Nyasavajjala SM, Phillips BE, Chakrabarty M, Lund JN. Surgical resection
of primary tumour improves aerobic performance in colorectal cancer. European journal of
surgical oncology : the journal of the European Society of Surgical Oncology and the British
Association of Surgical Oncology. 2014;40:220-226.
1602.
Yaegashi M, Otsuka K, Itabashi T, et al. Daikenchuto stimulates colonic motility after
laparoscopic-assisted colectomy. Hepato-gastroenterology. 2014;61:85-89.
1603.
Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the
treatment of hepatic metastases from neuroendocrine tumor. World journal of gastroenterology :
WJG. 2014;20:14348-14358.
1604.
Bhalla A, Sandhu F, Sieber S. Primary adrenal leiomyosarcoma: a case report and
review of the literature. Connecticut medicine. 2014;78:403-407.
1605.
Chung H, Chapman WC. Liver transplantation for metastatic neuroendocrine tumors.
Advances in surgery. 2014;48:235-252.
1606.
Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. Journal of
gastrointestinal oncology. 2014;5:374-387.
1607.
D'Haese JG, Tosolini C, Ceyhan GO, et al. Update on surgical treatment of pancreatic
neuroendocrine neoplasms. World journal of gastroenterology : WJG. 2014;20:13893-13898.
1608.
Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with
multiple liver metastases. World journal of hepatology. 2014;6:596-600.
1609.
Kolbeck KJ, Farsad K. Catheter-based treatments for hepatic metastases from
neuroendocrine tumors. AJR. American journal of roentgenology. 2014;203:717-724.
1610.
Kopljar M, Patrlj L, Busic Z, et al. Potential use of Doppler perfusion index in detection
of occult liver metastases from colorectal cancer. Hepatobiliary surgery and nutrition.
2014;3:259-267.
1611.
Lahat E, Eshkenazy R, Zendel A, et al. Complications after percutaneous ablation of
liver tumors: a systematic review. Hepatobiliary surgery and nutrition. 2014;3:317-323.
1612.
Magata H, Kondo K, Otani K, et al. [A case of long-term survival after low-dose FP
systemic chemotherapy for a tumor thrombus in the inferior caval vein and multiple lung
metastases from recurrent hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer &
chemotherapy. 2014;41:1147-1150.
1613.
Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant
chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a
systematic review of comparative studies. The surgeon : journal of the Royal Colleges of Surgeons
of Edinburgh and Ireland. 2014.
1614.
Park J, Chen YJ, Lu WP, Fong Y. The Evolution of Liver-Directed Treatments for
Hepatic Colorectal Metastases. Oncology (Williston Park, N.Y.). 2014;28.
1615.
Patrlj L, Kopljar M, Klicek R, et al. The surgical treatment of patients with colorectal
cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary surgery and
nutrition. 2014;3:324-329.
1616.
Rossi RE, Massironi S, Conte D, Peracchi M. Therapy for metastatic pancreatic
neuroendocrine tumors. Annals of translational medicine. 2014;2:8.
1617.
Treasure T, Milosevic M, Fiorentino F, Pfannschmidt J. History and present status of
pulmonary metastasectomy in colorectal cancer. World journal of gastroenterology : WJG.
2014;20:14517-14526.
1618.
Wei IH, Healy MA, Wong SL. Surgical treatment options for stage IV melanoma. The
Surgical clinics of North America. 2014;94:1075-1089, ix.
1619.
Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A. "Vanishing liver
metastases"-A real challenge for liver surgeons. Hepatobiliary surgery and nutrition.
2014;3:295-302.